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Recent re-evaluations of dietary reference intakes/values (DRI/DRV) for vitamin D on either 
side of the Atlantic have established intake requirements at the 97.5th percentile between 10 
and 20 µg/d, and between 7.5 and 10 µg/d  at the 50th percentile (overviewed in Chapter 2).  
National nutrition surveys indicate that mean habitual intakes of vitamin D in young and adult 
populations are typically in the range 3-7 µg/d. As vitamin D supplementation will not be 
effective at a population level because the uptake is generally low, creative food-based 
solutions are needed to bridge the gap between current intakes and these new requirement 
values, and so as to counteract vitamin D inadequacy in Europe and elsewhere. 
 
While DRV/DRI for vitamin D are established on the premise that the needs of all other 
nutrients are being met, in practice this may not always be the case where calcium intakes, for 
example, can be inadequate for a significant portion of the population. The US Dietary 
Guidelines Committee has again recently identified both vitamin D and calcium as nutrients 
of public health concern. This is of consequence as there are some animal studies and older 
human data to suggest that a low calcium intake may lead to the increased degradation of 
serum 25-hydroxyvitamin D [25(OH)D], thus potentially increasing the dietary requirement 
for vitamin D. The US-based Institute of Medicine in their DRI report on calcium and vitamin 
D highlighted that the relationship between habitual calcium intakes and vitamin D activation 
and catabolism was a key knowledge gap.  We performed post-hoc analysis of data from our 
previous placebo-controlled, dose-related, vitamin D randomized controlled trials (RCTs) and, 
in addition, undertook a new specifically designed double-blind, randomised, placebo 
controlled intervention trial (Chapter 3), to address this important area.  Collectively, the data 
showed that dietary calcium does not interact with vitamin D3 in terms of determining the 
response and catabolism of serum 25(OH)D during winter in older adults, and thus the dietary 
vitamin D requirement is not altered by typical calcium intakes within the population ranging 
from low to high. This data contributes to a sound scientific basis for development of not only 
DRV but also nutrition policy and supplementation/fortification programmes for ensuring 
adequate vitamin D status in the population. 
 
Biofortification of food with vitamin D is a novel approach aimed at improving the dietary 
availability of vitamin D from the current food supply and by that means, increasing the 
distribution of vitamin D intakes in the population. This method, whereby the vitamin D 
content of the animal diet is increased and thus is incorporated into animal tissues, and 
ultimately consumed by humans, was tested in a number of animal feeding trials (in hens, pigs 
and beef heifers) which adhered to the EU upper allowable level of addition of vitamin D 





vitamin D activity of pork and beef meat, but particularly eggs, can be increased by this 
approach, and also the resulting food produce which had a good consumer acceptability 
profile, based on the data from sensory trials.  For example, vitamin D biofortifed eggs were 
shown to have ~5 g vitamin D per medium egg, which would supply half the IOM’s 
estimated average requirement for vitamin D.  Importantly, we also provided the first RCT 
evidence, to our knowledge, that consumption of seven of these vitamin D biofortified eggs 
per week, which does not conflict with healthy eating guidelines, helped to maintain serum 
25(OH)D concentrations over winter months, and prevented the occurrence of vitamin D 
deficiency, as evidenced in a control group who consumed up to 2 commercial eggs per week 
(Chapter 5). 
 
As new roles for vitamin K emerge beyond coagulation, there is increased interest in 
measuring vitamin K status in population-based studies, particularly, nationally representative 
samples. In this regard, the present work (Chapter 6) estimated phylloquinone intakes and, in 
addition for the first time assessed a biomarker of vitamin K status (percent undercarboxylated 
osteocalcin in serum [%ucOC]), in a representative sample of Irish adults aged 18-90 years. 
The data suggest that a significant portion of Irish adults may have intakes of vitamin K that 
are likely inadequate. This finding may have implications for bone health, as the present study 
showed an association between a serum %ucOC and a serum-based biochemical marker of 
bone resorption. Thus, strategies to increase phylloquinone intakes in the Irish population may 
need to be considered. 
 
Overall, the collective findings of this thesis will contribute to advancement of knowledge in 
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The classic role of vitamin D is to regulate calcium absorption and homeostasis and thus, 
prevent the development of rickets in infancy, facilitate bone growth in children and, to 
help reduce risk of osteomalcia in adults (Jones et al, 1998). In more recent times, and 
stemming from the greater recognition of vitamin D’s non-calcemic roles, low vitamin D 
status has been associated with cardiovascular outcomes, all-cause mortality, several types 
of cancer, amongst other health outcomes (Newberry et al, 2014). While there are many 
controversial issues in relation to the impact of vitamin D intake and status on human 
health, there is general agreement that prevention of vitamin D deficiency is a public health 
priority. However, vitamin D deficiency is evident worldwide (van Schoor & Lips, 2013), 
and recent data show that 13% of European individuals have serum 25-hydroxyvitamin D 
[25(OH)D] concentration <30 nmol/L on average in the year (Cashman et al, 2016). These 
first pan-European data to quantify the scale of vitamin D deficiency, using one of the most 
conservative international thresholds to define deficiency, again dramatically underscores 
the urgent need for responsive public health strategies to address this public health 
problem.   
Vitamin D dietary requirement recommendations [known as Dietary Reference Intakes 
(DRI) in the US and Dietary Reference Values (DRV) in Europe] are crucial from a public 
health perspective in providing a framework for prevention of vitamin D deficiency and 
optimizing vitamin D status of individuals. Their development is an iterative process and 
is based on the knowledge that is available at the time (Cashman & Kiely, 2011).  The 
explosion in scientific research in vitamin D and health over the last two decades has led 
to a dramatically increased evidence-base in relation to vitamin D and has prompted several 
regulatory agencies to re-evaluate their DRV/DRI (Cashman, 2015; and overviewed in 
Chapter 2 of this thesis). At the conclusion of DRI and DRV development processes, the 
associated reports highlight key knowledge gaps that need to be addressed by research to 
inform future revisions of these vitamin D recommendations.  The Institute of Medicine 
(IOM) in the US was the first in the modern era to complete their most comprehensive re-
evaluation of vitamin D requirements.  In their 2011 DRI report, the committee highlighted 
a considerable number of key knowledge gaps and associated research needs (IOM, 2011).  
Many of these identified key knowledge gaps in relation to vitamin D will impact on the 
work of other agencies in Europe, who likewise were about to begin the process of re-
evaluation of their own vitamin D DRVs. We had noted in particular that the vitamin D 
DRI established by the IOM in 2011, as per convention, was based on the assumption that 
the requirement for dietary calcium was being achieved (IOM, 2011), however a significant 
portion of adult populations in Europe and North America fail to meet respective dietary 





inadequate calcium intakes to cause changes in the efficient handling of, or physiological 
response to, vitamin D that might not otherwise be present.  This could translate into higher 
vitamin D dietary requirements.  This priority research question framed the initial aim of 
my PhD’s research programme, outlined in the Workflow diagram at the end of this section, 
namely to elucidate the relationship between habitual calcium intakes and the dietary 
vitamin D requirement. The research conducted to address this knowledge gap is presented 
in Chapter 3 and contributed to several published papers.  
 
As will be discussed in Chapter 2, the DRV/DRI established by several key agencies over 
the last 5 years, are important public health instruments and can act as vitamin D intake 
targets. The low dietary vitamin D intakes in European populations, as outlined 
comprehensively by Vinas et al. (2011), highlight the fact that the current food supply 
(even including current food fortification and vitamin D supplementation practices) is not 
enough to meet these dietary vitamin D targets.  These low intakes undoubtedly contribute 
to the wide-scale low vitamin D status in Europe (Cashman et al. 2016).  Thus, strategies 
to increase the distribution of vitamin D intakes and reduce the prevalence of vitamin D 
deficiency in the population are paramount.  Such approaches include: encouraging greater 
consumption of vitamin D-rich foods, vitamin D supplementation and food fortification 
policies, and potentially including ‘biofortification’. Natural sources of vitamin D in the 
diet are limited and many are infrequently consumed (Black et al, 2014), thus 
recommendations to increase intakes of current vitamin D sources are unlikely to succeed 
in improving vitamin D intakes. Supplementation has been shown to significantly improve 
serum 25(OH)D concentrations in a dose-related manner, across population sub groups 
(Cashman & Kiely 2011; Cashman et al. 2011; Whiting et al. 2015). However, 
supplementation with vitamin D, while effective in those who consume them, is not a 
suitable public health policy, as uptakes are typically lower than 40% in the population 
(Fulgoni et al. 2011; Whiting et al. 2011; Black et al. 2015). Current fortification practices 
do significantly contribute to vitamin D intakes but are not effective at increasing vitamin 
D intakes across the population. For example, Fulgoni et al. (2011) reported using 
NHANES (2003-2006) data that 69.5% of the US population over 2 years of age did not 
achieve the Estimated Average Requirement (EAR) of 10 g/d set by IOM, even after 
accounting for the contribution of supplement usage and consumption of vitamin D 
fortified foods. The percentage of the population with intakes below the EAR is an 
indicator of the degree of inadequacy of nutrient intake in that population.  Two systematic 
reviews of available RCT data have highlighted that food fortification is effective in 
increasing serum 25(OH)D concentrations (O’Donnell et al, 2008; Black et al, 2012), and 





population. However, it has also been suggested that the selection of available fortified 
foods should be expanded to accommodate diversity in the diet (Vantanparast et al, 2010; 
Black et al, 2012; Cashman & Kiely, 2016).  In this regard, there is a need for creative 
food-based solutions that are effective across the whole population.  
 
Biofortification of food with vitamin D is a novel approach aimed at improving the dietary 
availability of vitamin D from the current food supply and by that means, increasing the 
distribution of vitamin D intakes in the population. In this approach, animal produce (such 
as, for example, cultured fish, beef, pork, lamb, chicken, and eggs) could have increased 
vitamin D and/or 25-hydroxyvitamin D contents by virtue of addition of vitamin D and/or 
25-hydroxyvitamin D (where permissible) to the livestock feeds.  This method also has the 
benefit of improving the levels of 25-hydroxyvitamin D in the food, in addition to vitamin 
D per se, which could boost the overall effectiveness of these foods in raising vitamin D 
status (Cashman et al, 2015).  Findings from numerous animal feeding trials (in hens, pigs 
and cattle) form a very strong evidence-base to illustrate that this biofortification approach 
leads to animal produce (eggs and meat) with much improved vitamin D content (as 
reviewed in Chapter 2), however, the difficulty with this evidence-base is that the majority 
of these previous studies in hens, pigs or cattle included levels of vitamin D and/or HyD® 
(as commercially available 25-hydroxyvitamin D) in the feed in excess of the EU allowable 
maximum levels for use in respective feeds. Accordingly, Chapter 4 of the present thesis 
focuses on the feasibility of biofortification of animal sources with vitamin D, using levels 
of vitamin D3 and/or 25-hydroxyvitamin D3 (commercially available as HyD®) that comply 
with EU regulations, and whereby the resulting foods would be fit for human consumption. 
The impact of several combinations of vitamin D and/or HyD®, where permissible, on 
vitamin D content of the resulting produce was determined through a series of animal trials 
in laying hens, pigs and beef heifers performed in Lyons Research Farm in collaboration 
with our colleagues in University College Dublin.  Provision of evidence of effectiveness 
of food fortification approaches from randomized controlled trails (RCTs) which evaluate 
their impact on reducing the prevalence of vitamin D deficiency in the populations studied 
is a key priority in terms of the evidence-base (Cashman & Kiely, 2011).  Thus, Chapter 5 
in the present thesis presents our new RCT data (just accepted for publication) on the 
effectiveness of vitamin D biofortified eggs (arising from the work in Chapter 4) in 
protecting against low serum 25(OH)D concentrations in adults in winter.  
 
In a separate and final piece of my PhD’s research programme, we aimed to gain some 
insight into vitamin K status in a nationally representative sample of Irish adults (Chapter 
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Chapter 7 - General discussion 
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There is widespread acknowledgement of the presence of vitamin D deficiency in the 
community and the pressing need from a public health perspective to address this deficiency 
(Cashman & Kiely, 2011). Taking a serum 25-hydroxyvitamin D [25(OH)D] concentration of 
30 nmol/L as the cut-off below which the risk of clinical vitamin D deficiency increases 
(manifesting as nutritional rickets in children and osteomalacia in adults) (IOM, 2011; Munns 
et al, 2016), prevalences of vitamin D deficiency based on standardized serum 25(OH)D data 
from representative population samples in the United States (US) (n=15,652) (Schleicher et 
al, 2016), Canada (n=11,336) (Sarafin et al, 2015) and Europe (n= 55,844) (Cashman et al, 
2016a) have been recently reported as 5.9%, 7.4% and 13%, respectively. Even a crude 
estimation based on the magnitude of populations in these three regions and the above 
prevalences suggests something in the region of 120 million individuals are deficient.  
 
Dietary reference intervals for vitamin D, which are estimates of the dietary requirements for 
vitamin D, are crucial from a public health perspective in providing a framework for 
prevention of vitamin D deficiency and optimizing vitamin D status of individuals (Cashman, 
2015). While in North America the term used to describe the distribution of dietary 
requirements is Dietary Reference Intakes (DRI), its equivalent in Europe is Dietary Reference 
Values (DRV) (Cashman, 2012a). An enormous body of research in relation to various aspects 
of vitamin D and health over the last decade and a half has been instrumental in informing 
recent DRV/DRI for vitamin D (Cashman, 2015). While there are a family of nutrient 
reference values within the DRI and DRV, two shared constituent values within both, and 
which are of key public health importance, are the Estimated Average Requirement (EAR) 
and the Recommended Dietary Allowance (RDA; or its equivalent). The EAR is the level of 
(nutrient) intake that is adequate for half of the people in a population group, and also serves 
as the basis for calculating the RDA (or equivalent), a value intended to meet the needs of 
nearly all (i.e., 97.5%) healthy individuals in a population (IOM, 2011; EFSA, 2010). Despite 
the fact that the DRI/DRV for vitamin D have been re-evaluated on either side of the Atlantic 
in the last 5 years (Cashman, 2015), and have resulted in quite contrasting recommendations 
(see below), nevertheless, they collectively point very strongly towards a need for creative 
food-based approaches for prevention of vitamin D deficiency and maintenance of nutritional 
adequacy.  However, persistent knowledge gaps are barriers to developing and implementing 
safe and effective food-based approaches towards prevention of vitamin D deficiency 
(Cashman & Kiely, 2015). The present review will first of all concisely overview current 
DRI/DRV for vitamin D as key dietary targets. It will then also briefly benchmark current 
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intakes of vitamin D in selected representative samples in Europe and North America against 
these dietary targets, and, finally, it will consider means of addressing the gap between current 
intakes and these dietary targets. In particular, focus will be placed on the area of fortification 
of food with vitamin D, and especially ‘bio-fortification’ with vitamin D, as a means of 
increasing the distribution of vitamin D intake in the population to prevent vitamin D 
deficiency. These three aspects of dietary vitamin D in the present review were the central 
thrust of one of the authors’ (AH) accompanying presentation at the Nutrition Society (NS) 
Irish Section Postgraduate Conference in Cork in 2016. 
2.2 Dietary Reference Intakes/Values from North America, the United Kingdom 
and European Union: variable estimates of dietary vitamin D requirement  
 
It is important to re-iterate that devising nutrient recommendations for population intakes 
relies on scientific analysis and judgement of data that exist within a specified time frame and 
is an iterative process (Cashman & Kiely, 2011). It is notable in that context, that within the 
last five years there have been re-evaluations of vitamin D recommendations by at least 6 
expert bodies on either side of the Atlantic, and four of these have been reviewed in detail 
elsewhere (Cashman, 2012a; 2015; Cashman & Kiely; 2014; 2016). For this present work, we 
will focus on the two very most recent DRV in Europe, namely those from the Scientific 
Advisory Committee on Nutrition [SACN] in the United Kingdom (UK) (SACN, 2016) and 
the European Food Safety Authority [EFSA] (EFSA, 2016), as well as referencing the DRI 
from the Institute of Medicine [IOM] in the US (IOM, 2011), as their most current 
recommendations but also a landmark evaluation and report in the current era of dietary 
requirement estimates for vitamin D. Of note, despite being based on a largely similar 
underpinning scientific evidence-base, there is significant variation in the recommendations 
from these 3 sets of DRI/DRV (see below). It is not within the scope of the present review to 
explore in detail all the reasons why the recent DRI/DRV differ, but in the context of 
considering food-based solutions for prevention of vitamin D deficiency, it is worth 
summarizing briefly what these 3 agencies established as the DRI/DRV and also based on 
what criteria to establish nutrient adequacy for vitamin D.  All 3 agencies used serum 
25(OH)D as the biochemical indicator of vitamin D exposure/status (IOM, 2011; SACN, 
2016; EFSA, 2016). This is not surprising as it has been shown to be a robust indicator of 
vitamin D status (Seamans & Cashman, 2009), albeit with some potential limitations 
(Cashman & Kiely, 2011). All three agencies adhered to the risk assessment framework for 
DRI/DRV development and, as such, following a review of the evidence-base in relation to 
vitamin D and health (skeletal and non-skeletal) effects, all three agencies used (musculo-
)skeletal health outcomes (and in addition EFSA used pregnancy-related health outcomes) 
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upon which to base the development of their respective DRI/DRV (IOM, 2011; SACN, 2016; 
EFSA, 2016).  The IOM’s DRI committee selected calcium absorption, bone mineral density 
(BMD) and either rickets in children or osteomalacia in adults, for which the evidence was 
sufficiently strong, for DRI development for vitamin D (IOM, 2011). SACN selected 
musculoskeletal health (rickets, osteomalacia, falls, muscle strength and function, depending 
on age group) (SACN, 2016), whereas EFSA considered that the available evidence on serum 
25(OH)D concentration and musculoskeletal health outcomes and pregnancy-related health 
outcomes were suitable to set DRVs for vitamin D for adults, infants, children, and pregnant 
women, respectively (EFSA, 2016).  
 
Even though the DRI/DRV were majorly influenced by bone-related health outcomes, the 
choice of these different individual outcomes, either collectively or individually, influenced 
the selection of serum 25(OH)D concentration(s) upon which to base the DRI/DRV (Table 
1). The IOM’s DRI committee established a serum 25(OH)D concentration of 40 nmol/L as 
the median value above which approximately half the population might meet its vitamin D 
requirement in terms of bone health (and below which half might not; and which formed the 
basis for establishment of their EAR) and 50 nmol/L as its estimate of the serum 25(OH)D 
concentration that would meet the requirement of nearly all (i.e. 97.5 %) “normal healthy 
persons”, and which thus formed the basis of the establishment of their RDA (IOM, 2011). 
The EFSA panel concluded that a serum 25(OH)D concentration of 50 nmol/L is a suitable 
target value to set the DRVs for vitamin D, for all age and sex groups (adults, infants, children, 
pregnant and lactating women) (EFSA, 2016). In contrast, SACN considered that the evidence 
overall suggested the risk of poor musculoskeletal health was increased at serum 25(OH)D 
concentrations below ~20-30 nmol/L (SACN, 2016). They felt it was not possible to identify 
a specific serum 25(OH)D threshold concentration between 20-30 nmol/L associated with 
increased risk of poor musculoskeletal health due to different analytical methods for serum 
25(OH)D used in the various studies, so decided to retain the previously used 25 nmol/L 
(SACN, 2016). This previous threshold was used to indicate increased risk of vitamin D 
deficiency as relates to rickets and osteomalacia (DOH, 1991), which is largely consistent with 
the 30 nmol/L which the IOM DRI committee had indicated reflects increased risk of vitamin 
D deficiency (IOM, 2011). Furthermore, SACN suggested that the use of 25 nmol/L represents 
a ‘population protective level’ in that it is a concentration that individuals in the UK should 
be above, throughout the year, in terms of protecting musculoskeletal health (SACN, 2016). 
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Table 1. Selected Dietary Reference Values/Intakes for vitamin D*. 
 












Age group (g/d) 
0-6 months 8.5-10¶ - - 10‡ 
7-12 months 8.5-10¶ 
 
10 - 10‡ 
1-3 years 10¶ 15 10 15 
4-6 years 10 15 10 15 
7-8 years 10 15 10 15 
9-10 years 10 15 10 15 
11-14 years 10 15 10 15 
15-17 years 10 15 10 15 
18-64 years 10 15 10 15 
65+ years 10¶ 15 10 15 (20 for 
70+ years) 
Pregnancy 10¶ 15 10 15 
Lactation 10¶ 15 10 15 
  
DRI, Dietary Reference Intakes; DRV, Dietary Reference Values/; RNI, Reference Nutrient 
Intake; AI, Adequate Intake; RDA, Recommended Dietary Allowance; EAR, Estimated 
Average Requirement; 25(OH)D, 25-hydroxyvitamin D 
*All established under conditions of minimal cutaneous vitamin D synthesis 
To convert vitamin D reference intakes from g/d to IU/d, multiply by 40. 
¶Set as a Safe Intake; set for some nutrients if there were insufficient data to set DRVs.  They 
are judged to be a level or range of intake at which there is no risk of deficiency, and below a 
level of where there are undesirable effects (DoH, 1991).  
‡Set as Adequate Intake.  
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Using these various serum 25(OH)D target concentrations, the 3 expert bodies were able to 
derive dietary requirement estimates which form their respective DRI/DRV for vitamin D 
Both IOM and EFSA used a meta-regression approach on data from winter-based vitamin D 
randomized controlled trials (RCTs) which reported serum 25(OH)D response (IOM, 2011; 
EFSA, 2016), while SACN used requirement estimates derived from analysis and modelling 
of individual subject-level data from what they considered as 3 highly UK-appropriate vitamin 
D dose-related RCTs (Cashman et al, 2008; 2009; 2011a), all of which focussed on the 
estimation of vitamin D dietary requirements in different population age-groups. The pros and 
cons of these two different approaches have been well versed elsewhere (Cashman et al, 
2011b; IOM, 2011; Cashman, 2015; SACN, 2016; EFSA, 2016), but undoubtedly contribute 
to intake estimates which differ dramatically, even if one uses the same serum 25(OH)D target 
concentration (Cashman et al, 2011b). Irrespective of this, it is notable that while all three 
agencies have an EAR and RDA (or equivalent) available within their family of respective 
DRV/DRI, the IOM established EAR and RDA values for most age-groups (IOM, 2011), 
while SACN established only a Reference Nutrient Intake (RNI, an RDA equivalent) for most 
age-groups but not an EAR (because there is never as high as 50% with serum 25(OH)D <25 
nmol/L, prohibiting its estimation) (SACN, 2016), and EFSA established Adequate Intake 
values in place of either EARs or Population Reference Intakes (PRI; their RDA equivalent) 
(EFSA, 2016) (Table 1). EFSA in their 2010 scientific opinion on principles for deriving and 
applying DRV had proposed that an AI should be derived when a PRI cannot be established 
for a nutrient because an EAR cannot be determined (EFSA, 2010). An AI is the average 
observed daily level of intake by a population group (or groups) of apparently healthy people 
that is assumed to be adequate (EFSA, 2010). To illustrate the variability in the current 
recommendations, if one selects adults aged 18-64 years as an example, the vitamin D intakes 
established to ensure the adequacy of the vast majority of individuals (97.5%) in either North 
America or the European Union are 15 g/d (with serum 25(OH)D at 50 nmol/L as the target), 
10 g/d will meet the needs of half the individuals in North America (again at 50 nmol/L as 
the target), whereas in the UK, 10 g/d will  ensure the adequacy of the vast majority of 
individuals but using serum 25(OH)D at 25 nmol/L as the target (see Table 1).  
 
Not only do the types of DRV/DRI that the 3 different agencies established differ, so too does 
their application from a public health nutrition perspective in terms of assessing the risk of 
(in)adequacy of nutrient intake in populations. For example, EFSA in their 2010 opinion on 
general principles for development and application of DRV suggest that the EAR can be used 
to estimate the prevalence of inadequate intakes of micronutrients (the Average Requirement 
cut-point method), if the distribution of nutrient intakes is normal, and intakes are independent 
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from requirements (EFSA, 2010). The percentage of the population with a habitual daily 
nutrient intake that is lower than the EAR is taken as an estimate of the percentage of the 
population with probable inadequate intakes. Thus, the IOM established EAR (IOM, 2011) 
can be utilized in this context in terms of nutritional surveillance. The RDA (and RNI/PRI) is 
an intake level that covers the requirement of 97.5% of all individuals when requirements of 
the group have a normal distribution (IOM, 2011; SACN, 2016; EFSA, 2016), it should 
therefore not be used as a cut-point for assessing nutrient intakes of groups because a certain 
overestimation of the proportion of the group at risk of inadequacy would result (EFSA, 2010). 
The current North American RDA (IOM, 2011) and UK RNI (SACN, 2016), however, will 
have application in terms of assessing diets of individuals (EFSA, 2010; Cashman, 2012a). 
Groups with mean intakes at or above the AI (as established by EFSA and for infants and/or 
young children by IOM and SACN) can be assumed to have a low prevalence of inadequate 
intakes for the defined criterion of nutritional status (EFSA, 2010). Higher intakes convey no 
additional health benefit and in fact if they exceed the tolerable upper level may lead to harm 
(EFSA, 2010).  
2.3 A clear public health lesson from these disparate DRV/DRI  
 
Notwithstanding the variability in current DRV/DRI, benchmarking European population 
intakes against a vitamin D intake value of 10 g/d, corresponding both to the North American 
EAR (IOM, 2011) and the RNI in the UK (SACN, 2016), shows that there are between 55-
100% of adults (19-64 y) and older adults (>64 y) with inadequate intakes (Vinas et al, 2011) 
on this basis.  Typical average intakes by adult populations in the EU are generally around 3-
7.5 g/d, depending on the country (Vinas et al, 2011). The European Nutrition and Health 
Report summarized vitamin D intake in children and teenagers (aged 4-14 y) and showed that 
intakes were in the range 1.2-6.5 g/d (Elmadfa et al, 2009). The dietary intakes of children 
and adults in North America and some European countries have been comprehensively 
reviewed elsewhere by Kiely & Black (2012), and the readers are referred to that review for 
more detailed analysis of population intakes of vitamin D from select countries relative to the 
EAR. The estimates clearly show that the habitual mean vitamin D intakes by European and 
North American populations are below the estimates of intake requirement.  
 
While at first glance recommending improving intake of naturally occurring vitamin D-rich 
foods would appear intuitive, it is the least likely strategy to counteract low dietary vitamin D 
intake due to the fact that there are very few food sources that are rich in vitamin D (Kiely & 
Black, 2012; Cashman 2015). Furthermore, most of these are not frequently consumed by 
many in the population (Henderson et al, 2004; Kiely & Black, 2012; Black et al, 2015; 
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SACN, 2016). While there have been calls for use of vitamin D supplements as a means of 
correcting low vitamin D status in European populations, the principal reason why relying on 
supplements is not an appropriate public health strategy to increase vitamin D intakes across 
the population distribution, i.e., uptake within the population being generally too low to 
provide widespread population protection, has been outlined elsewhere (Cashman, 2012b; 
Cashman & Kiely, 2015; Kiely & Cashman, 2016). Data from three nationally representative 
cross-sectional dietary surveys in Ireland (a survey in children (n=594; 5–12 years) (Black et 
al, 2014), teenagers (n=441; 13–17 years) (Black et al, 2014) and adults (n=1274; 18-64 y) 
(Black et al, 2015), illustrate this point very clearly. The surveys showed that 97–99% of all 
boys, 98–99% of all girls, and 90% of all adults had inadequate intakes of vitamin D, as 
defined as ≤10 g/d. The percentage of adults who consumed vitamin D–containing 
supplements was only 16% (Black et al, 2015), and a total of 21% of 5–8-year-olds, 16% of 
9–12-year-olds and 15% of 13–17-year-olds consumed a vitamin D-containing supplement at 
least once during the recording days of their survey (Black et al, 2014). Moreover, even in 
users of vitamin D-containing supplements within the three surveys, 88–96% of those boys 
and 88–90% of those girls, and 57% of those adults (aged 18-64 y) with supplemental vitamin 
D had inadequate intakes (Black et al, 2014; 2015).  
 
In comparison to vitamin D supplementation or relying on improving intake of naturally 
occurring vitamin D-rich foods, food fortification may represent the best opportunity to 
increase the vitamin D supply to the population, even though it is not also without its 
challenges.  Fortification of foods with vitamin D in the US and Canada has an important 
effect on the mean daily intake of vitamin D by the average adult; however, Calvo & Whiting 
(2013) suggest that the current level of fortification in the US and Canada is not effective in 
reaching the required levels of vitamin D intake.  Fulgoni et al. (2011) showed using data from 
NHANES 2003-2006 that the percentage of individuals in the US aged 2 and older below the 
EAR was reduced when the contribution of vitamin D-fortified foods was accounted for, but 
still 69.5% did not reach the EAR. The adult nutrition survey in Ireland, mentioned above, 
recently showed that the percentage failing to meet the EAR was 98% in non-consumers of 
vitamin D supplements or vitamin D-fortified foods, and 95% in non-consumers of vitamin D 
supplements but who consumed vitamin D-fortified foods (Black et al, 2015). Flynn et al. 
(2009) have shown that the 95th percentile of intake of vitamin D from voluntary fortified 
foods in Europe is low (Flynn et al, 2009). These findings showing the relatively low impact 
of vitamin D-fortified foods to date may relate to the level of fortification, types and choice of 
food vehicles and the issue of mandatory or optional/voluntary fortification (Kiely & Black, 
2012; Cashman, 2015) as well as market penetrance of voluntary fortified foods. The 
remainder of the review will focus on how careful application of traditional food fortification 
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(nutrient addition in controlled amounts) and ‘bio-fortification’ (enrichment of animal food 
sources, such as meats, eggs, and fish, as well as of mushrooms) strategies could be used to 
safely increase intakes of vitamin D across the distribution and prevent deficiency within the 
general population.  In addition, it will highlight the ongoing need and role research has in 
terms of addressing persistent knowledge gaps that exist and which are barriers to developing 
and implementing such safe and effective food-based approaches towards prevention of 
vitamin D deficiency. 
2.4 Using food-based solutions for increasing vitamin D intake in the population 
 
While under legislation in North America and Europe, several food types can be fortified, milk 
and margarine are the foods with the longest tradition of fortification (Cashman & Kiely, 
2016). Canada currently has mandatory fortification of milk and margarine with vitamin D as 
stipulated by the Canadian Food and Drug Regulations, and while fluid milk in the US is not 
required to have vitamin D added unless the label declares that it is fortified, in practice almost 
all milk is fortified with vitamin D on a voluntary fortification basis (Calvo & Whiting, 2013). 
Currently within Europe, fortification practices vary between countries and may be applied 
voluntarily by manufacturers or implemented by national legislation.  The evidence-base for 
effectiveness of vitamin D fortification of milk and other dairy food in terms of its impact on 
vitamin D intake and serum 25(OH)D has been reviewed elsewhere (Black et al, 2012; 
Cashman & Kiely, 2016), and ranges from supportive data from several RCTs to evidence 
from modeling of population intakes and status. Overall, there is little doubt that vitamin D-
fortified dairy foods play a key role in addressing low vitamin D intakes, especially where 
there is mandatory fortification (Cashman & Kiely, 2016).  However, even in Canada with 
mandatory fortification, recent modeling of their nationally representative data (2004 
Canadian Community Health Survey 2.2 with n=34,381) showed that the prevalence of dietary 
inadequacy of vitamin D could be decreased from >80% to <50% in all groups with increased 
vitamin D levels in milk and the addition of vitamin D to cheese and yogurt at various levels 
(Shakur et al, 2014). Furthermore, in countries where fortification of milk is voluntary and the 
uptake is far less than in the US, the impact of vitamin D-fortified milk and dairy on adequacy 
of intake of the vitamin is understandably low.  The problem of fortifying a single staple, e.g., 
milk, or focusing on a commodity sector such as dairy, is that it does not increase the vitamin 
D supply in non- or low consumers (Black et al, 2012). Thus, while acknowledging the 
valuable contribution fortified milk makes to vitamin D intakes among consumers, particularly 
in children, and the continued need for fortification of milk and other dairy products, 
additional strategic approaches to fortification, including bio-fortification, of a wider range of 
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foods, have the potential to increase vitamin D intakes in the population (Cashman & Kiely, 
2016).  
2.5 Traditional fortification of foods other than dairy with vitamin D 
 
In terms of diversification of food fortification beyond milk, Madsen et al. (2013) recently 
provided experimental evidence, in the form of  RCT data, of the effects of vitamin D-fortified 
milk and bread on serum 25(OH)D in 201 families (n=782 children and adults, aged 4–60 
years) in Denmark during winter. Bread was included as an additional vehicle for fortification 
in recognition of the skewness of milk intake across some population groups. The groups 
randomized to vitamin D unfortified and fortified foods had median intakes of vitamin D of 
2.2 and 9.6 g/d, respectively over the 6 months of the study. By the end of the study period, 
none and 16% in the fortified food group had serum 25(OH)D levels below 25 and 50 nmol/L, 
respectively, with the corresponding prevalence estimates for the group receiving unfortified 
foods at 12 and 65%, respectively (Madsen et al, 2013). Evidence of effectiveness of food 
fortification approaches from RCTs which evaluate their impact on reducing the prevalence 
of vitamin D deficiency in the populations studied is a key priority (Cashman & Kiely, 2011), 
but also dietary modelling analysis based on data from nationally representative dietary 
surveys can provide in silico projections of how these food interventions may impact on the 
degree of vitamin D intake inadequacy in the population (Black et al, 2015).  For example, 
Allen et al. (2015) recently modeled the impact of a number of simulated vitamin D 
fortification scenarios, with milk and wheat flour identified as primary fortification vehicles, 
on vitamin D intake distribution within the first 2 years (2008-2010) of the UK National Diet 
and Nutrition Survey rolling programme (n=2127 individuals).   At a simulated fortification 
of 10 μg vitamin D/100 g wheat flour, the proportion of at-risk groups estimated to have 
vitamin D intakes below the UK RNI was reduced from 93% to 50% (Allen et al, 2015). 
Interestingly, the simulation of the fortification of wheat flour at this concentration was more 
effective than that of the fortification of milk (at concentrations between 0.25 and 7 mg 
vitamin D/100 L milk) or of the fortification of milk and flour combined.  The authors 
suggested that vitamin D fortification of wheat flour could be a viable option for safely 
improving vitamin D intakes and the status of the UK population groups at risk of deficiency 
(Allen et al. 2015)  
 
The mandatory fortification of a food vehicle other than milk or margarine raises an interesting 
issue. A general consideration underpinning the establishment of DRV/DRI is that there is the 
presupposition that in setting the requirements for one nutrient, requirements for energy and 
all other nutrients are met (IOM, 2011; SACN, 2016; EFSA, 2016). For example, despite the 
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strong interactions between vitamin D and calcium, the DRV/DRI for vitamin D are set on the 
assumption that requirements for calcium are met and vice versa. In reality, however, this does 
not happen, since a significant proportion of populations in the US and Europe have dietary 
calcium intakes that are inadequate (Flynn et al, 2009; IOM, 2011). In fact, the US 2015-2020 
Dietary Guidelines for Americans Committee identified both vitamin D and calcium as two 
of the four identified nutrients of public health concern (DHSS, 2015). The IOM in their DRI 
report on calcium and vitamin D highlighted that there was ambiguity in the available data on 
the influence of dietary calcium intakes on regulation of serum 25(OH)D and its catabolism 
(IOM, 2011). This is of consequence when considering vitamin D fortification policies, due 
to the inter-relationship that exists between calcium and vitamin D in the body, and raises the 
question of whether the range of foods for vitamin D fortification should have calcium 
naturally present (e.g. dairy produce) or if both of these nutrients should be added in tandem.  
 
There have been animal data that suggested that the plasma half-life of 25(OH)D will be 
reduced by low calcium intake accompanied by an increased hepatic conversion of 25(OH)D 
to metabolites, which are excreted in bile (Fraser et al, 1987) , thus potentially increasing the 
dietary vitamin D requirement. Indeed, calcium intake has been reported as a significant 
determinant of serum 25(OH)D in some, but not all observational studies (Lips et al, 2012).  
One RCT in healthy men reported a large increase (30%) in serum 25(OH)D in subjects 
supplemented with calcium compared to that in subjects with normal calcium intakes (Berlin  
& Björkhem, 1988), whereas 2 other RCTs showed no effect of additional calcium on serum 
25(OH)D in healthy adults (Goussous et al, 2005; McCullough et al, 2009). However, caution 
is needed because all three RCTs had design characteristics that may have affected the 
interpretation of their findings in relation to vitamin D DRI/DRVs. Data from our recent 15-
wk winter-based, randomized, placebo-controlled, double-blind vitamin D3 intervention study 
in older adults, aged >50 y (n = 125), who were stratified according to calcium intakes 
[moderate-low (<700 mg/d) or high (>1000 mg/d) intake], showed responses in serum 
25(OH)D concentrations throughout winter as well as indexes of vitamin D activation and 
catabolism were similar irrespective of whether the older adults had relatively low or high 
habitual calcium intakes (Cashman et al, 2014). Not only do these findings suggest that recent 
vitamin D DRI/DRV will cover the vitamin D needs of even those individuals who have 
inadequate calcium intakes (Cashman et al, 2014), it also strengthens the case for 
consideration of widening the range of foods for fortification or bio-fortification with vitamin 
D beyond those that are also a source of calcium. 
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2.6 Vitamin D biofortified foods 
 
While traditional fortification practices in which exogenous vitamin D is added to dairy and 
other foodstuffs will continue to be an important approach for increasing vitamin D in the food 
supply, the use of vitamin D ‘biofortified’ [also referred to as ‘bio-addition’ (Calvo & Whiting, 
2013)] foods also merits serious attention (Cashman, 2015; Cashman & Kiely, 2016). In this 
approach, the animal produce (such as, for example, cultured fish, beef, pork, lamb, chicken, 
and eggs) could have increased vitamin D and/or 25-hydroxyvitamin D contents by virtue of 
addition of vitamin D and/or 25-hydroxyvitamin D (where permissible) to the livestock feeds. 
In bio-fortification, the vitamin D compounds in the resulting foodstuffs from the animals will 
be incorporated in a manner similar to native vitamin D and unlike in traditional fortification 
will be under some degree of biological regulatory control mechanisms in the animal.  In this 
regard, it is possible that bio-fortification may hold more consumer appeal in some cases. An 
important concept in relation to vitamin D bio-fortification is that it can increase the ‘total 
vitamin D activity’ of the biofortified foods.  Total vitamin D activity is used in several of the 
food composition tables (Saxholt et al, 2008; Zurich, 2010), including the UK McCance & 
Widdowson tables (FSA, 2008), and accounts not only for the vitamin D content of the food 
but also the content of the key metabolite in the food, 25-hydroxyvitamin D (which is usually 
multiplied by a factor of 5). In an RCT setting, consumption of orally consumed synthetic 25-
hydroxyvitamin D3 has been shown to be 5 times more effective than an equivalent amount of 
vitamin D3 at improving serum 25(OH)D concentrations of older adults in winter (Cashman 
et al, 2012).  Improving the total vitamin D activity (i.e., content of vitamin D3 plus 25-
hydroxyvitamin D  5) of these foods may be of consequence not only to the population as a 
whole, but in particular, for low or non-consumers of vitamin D-fortified dairy products and 
also ethnic sub-groups. For example, in the Irish adult diet, the meat, fish, egg food groups, 
even without bio-fortification, collectively contribute ~40% to the mean daily intake of 
vitamin D (Black et al, 2015).  Van Horn et al. (2011) reported that in US adolescent girlsthe 
meat and bean food group contributed ∼4% to the mean daily intake of vitamin D in white 
girls, but contributed 26% to the mean daily intake of vitamin D in African American girls.  
The possibility of enhancing the vitamin D activity of meat and other relevant foods further 
by bio-fortification and its potential impact on population and ethnic subgroup intake 
estimates is of significant public health nutrition relevance.   
 
The most researched vitamin D biofortified food to date is, without doubt, eggs. In the last 15 
years, there have been several reports illustrating that the vitamin D3 content of eggs can be 
significantly increased by the greater addition of vitamin D3 to the feed of hens (Mattila  et al, 
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1999; 2003; 2004; 2001; Yao et al, 2013; Browning & Cowieson, 2014; Hayes et al, 2016), 
however, several of these studies (Mattila et al, 2003; 2004; 2011; Yao et al, 2013; Browning 
& Cowieson, 2014) used levels of inclusion above the upper allowable level for feeds in 
Europe [3000 IU/kg diet (EC) No. 1831/2003] (see Figure 1). Addition of commercially 
available 25-hydroxyvitamin D3 to the diet of hens has also been shown to increase egg 25-
hydroxyvitamin D3 content (Mattila et al, 2011; Browning & Cowieson, 2014; Hayes et al, 
2016), albeit two studies (Matilla et al, 2011; Browning & Cowieson, 2014) used 25-
hydroxyvitamin D3 at levels above the upper allowable level [0.080 mg/kg diet (EFSA 
FEEDAP panel, 2005)]. Many of these studies were predominantly focused on the effect that 
higher levels of vitamin D compounds in animal feeds may have on the welfare of the animal 
itself or the quality of their produce (e.g. egg shell strength, laying rate) rather than its impact 
on the vitamin D activity of the resulting eggs and their potential to improve the vitamin D 
status of humans.  In terms of producing eggs that would be acceptable for human 
consumption, we have recently demonstrated that additional vitamin D and/or 25-
hydroxyvitamin D3 at levels adhering to the maximum allowable EU regulation [(EC) No. 
1831/2004; EFSA FEEDAP panel, 2005], resulted in eggs with increased vitamin D activity 
(providing ~5 μg/egg), and, importantly, no deterioration of consumer acceptability of the 
biofortified eggs compared to usual eggs (Hayes et al, 2016). Thus, such vitamin D-
biofortified eggs could supply half the EAR for vitamin D.  
 
As mentioned above, evidence of effectiveness of food fortification approaches from RCTs, 
which evaluate their impact on reducing the prevalence of vitamin D deficiency in the 
populations studied, is a key priority in terms of the evidence-base. Importantly, in that 
context, we have also very recently shown in a winter-based RCT of older adults (n=55) that 
weekly consumption of 7 vitamin D-biofortified eggs, produced by hens provided with feed 
containing either vitamin D3 or 25-hydroxyvitamin D3 at the allowable maximum content, 
prevented the typical decline in serum 25(OH)D concentration during winter and any 
incidence of vitamin D deficiency (Hayes et al, 2016). The control group in the study, who 
were requested to consume weekly up to a maximum of 2 commercially available eggs, had a 
significant decline in serum 25(OH)D over the 8 weeks of winter, and 22% had vitamin D 
deficiency (serum 25(OH)D <25 nmol/L) at endpoint (Hayes et al, 2016). From a dietary 
guideline perspective, the general population can include up to seven eggs a week in their diet 
(Krauss et al, 2000), and our RCT showed no difference in serum total cholesterol among 








Figure 1. The achieved vitamin D3 content of egg yolk (µg/100g) reported from published studies on the effect of different vitamin D and 25-
hydroxyvitamin D supplementation rates in laying hen feeds. The first number in parenthesis on the X axis denotes the study from which these 
data are derived as follows: 1) Mattila et al., 1999; 2) Mattila et al., 2003; 3) Mattila et al., 2004; 4) Mattila et al., 2011; 5) Yao et al., 2013; 6) 
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In a similar fashion, the potential of bio-fortification of other animal-derived foods (such as 
beef, pork, and cultured fish) with vitamin D compounds is currently under investigation in a 
number of animal feeding trials in both an EU Framework 7 (FP7) collaborative project called 
‘ODIN; Food-based solutions for Optimal vitamin D Nutrition and health through the life 
cycle’ (www.ODIN-vitD.eu) and an Irish nationally funded project (‘EnhanceD Meats’; 
http://www.ucc.ie/en/vitamind/history/ongoing/enhancedmeats). Some of these vitamin D 
biofortified foods have also been tested in a winter-based RCT, within the ODIN project, in 
terms of evaluating their potential at raising serum 25(OH)D in Danish white and South Asian 
women at high risk of vitamin D deficiency. The results of this research will become available 
over the next 12 months. Following the demonstration of efficacy of these vitamin D 
biofortified foods on response of serum 25(OH)D in RCT settings, as mentioned above, 
dietary modelling analysis based on data from nationally representative dietary surveys within 
ODIN will provide in silico projections of how these food interventions may impact on the 
degree of vitamin D intake inadequacy in the population. 
 
Finally, bio-fortification with vitamin D could also embrace the practice of UVB-irradiation 
of mushrooms and baker’s yeast, which has been shown to stimulate their endogenous vitamin 
D2 content. These foods may be a useful strategy to increase vitamin D intakes for vegetarians 
or those who do not consume meat or animal-derived foods for cultural reasons, but also for 
the wider population, particularly in the case of bread, as mentioned above.  From a 
technological perspective, these UV irradiated foods can be produced with anything from low 
to very high levels of vitamin D2.  However, in terms of RCT-based evidence of effectiveness, 
a recent 8-week RCT within the ODIN project (Itkonen et al, 2016), investigated the 
bioavailability of D2 from UV-irradiated yeast present in bread in healthy 20-37-year-old 
women (n=33) in Helsinki (60°N) during winter. Four study groups were given different study 
products, either a placebo pill and regular bread (providing 0 μg vitamin D2 or D3 per day); a 
vitamin D2 supplement and regular bread (providing 25 μg vitamin D2 per day); a vitamin D3 
supplement and regular bread (providing 25 μg vitamin D3/d); or a placebo pill and vitamin 
D2-fortified bread (made with UV yeast) (providing 25 μg D2/d). Serum 25(OH)D 
concentration was measured at baseline, midpoint (week 4) and endpoint (week 8). The study 
showed that consumption of the UV yeast-vitamin D2-fortified bread did not affect serum 
25(OH)D concentration, unlike the increases seen in those receiving supplemental vitamin D 
together with regular bread  (Itkonen et al, 2016). This was despite the fact that the bread, 
even following the baking process, was analysed and shown to actually contain the 25 μg 
vitamin D2. Thus, these new data suggest that vitamin D2 from UV-irradiated yeast in bread, 
despite being present post-baking, was not bioavailable in humans. 
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The RCT data demonstrating that the vitamin D2 in UV-treated mushrooms can increase 
vitamin D status of consumers have been quite mixed, and accordingly, we recently undertook 
a systematic review and meta-analysis of the impact of UV-exposed mushrooms on serum 
25(OH)D response in these RCTs (Cashman et al, 2016b), again within the ODIN project.  
Our structured search yielded 6 RCTs meeting our inclusion criteria, and a meta-analysis of 
these 6 RCTs showed serum 25(OH)D was not significantly increased (P=0.12) by UV-
exposed mushrooms, but there was high heterogeneity (I2=87%). Including only the 3 
European-based RCTs [mean baseline 25(OH)D, 38.6 nmol/L], serum 25(OH)D was 
increased significantly by UV-exposed mushrooms, whereas there was no significant effect in 
the 3 US-based RCTs [P=0.83; mean baseline 25(OH)D: 81.5 nmol/L] (Cashman et al, 
2016b). Analysis of serum 25(OH)D2 and serum 25(OH)D3 (n=5 RCTs) revealed a statistically 
significant increase and decrease after supplementation with UV-exposed mushrooms 
(weighted mean differences of 20.6 nmol/L and -13.3 nmol/L, respectively: P≤0.001) 
(Cashman et al, 2016b). Thus, consumption of UV-exposed mushrooms may increase serum 
25(OH)D when baseline vitamin D status is low via an increase in 25(OH)D2 and despite a 
concomitant but relatively smaller reduction in 25(OH)D3. However, when baseline vitamin 
D status is high, the mean increase in 25(OH)D2 and a relatively similar reduction in 25(OH)D3 
explain the lack of effect on serum 25(OH)D. 
 
Artificial UV light technology has also recently been shown to increase the vitamin D3 content 
of exposed milk during processing to enhance shelf-life, a process approved by the European 
Food Safety Authority (EFSA, NDA panel, 2016). Furthermore, UVB light exposure of 
animals has been shown to improve the vitamin D activity of animal-based foods such as eggs 
(Kühn et al, 2015) and pork (Burild et al, 2015). 
2.7 Conclusion 
 
While current DRI/DRV for vitamin D are essential public health policy instruments in terms 
of promoting adequate vitamin D status in the population and prevention of vitamin D 
deficiency, the present review highlights how even the most recent DRV in Europe differ 
widely.  Notwithstanding this, there is little doubt, irrespective of which set of vitamin D 
recommendations you choose, that current European population intakes of vitamin D fall well 
short of these targets.  Increasing vitamin D intakes across the population distribution is 
important from a public health perspective to reduce the high degree of inadequacy of vitamin 
D intake in Europe and elsewhere, which contribute to prevalence of vitamin D deficiency. 
Fortification, including bio-fortification, of a wider range of foods, which accommodate 
diversity, is likely to have the potential to increase vitamin D intakes across the population 
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distribution and in so doing minimize the prevalence of vitamin D deficiency.  Vitamin D 
biofortified eggs are a good example of one of these novel food-based solutions, which 
together with other vitamin D-containing foods, can play a role in tackling low vitamin D 
intakes.  The development of vitamin D biofortified eggs is underpinned by a number of hen 
feeding trials which have examined different vitamin D compounds and doses, and the testing 
of the resulting egg not only in terms of vitamin D content but also egg quality characteristics 
and consumer acceptability, but also of key importance, evidence of efficacy in an RCT 
setting.   This exemplifies the role research has had, and continues to have, in terms of 
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Calcium and vitamin D are metabolically inter-related to serve endocrine functions within 
the body. Vitamin D, as the active metabolite (1,25-dihydroxyvitamin D [1,25(OH)2D]), 
forms part of the endocrine system that maintains serum calcium concentrations within the 
range necessary for proper regulation of bone mineralisation (DeLuca, 2008), 
neuromuscular  function, vasodilation, nerve transmission and hormonal secretion (Holick, 
2011). Interactions between vitamin D and calcium have implications for the regulation of 
serum 25-hydroxyvitamin D [25(OH)D] concentrations and its catabolism and, 
consequently, for the dietary vitamin D requirement. For example, if dietary calcium intake 
remains habitually low, and serum calcium concentrations decrease, the compensatory 
metabolic response is the activation of 1,25(OH)2D from 25(OH)D (via an increase in 
circulating parathyroid hormone [PTH] concentration), which normalises serum calcium 
concentrations. There have been animal data that suggested that the plasma half-life of 
serum 25(OH)D will be reduced when dietary calcium intake is low, accompanied by an 
increased hepatic conversion of 25(OH)D to metabolites, which are then excreted in bile 
(Clements et al, 1987).  
 
Mechanistically, the increased synthesis of 1,25(OH)2D during times of low calcium 
induces the synthesis of the 24-hydroxylase enzyme, which converts serum 25(OH)D to 
24,25 dihydroxyvitamin D [24,25(OH)2D]. This metabolite is then further catabolised in 
the body, and the conversion of 25(OH)D to 24,25(OH)2D is suggested to be the first step 
in a 5-step, vitamin D-inducible pathway to water soluble truncated degradation products 
(Jones, 2013). However, older animal data suggests that 24,25(OH)2D (and its metabolite 
1,24,25 trihydroxyvitamin D) may stimulate intestinal calcium absorption and bone 
calcium mobilization (Boyle et al, 1971; Holick et al, 1973), suggesting a biological 
activity in addition to a role in the degradation of vitamin D. Clements et al, (1992) showed 
that the elimination half-time of radio-labelled 25(OH)D administered intravenously was 
significantly shortened by oral 1,25(OH)2D treatment. Further evidence from children with 
calcium responsive rickets suggest that a low calcium intake induced a higher rate of serum 
25(OH)D catabolism (Pettifor, 1991). 
 
While such perturbations may confound the estimation of the true requirement for vitamin 
D, this has received relatively little research attention to date in healthy humans. Of 
particular note, the Institute of Medicine (IOM)’s Dietary Reference Intakes (DRI) report 
on calcium and vitamin D recently highlighted that the elucidation of the inter-relationships 
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between calcium and vitamin D, and the examination of the influence of calcium intake on 
the regulation of vitamin D activation and catabolism are key information gaps (IOM, 
2011). Even within the relatively limited data that does exist, there is ambiguity. Calcium 
has been reported as a significant determinant of serum 25(OH)D in some (van der Wielen 
et al, 1995; Kinyamu et al, 1998; Hill et al, 2004; Andersen et al, 2005), but not all 
observational studies (Andersen et al, 2007; Hill et al, 2008). One randomised control trial 
(RCT) in healthy men reported a large increase in serum 25(OH)D in those supplemented 
with calcium compared to those on their normal calcium intake (Berlin & Björkhem, 1988), 
while two other RCTs found no effect of additional calcium on serum 25(OH)D in healthy 
adults (Goussous et al, 2005; McCullough et al, 2009). However, caution is needed as all 
three RCTs had design characteristics that may impact on the interpretation of their findings 
in relation to vitamin D DRIs.  For example, vitamin D DRIs have been established for 
winter-time (IOM, 2011) when serum 25(OH)D concentrations naturally decline, a design 
consideration which none of the three RCTs addressed, and adequacy of serum 25(OH)D 
may influence 1,25(OH)2D (Schoenmakers et al, 2010; Lagunova et al, 2011) which, in 
turn, influences 24-hydroxylase. 
 
3.1.1 Aims of the present research 
 
The overall aim of the current research was to assess if different levels of habitual calcium 
intakes influence dietary vitamin D requirements using a three-pronged approach. Firstly, 
post-hoc analysis of existing individual participant data from four placebo-controlled, dose-
related vitamin D RCTs in children, adults and the elderly (Cashman et al, 2008; Cashman 
et al, 2009; Cashman et al, 2011a) was conducted to mathematically model the impact of 
calcium intake on the vitamin D intake-status relationship [will be referred to as Part A]. 
This data, in addition to published data from several winter-based vitamin D RCTs 
(conducted in study locations at >50°N) (Cashman et al, 2011b), was also used in a meta-
regression approach to further explore the impact of calcium intake on response of 
25(OH)D to vitamin D, as well as to inform the design of a de novo vitamin D intervention 
RCT in apparently healthy older adults (>50 years). This winter-based randomised, 
placebo-controlled, single-dose vitamin D RCT in older adults stratified by calcium intake 
(<EU Estimated Average Requirement (EAR) [550 mg/d] and >US Recommended Dietary 
Allowance (RDA) [1000 mg/d] aimed to provide new data on the impact of different levels 
of calcium intake, ranging from low-moderate to high, on serum 25(OH)D concentrations 
achieved following increased vitamin D intake [Part B]. The effects of these two different 
levels of calcium intake on indices of vitamin D activation and catabolism, as explanatory 
variables, during winter-time in the older adults were also determined. The Part A models 
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would be used to predict the dietary requirement for vitamin D at low-moderate and higher 
calcium intakes, if the interaction is confirmed in the de novo RCT in Part B.  
 
Lastly, to augment the findings of Part A and B, we assessed the impact of low and high 
calcium intakes in the absence and presence of low and high serum 25(OH)D status on 
serum 24,25(OH)2D3, using data and bio-banked serum samples from a subset of adults 
from the representative National Adult Nutrition Survey (NANS) in Ireland (Irish 
Universities Nutrition Alliance [IUNA], 2011) [Part C]. 
 






Due to the stepwise nature of our approach, where Part A informs Part B and vice versa, 
and Part C may help us to interpret some of the findings of Part B, the Methods, Results 
and associated Discussion are presented for the three parts separately, and then the findings 




3.2 Part A – Post hoc analysis of existing vitamin D RCT data 
 
3.2.1 Specific objectives 
 
 To perform post hoc analysis using existing individual dietary and serum 25(OH)D 
data from four placebo-controlled, dose-related vitamin D RCTs in children, adults 
and elderly to assess the impact of levels of calcium intake on the dietary 
requirement for vitamin D (i.e., the intake needed to maintain serum 25(OH)D 
above selected thresholds for the majority of individuals).  
 
 To use existing published vitamin D RCT data [(as used recently in meta-regression 
analysis by the IOM and ourselves (Cashman et al, 2011b)] to assess the possible 
interaction between calcium intake and the response of serum 25(OH)D to vitamin 
D intake using a meta-regression approach, which may provide for a more 
representative response as it uses data from several RCT within the model.   
 
3.2.2 Tasks within Part A and associated methodology 
 
Task 1.  Mathematical modelling the impact of calcium intake on the vitamin D intake-
status relationship.  
 
The present analyses used more complex versions of our previous models (Cashman et al., 
2008, 2009, 2011a) such that they included calcium intake, both as a continuous variable, 
as well as a categorical variable (</>EU EAR (550 mg/d), or UK Reference Nutrient Intake 
[RNI] (700 mg/d), or US EAR/RDA (800/1000 mg/d, dependent on age) to test for an 
interaction with dietary vitamin D requirement.   
 
Task 2.  Within treatment group response of serum 25(OH)D to vitamin D intake at different 
levels of calcium intake.  
 
Some RCT suggest that calcium intake (as supplemental calcium) modifies the response of 
serum 25(OH)D to vitamin D, but the effect of habitual calcium intake has not been 
explored. Whether the achieved mean serum 25(OH)D within the four discrete dose groups 
(0,5,10,15 g vitamin D3/d) in the two adult/older adult RCTs (and three doses [0,5,10 g 
vitamin D3/d] in 11 year-old girls) differs at the end of 5-months intervention following 
stratification by habitual calcium intake using several cut-offs (outlined in Task 1), and 
after accounting for possible confounding factors (age, sex, dietary vitamin D, smoking, 
and BMI), was explored. In addition, for comparative purposes we did this analysis 
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comparing those with habitual calcium intakes <550 mg/d (and <700 mg/d) versus >1000 
mg/d.  
 
Task 3.  Update of database of vitamin D RCTs and meta-regression analyses.  
 
As an additional approach, the published group mean data from ~15 winter-based vitamin 
D RCTs conducted at latitudes >50oN [identified by the IOM and ourselves (Cashman et 
al., 2011b)] were used to investigate a possible interaction between mean group calcium 
intake and response of serum 25(OH)D to vitamin D intake in meta-regression models 
which would be cognisant of the vitamin D intake range appropriate for the UK and Ireland. 
While such group mean data were not from UK/Ireland-only based RCTs, it represented a 
latitude range of 51-63oN covering from South of England to Scotland.  To undertake this 
task, our database of relevant data from published vitamin D RCT (Cashman et al., 2011b) 
was re-visited to include data on calcium intake, and was also updated for any appropriate 
vitamin D RCT published between February 2011 and March 2013. Following this data 
collection, meta-regression analyses was undertaken to test for a possible interaction 
between calcium intake and vitamin D intake-status relationship (i.e., an interaction 
between the predicted response of serum 25(OH)D to total vitamin D intake and habitual 
calcium intake). 
 
Statistical analysis of the data was conducted using SPSS© for WindowsTM Version 22.0 
(SPSS, Inc., Chicago, IL, USA).  
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3.2.3  Results of Part A 
 
Task 1. Mathematical modelling of the impact of calcium intake on the vitamin D intake-
status relationship.  
 
The regression models used in previous vitamin D RCTs by the Vitamin D Research Group 
(Cashman et al., 2008, 2009, 2011a), which aimed to establish the dietary vitamin D 
requirement, were performed again but this time included habitual calcium intake as a new 
potential determinant. This analysis showed that category of habitual calcium intake (< and 
≥ 550 mg/d, < and ≥ 700 mg/d, < and ≥ 800 mg/d and < and ≥ 1000 mg/d; corresponding 
to the EU EAR, UK RNI, US EAR and US RDA values, respectively) was not a significant 
predictor of winter serum 25(OH)D concentration and did not interact with total vitamin D 
intake in 11 year-old girls, 20-40 year-old healthy adults, or 64+ year-old older adults 
(P>0.1, in all cases).  Likewise, the lack of significance of habitual calcium intake in the 
models remained the case (P>0.3 in all cases) when it was included as a continuous variable 
(mg/d) rather than as a categorical above or below the threshold. 
 
Task 2. Within treatment group response of serum 25(OH)D to vitamin D intake at different 
levels of calcium intake.  
3.2.3.1  Baseline serum 25(OH)D concentration in those above and below thresholds of 
habitual calcium intake in post-hoc analysis 
 
Following stratification of individual data points within each treatment group according to 
their habitual calcium intake being above or below four different cut-off points i.e. 550, 
700, 800, and 1000 mg/d, there was no significant difference in baseline serum 25(OH)D 
concentrations in 20-40 year old healthy adults (Table 1) or older adults, 64+ years (Table 
2), with the exception of those older adults with habitual calcium intakes above or below 
700 mg/d where a significant difference did exist (P ≤0.05); (Median [IQR; n] serum 
25(OH)D of 46.2 [39.2, 59.7; 58] versus 59.5 [43.3, 75.0; 142] nmol/L for < and ≥ 700 
mg/d, respectively; Table 2). However, following adjustment within the model for sex, age, 
study centre, smoking and BMI, this statistical difference no longer existed (P=0.189). 
Baseline serum 25(OH)D concentrations of 11-year-old girls (n=155) who participated in 
a vitamin D intervention trial stratified according to several cut-off points for habitual 
calcium intake are shown in Table 3. There were significant differences in baseline serum 
25(OH)D concentrations between groups < or ≥ 700 mg Ca/d (P=0.028) and < or 800 mg/d 





Table 1. Baseline serum 25-hydroxyvitamin D [25(OH)D] in 20-40 year-old healthy adults 
who participated in a vitamin D RCT (Cashman et al., 2008), stratified by thresholds of 
habitual calcium intake 
 
RCT, Randomised Control Trial; IQR, interquartile range. 
*No significant difference were observed; via unpaired t-tests, P>0.05 in all cases 
Calcium intake 
threshold (mg/d) 
Baseline serum 25(OH)D (nmol/L)* 
Below threshold Above threshold 
Median IQR n Median IQR n 
550 65.9 45.6-86.2 22 70.9 54.4-94.9 192 
700 69.9 57.0-89.6 50 70.8 53.3-91.3 164 
800 67.3 53.2-88.7 70 72.6 54.4-93.0 144 





Table 2. Baseline serum 25-hydroxyvitamin D [25(OH)D] concentrations in healthy older 
adults (64+ years) who participated in a vitamin D RCT (Cashman et al., 2009), stratified by 
thresholds of habitual calcium intake.  
 
RCT, Randomised Control Trial; IQR, interquartile range. 




Baseline serum 25(OH)D (nmol/L) 
Below threshold Above threshold 
Median IQR n Median IQR n 
550 44.2 39.3-79.8 19 55.9 41.7-72.1 181 
700 46.2 39.2-59.7 58 59.5* 43.3-75.0 142 
800 48.2 39.3-67.8 83 59.4 44.0-75.0 117 




Table 3.  Baseline serum 25-hydroxyvitamin D [25(OH)D] concentrations in 11 year-old 
healthy girls who participated in a vitamin D RCT (Cashman et al., 2011a), stratified by 
thresholds of habitual calcium intake. 
 
RCT, Randomised Control Trial; IQR, interquartile range. 
*Significantly different from below threshold value; via unpaired t-tests, P<0.05.  




Baseline serum 25(OH)D (nmol/L) 
Below threshold Above threshold 
Mean SD n Mean SD n 
550 54.0 16.7 25 57.4 16.7 130 
700 52.8 14.7 41 53.3* 12.9 114 
800 53.2 13.9 48 58.5* 13.2 107 
1000 53.8 15.2 68 58.6¶ 17.7 87 
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A borderline difference existed for < or ≥ 1000 mg/d (P= 0.064) but no such difference was 
present between groups < or ≥ 550 mg/d.  
Adjustment for study centre and BMI in these models had no effect on these outcomes in any 
of the groups. The significant differences in the 11 year old girls with habitual calcium intakes 
< or ≥ 700, 800 and 1000 mg/d were strengthened after controlling for the above confounding 
factors. 
3.2.3.2  Response of serum 25(OH)D concentrations to intervention in all groups 
 
The response of serum 25(OH)D concentrations to dose-related vitamin D supplementation in 
winter-time during these trials have been stratified using the aforementioned thresholds for 
habitual calcium intake and are outlined in Tables 4-6. Significant differences existed between 
placebo and intervention groups, as expected, in the response of serum 25(OH)D 
concentrations to supplementation with vitamin D (P<0.0001, in all cases). 
The change in winter serum 25(OH)D concentrations from pre- to post- intervention in 11 
year-old girls that had been stratified by habitual calcium intakes of < or ≥ 550 (Table 4a), 
700 (Table 4b), 800 (Table 4c), and 1000 mg/d (Table 4d) were compared separately in each 
of the treatment groups (Placebo, 5 µg, 10 µg vitamin D/d). No significant differences were 
observed (P > 0.05, in all cases). Similarly, following stratification of the intervention groups 
as above, the change in winter serum 25(OH)D concentrations from pre- to post- intervention 
in each of the 4 treatment groups (Placebo, 5 µg, 10 µg, 15 µg)  were examined independently 
in healthy 20-40 year olds (Tables 5a-d) and no significant differences were observed (P≥ 
0.1, in all cases). 
Pre- and post-intervention serum 25(OH)D concentrations in 64+ year olds stratified by a 
habitual calcium intake threshold of 550 mg/d across vitamin D treatment groups (Placebo, 
10 vitamin D µg/d, 15 vitamin D µg/d) are shown in Table 6a. Data are not included for the 
5 µg vitamin D/d treatment group as upon stratification by 550 mg Ca/d, there were only 2 
subjects with a habitual calcium intake of less than 550 mg/d. The change in serum 25(OH)D 
concentration following intervention with placebo or vitamin D is also shown. There were no 
significant differences in the change of serum 25(OH)D concentrations between groups 







Table 4a. Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 
11 year-old girls, stratified by habitual calcium intake above or below a selected threshold of 550 mg/d1. 
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 
Habitual calcium intake <550mg Ca/d    
n 9 9 7 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 47.5 (11.3) 60.5 (16.4) 54.1 (21.3) 
Post-intervention3 20.9 (13.4) 44.6 (4.9) 59.0 (9.9) 
Change -26.6 (19.2) -15.9 (14.4) 4.9 (14.7) 
    
Habitual calcium intake >550mg Ca/d    
n 46 46 45 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 54.1 (18.7) 54.3 (16.3) 57.4 (15.1) 
Post-intervention3 28.9 (13.5) 42.1 (18.2) 53.6 (19.8) 
Change -25.2 (18.0) -12.2 (17.4 -3.8 (23.9) 
P-value4 0.081 0.054 0.378 
1Values represent means (SD) 
2 All baseline blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between September and October, 2001 or 2002 
3 All endpoint blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between March and April, 2001 or 2002  




Table 4b.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 
11 year-old girls, stratified by habitual calcium intake above or below a selected threshold of 700 mg/d1.  
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 
Habitual calcium intake <700mg Ca/d    
n 15 16 10 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 49.1 (9.9) 55.3 (16.2) 54.4 (18.1) 
Post-intervention3 23.9 (11.6) 46.6 (6.4) 52.1 (20.3) 
Change -25.3 (15.3) -8.8 (15.3) -2.3 (25.9) 
    
Habitual calcium intake >700mg Ca/d    
n 38 39 42 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 54.5 (20.0) 55.3 (16.6) 57.5 (15.4) 
Post-intervention3 29.0 (14.3) 40.8 (19.3) 54.8 (18.8) 
Change -25.5 (19.3) -14.5 (17.4) -2.7 (22.6) 
P-value4 0.255 0.924 0.303 
1Values represent means (SD) 
2 All baseline blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between September and October, 2001 or 2002 
3 All endpoint blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between March and April, 2001 or 2002  










Table 4c. Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 
11 year-old girls, stratified by habitual calcium intake above or below a selected threshold of 800 mg/d1. 
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 
Habitual calcium intake <800mg Ca/d    
n 16 20 12 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 49.1 (9.6) 55.6 (15.1) 54.7 (16.4) 
Post-intervention3 23.8 (11.2) 45.5 (7.3) 54.0 (19.1) 
Change -25.3 (14.7) -10.1 (14.6) -0.7 (23.8) 
    
Habitual calcium intake >800mg Ca/d    
n 37 35 40 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 54.6 (20.2) 55.2 (17.2) 57.6 (15.8) 
Post-intervention3 29.2 (14.4) 40.7 (20.2) 54.4 (19.2) 
Change -25.2 (19.9) -14.4 (18.1) -3.2 (23.0) 
P-value4 0.311 0.476 0.189 
1Values represent means (SD) 
2 All baseline blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between September and October, 2001 or 2002 
3 All endpoint blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between March and April, 2001 or 2002  







Table 4d.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 
11 year-old girls, stratified by habitual calcium intake above or below a selected threshold of 1000 mg/d1.   
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 
Habitual calcium intake <1000mg Ca/d    
n 25 27 17 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 51.2 (12.1) 56.9 (14.1) 52.5 (20.4) 
Post-intervention3 26.0 (10.2)  47.3 (7.8) 56.3 (16.8) 
Change -25.3 (14.0) -9.6 (12.7) 3.9 (26.1) 
    
Habitual calcium intake >1000mg Ca/d    
n 28 28 35 
Serum 25(OH)D (nmol/L):    
Pre-intervention2 54.5 (21.8) 53.8 (18.3) 59.1 (12.8) 
Post-intervention3 29.0 (16.2)  37.8 (21.4) 53.3 (20.1) 
Change -25.2 (21.3) -16.0 (19.9) -5.8 (21.0) 
P-value4 0.946 0.444 0.217 
1Values represent means (SD) 
2 All baseline blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between September and October, 2001 or 2002 
3 All endpoint blood samples of girls (a subset of those in the original 12-month intervention trials) were taken between March and April, 2001 or 2002  







Table 5a.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treament groups pre- and post-intervention and its change in 20-40 year-
old adults, stratified by habitual calcium intake above or below a selected threshold of 550 mg/d1.   
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <550mg Ca/d     
n 5 5 6 6 
Serum 25(OH)D nmol/L):     
Pre-intervention2 61.2 [45.4, 113.7] 53.7 [45.4, 77.4] 64.6 [38.4, 97.3] 85.0 [69.5, 88.7] 
Post-intervention3 40.0 [30.8, 63.0] 46.6 [45.7, 58.7] 54.6 [31.3, 76.7] 74.5 [ 61.4, 79.1] 
Change -23.5 [-52.3, -13.4] -8.2 [-24.3, 6.4] -8.8 [-38.2,6.2] -10.5 [-23.0, 5.6] 
     
Habitual calcium intake >550mg Ca/d     
n 51 44 51 46 
Serum 25(OH)D nmol/L):     
Pre-intervention2 66.5 [59.0, 96.2] 60.0 [50.5, 94.5 ] 73.1 [56.8, 95.4] 75.5 [55.9, 91.8] 
Post-intervention3 35.8 [30.7, 48.2] 50.5 [ 43.9, 61.8 ] 62.0 [50.0, 68.7] 68.5 [59.1, 85.0] 
Change -26.8 [-48.7, -22.3] -14.6 [-31.9, -5.4 ] -15.7 [-27.8, 3.7] -9.8 [-25.6, 18.7] 
P-value4 0.288 0.307 0.929 0.625 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 2nd October – 7th November, 2006. 
3All endpoint blood samples taken between 27th February – 7th April, 2007 







Table 5b.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 20-40 year-
old adults, stratified by habitual calcium intake above or below a selected threshold of 700 mg/d1.  
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <700mg Ca/d     
n 13 10 14 13 
Serum 25(OH)D nmol/L):     
Pre-intervention2 72.4 [48.8, 110.2] 59.3 [51.8, 75.2] 66.2 [54.8, 111.4] 78.1 [66.7, 89.2] 
Post-intervention3 41.8 [33.5, 64.3] 46.8 [45.7, 58.3] 62.8 [45.8, 74.7] 75.0 [64.9, 84.6] 
Change -25.4 [-72.5, -15.0] -12.5 [-18.8, -6.1] -8.8 [-35.8, 2.6] -10.5 [-24.7, 15.9] 
     
Habitual calcium intake >700mg Ca/d     
n 43 39 43 39 
Serum 25(OH)D nmol/L):     
Pre-intervention2 72.4 [56.3, 109.2] 60.1 [50.0, 96.5] 75.8 [56.6, 90.8] 76.0 [54.3, 90.0] 
Post-intervention3 35.7 [29.7, 47.9] 50.6 [41.9, 62.5] 59.0 [50.0, 68.6] 67.6 [59.1, 84.9] 
Change -26.8 [-45.2, -22.6] -14.8 [-34.7, -4.6] -15.7 [-27.8, 3.8] -11.3 [-25.6, 18.7] 
P-value4 0.165 0.562 0.982 0.727 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 2nd October – 7th November, 2006. 
3All endpoint blood samples taken between 27th February – 7th April, 2007 







Table 5c.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 20-40 year-
old adults, stratified by habitual calcium intake above or below a selected threshold of 800 mg/d1.   
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <800mg Ca/d     
n 18 18 18 16 
Serum 25(OH)D nmol/L):     
Pre-intervention2 68.0 [45.5, 100.3] 64.5 [53.8, 82.9] 66.2 [54.8, 111.4] 72.8 [48.7, 87.5] 
Post-intervention3 40.3 [31.4, 51.0] 47.3[45.4, 58.3] 63.0 [51.5, 74.7] 74.5 [60.2,83.8] 
Change -25.2 [-63.8, -15.9] -13.3 [-28.9, -8.6] -5.8 [-26.9, 5.4] -0.2 [-16.5, 23.4] 
     
Habitual calcium intake >800mg Ca/d     
n 38 31 39 36 
Serum 25(OH)D nmol/L):     
Pre-intervention2 65.6 [59.1, 90.9] 57.8 [48.8, 96.5] 76.2 [56.6, 90.8] 77.3 [60.7, 96.4] 
Post-intervention3 35.8 [30.4, 48.1] 50.8 [40.6, 62.5] 57.7 [45.2, 68.6] 67.9 [59.1, 85.0] 
Change -27.8 [-46.0, -22.7] -14.3 [-32.1, -2.5] -18.9 [-32.4, 0.4] -12.9 [-29.0, 12.0] 
P-value4 0.331 0.812 0.337 0.171 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 2nd October – 7th November, 2006. 
3All endpoint blood samples taken between 27th February – 7th April, 2007 







Table 5d.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 20-40 year-
old adults, stratified by habitual calcium intake above or below a selected threshold of 1000 mg/d1.   
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <1000mg Ca/d     
n 32 26 29 23 
Serum 25(OH)D nmol/L):     
Pre-intervention2 65.6 [52.8, 92.6] 59.3 [50.2, 78.5] 66.5 [58.6, 89.2] 76.2 [54.3, 88.2] 
Post-intervention3 37.4 [29.9, 47.9] 46.7 [41.5, 57.6] 62.0 [46.3, 71.6] 75.0 [60.3, 84.9] 
Change -25.8 [-38.7, -21.8] -11.7 [-24.0, -4.6] -9.7 [-24.2, 3.8] -0.7 [-18.2, 21.8] 
     
Habitual calcium intake >1000mg Ca/d     
n 24 23 28 29 
Serum 25(OH)D nmol/L):     
Pre-intervention2 67.7 [60.1, 102.7] 76.2 [50.0, 99.4] 81.2 [50.7, 101.1] 75.9 [58.4, 88.2] 
Post-intervention3 36.8 [32.3, 48.6] 53.4 [48.8, 67.4] 59.3 [50.3, 67.8] 67.6 [58.0, 84.5] 
Change -32.6 [-52.2, -22.4] -15.7 [-37.5, -4.6] -16.6 [-35.5, -0.1] -12.6 [-25.6, 11.5] 
P-value4 0.212 0.596 0.650 0.206 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 2nd October – 7th November, 2006. 
3All endpoint blood samples taken between 27th February – 7th April, 2007 







Table 6a.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 64+ 
year-old adults, stratified by habitual calcium intake above or below a selected threshold of 550 mg/d1*.   
Treatment Groups Placebo 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <550mg Ca/d    
n 5 7 6 
Serum 25(OH)D nmol/L):    
Pre-intervention2 79.8 [48.8, 113.0] 45.9 [33.3, 88.2] 41.8 [34.3, 49.7] 
Post-intervention3 56.2 [37.9, 62.8] 65.9 [58.6, 84.2] 68.1 [65.1, 79.1] 
Change -23.5 [-62.1, 0.92] 15.4 [2.2, 34.9] 31.7 [24.7, 39.0] 
    
Habitual calcium intake >550mg Ca/d    
n 48 44 44 
Serum 25(OH)D nmol/L):    
Pre-intervention2 59.0 [39.9, 75.5] 56.9 [43.5, 72.3] 55.1 [38.7, 69.9] 
Post-intervention3 39.6 [27.4, 54.2] 70.0 [58.2, 81.2] 68.2 [65.1, 95.2] 
Change -14.1 [-22.6, -6.1] 10.6 [-1.0, 19.5] 21.8 [7.0, 32.1] 
P-value4 0.534 0.180 0.093 
1Values represent medians [interquartile range] as non-normally distributed 
*The 5 µg vitamin D/d group was not included since there was only one subject with a habitual calcium intake , <550 mg Ca/d 
2All baseline blood samples taken between 28th September – 16th November, 2007. 
3All endpoint blood samples taken between 21st February and 5th April, 2008. 
4Unpaired t-test of the change from pre- to post- intervention serum 25(OH)D concentration between those below and above the habitual calcium intake. 
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Pre- and post-intervention serum 25(OH)D concentrations in 64+ year olds stratified by a 
habitual calcium intake threshold of 700 mg/d across vitamin D treatment groups (Placebo, 
5 µg vitamin D/d, 10 vitamin D µg/d, 15 vitamin D µg/d) are presented in Table 6b. The 
change in serum 25(OH)D concentration following intervention with placebo or vitamin D 
is also shown. There were significant differences in the change of serum 25(OH)D 
concentrations stratified by 700 mg Ca/d in the 5 g vitamin D/d (P=0.039) and 10 g 
vitamin D/d (P=0.019) treatment groups. There were no significant differences in the 
change of serum 25(OH)D concentrations between groups stratified by 700 mg Ca/d, in the 
placebo and 15 g vitamin D/d treatment groups (P>0.05, in both).  
Pre- and post-intervention serum 25(OH)D concentrations in 64+ year olds stratified by a 
habitual calcium intake threshold of 800 mg/d across vitamin D treatment groups (Placebo, 
5 µg vitamin D/d, 10 vitamin D µg/d, 15 vitamin D µg/d) are shown in Table 6c. The 
change in serum 25(OH)D concentration following intervention with placebo or vitamin D 
is also shown. There was a significant difference in the change of serum 25(OH)D 
concentrations between groups stratified by 800 mg Ca/d in the 5 g vitamin D/d treatment 
group (P=0.009). There were no significant differences in the change of serum 25(OH)D 
concentrations between treatment groups (P>0.05, in all cases).  
Pre- and post-intervention serum 25(OH)D concentrations in 64+ year olds stratified by a 
habitual calcium intake threshold of 1000 mg/d across vitamin D treatment groups 
(Placebo, 5 µg vitamin D/d, 10 vitamin D µg/d, 15 vitamin D µg/d) are shown in Table 6d. 
The change in serum 25(OH)D concentration following intervention with placebo or 
vitamin D is also shown. There was a significant difference in the change of serum 
25(OH)D concentrations between groups stratified by 1000 mg Ca/d in the 10 g vitamin 
D/d group (P=0.034). There were no significant differences in the change of serum 
25(OH)D concentrations between groups stratified by 1000 mg Ca/d in the remaining 
vitamin D treatment groups (P>0.05, in all cases). 
However, further analysis showed that after controlling for possible confounding effects 
(of sex, age, dietary vitamin D, BMI, smoking), the response of winter serum 25(OH)D 
does not differ in 64+ year-old adults by level of habitual calcium intake above and below 
any of the four thresholds (P>0.1 in all cases; data not shown).  Additional analysis in which 
the response of those with habitual calcium intakes <550 mg/d versus >1000 mg/d, 
unadjusted and adjusted for the confounding effects of sex, age, dietary vitamin D, BMI, 
smoking, showed no significant differences in the response of winter serum 25(OH)D in 







Table 6b. Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 64+ 
year-old adults, stratified by habitual calcium intake above or below a selected threshold of 700 mg/d1. 
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <700mg Ca/d     
n 13 9 20 16 
Serum 25(OH)D nmol/L):     
Pre-intervention2 44.0 [33.7, 69.3] 39.3 [36.3, 50.7] 48.8 [43.0, 65.1] 51.5 [41.2, 62.5] 
Post-intervention3 34.9 [25.8, 52.9] 49.9 [45.9, 61.0] 67.5 [58.7, 90.7] 78.8 [67.2, 91.8] 
Change -14.2 [-23.7, -2.8] 6.5 [3.1, 17.9] 16.5 [2.8, 30.6] 31.1 [20.6,34.7] 
     
Habitual calcium intake >700mg Ca/d     
n 40 37 31 34 
Serum 25(OH)D nmol/L):     
Pre-intervention2 63.0 [45.3, 78.5] 62.3 [45.2, 75.0] 61.8 [43.8, 76.3] 52.7 [37.4, 71.2] 
Post-intervention3 42.7 [28.0, 58.6] 53.7 [45.5, 71.6] 71.5 [58.0, 81.2] 67.2 [60.2, 86.4] 
Change -14.3 [-22.9, -7.9] -6.5 [-12.5, 12.5] 8.2 [-8.3, 16.6] 21.4 [6.8, 28.3] 
P-value4 0.864 0.039 0.019 0.115 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 28th September – 16th November, 2007. 
3All endpoint blood samples taken between 21st February and 5th April, 2008. 







Table 6c.  Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 64+ 
year-old adults, stratified by habitual calcium intake above or below a selected threshold of 800 mg/d1.   
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <800mg Ca/d     
n 20 12 27 24 
Serum 25(OH)D nmol/L):     
Pre-intervention2 57.8 [38.1, 79.7] 41.3 [35.3, 65.3] 51.2 [43.3, 67.8] 47.2 [37.3, 62.5] 
Post-intervention3 47.4 [26.3, 56.5] 50.6 [45.3, 75.1] 66.9 [56.4, 84.2] 74.0 [60.4, 90.2] 
Change -12.9 [-23.8, -4.3] 6.1 [1.7, 16.4] 14.4 [2.2, 25.3] 24.8 [15.5, 34.1] 
     
Habitual calcium intake >800mg Ca/d     
n 33 34 24 26 
Serum 25(OH)D nmol/L):     
Pre-intervention2 59.6 [44.6, 75.3] 59.9 [45.3, 74.8] 64.4 [42.2, 78.5] 56.0 [38.3, 71.9] 
Post-intervention3 39.5 [27.8, 54.5] 53.2 [45.5, 68.9] 72.6 [59.3, 81.1] 69.3 [61.5, 88.7] 
Change -15.6 [-22.8, -11.1] -6.8 [-13.8, 12.5] 7.7 [-8.8, 18.3] 21.8 [5.4, 31.5] 
P-value4 0.644 0.009 0.140 0.204 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 28th September – 16th November, 2007. 
3All endpoint blood samples taken between 21st February and 5th April, 2008. 







Table 6d. Serum 25-hydroxyvitamin D (25(OH)D) concentration among vitamin D treatment groups pre- and post-intervention and its change in 64+ 
year-old adults, stratified by habitual calcium intake above or below a selected threshold of 1000 mg/d1.   
Treatment Groups Placebo 5 µg vitamin D/d 10 µg vitamin D/d 15 µg vitamin D/d 
Habitual calcium intake <800mg Ca/d     
n 33 24 35 31 
Serum 25(OH)D nmol/L):     
Pre-intervention2 58.8 [38.6, 78.7] 51.2 [38.6, 71.2] 52.3 [43.3, 69.6] 52.6 [41.0, 69.6] 
Post-intervention3 40.3 [27.4, 56.4] 50.4 [45.4, 73.2] 68.1 [58.5, 83.8] 77.7 [62.3, 86.1] 
Change -13.4 [-23.7, -6.5 ] 3.44 [-9.2, 14.9] 14.4 [1.8, 25.4] 24.1 [9.0, 34.1] 
     
Habitual calcium intake >800mg Ca/d     
n 33 34 24 26 
Serum 25(OH)D nmol/L):     
Pre-intervention2 61.4 [44.9, 77.7] 58.7 [42.2, 74.8] 64.4 [41.8, 91.0] 55.7 [36.6, 64.1] 
Post-intervention3 39.5 [27.7, 55.1] 55.3 [45.5, 68.9] 72.6 [58.2, 80.8] 66.8 [60.3, 104.3] 
Change -15.6 [-22.6, -6.1] -6.8 [-10.9, 12.5] 7.7 [-13.8, 16.1] 23.8 [7.0, 32.9] 
P-value4 0.723 0.537 0.034 0.718 
1Values represent medians [interquartile range] as non-normally distributed 
2All baseline blood samples taken between 28th September – 16th November, 2007. 
3All endpoint blood samples taken between 21st February and 5th April, 2008. 
4Unpaired t-test of the change from pre- to post- intervention serum 25(OH)D concentration between those below and above the habitual calcium intake 
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This was also the case when <700 mg/d versus >1000 mg/d calcium intake cut-offs were 
compared, except for a significant difference in 64+ year olds adults which disappeared 
when controlled for confounding factors (data not shown). 
 
Task 3.  Update of database of vitamin D RCTs and meta-regression analyses.   
 
The database of published vitamin D RCTs performed in winter and at regions of latitude 
>46oN (or S) was updated using the same search strategy as used in our recent meta-
regression (Cashman et al., 2011b).  The search was from February 2011 to March 2013 
so as to update our previous systematic review.  The updated search yielded several new 
vitamin D RCTs but after consideration of inclusion and exclusion criteria we only 
identified two new vitamin D RCTs that could be included (Cashman et al., 2012; Logan 
et al., 2012).  Data from these two new RCTs were extracted as well as mean calcium 
intake data from the RCTs in the original database (Cashman et al., 2011b).  One of the 
RCTs in the original database (Smith et al., 2009) did not report calcium intake and as the 
group used in the RCT was multi-ethnic we could not identify a surrogate calcium intake 
from nationally representative intake data which could be used for this study.  Therefore, 
this RCT was not included in the present analysis.  The data acquired was used to test for 
an interaction between the predicted response of winter serum 25(OH)D to total vitamin 
D intake and mean habitual calcium intake in a meta-regression model approach as used 
by us previously (Cashman et al., 2011b). 
 
A review of the RCTs to be included in this analysis showed that the number of RCT arms 
with mean intakes of calcium below 550, 700 or 800 mg/d (as per Task 1 and 2) was 
extremely limited at 0, 0 and 1, respectively (see Table 7).  Therefore, as these cut-offs 
could not be used, we choose to use the median of the reported mean calcium intakes from 
the 11 RCTs in the updated Vitamin D RCT database as a cut-off.  The RCT arms were 
stratified on the basis of their mean calcium intakes being above or below this median 
intake of 1092 mg/d.   This yielded n 16 and n 12 RCT arms whose mean habitual calcium 
intakes were below or above this median intake, respectively (Table 7).   
 
A weighted linear regression analysis (total vitamin D intake versus achieved winter-time 
serum 25(OH)D) was performed for each of the two sub-groups of RCT arms separately. 
The relationship between total vitamin D intake versus achieved winter-time serum 
25(OH)D in the two subgroups of RCT arms is shown in Figure 1. The regression lines 
cross suggesting that an interaction exists between the response of winter serum 25(OH)D 
to total vitamin D and dietary calcium category (mean < and ≥ 1092 mg/d), such that those 
with lower mean calcium intakes had a less steep slope (response of serum 25(OH)D) 
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compared to those with higher mean calcium intakes (the two slopes were significantly 
different; 0.030 versus 0.044, respectively; P=0.023).  Therefore, achievement of a serum 
25(OH)D of 50 nmol/L required a lower vitamin D intake in those with a higher mean 
calcium intakes (≥1092 mg/d) than those with the lower mean intakes (<1092 mg/d).  The 
significance of the interaction between total vitamin D intake and category of calcium 
intake was also tested in a regression model (P=0.03). The 95% lower Confidence Interval 
(CI) of the regression lines (as per the IOM approach) would predict total vitamin D 
intakes of 129 and 35 IU/d (equivalent to 3.2 and 0.9 μg/d, respectively) at the 30 nmol/L 
serum 25(OH)D threshold for the below and above than median calcium intake groups of 
RCT arms, respectively. However, the use of 95%CI versus 95% Prediction Intervals (PI) 
in the regression models allow prediction at the average (EAR) and at the 97.5th percentile 
(RNI), respectively (Cashman & Kiely, 2014). Thus, the 95% lower PI would be more 
appropriate for the estimation of a population reference intake, such as the RNI, but its 
generation from meta-regression data is only an approximation and it lends itself much 
more to generation from individual data from an RCT.  As per our research strategy and 
approach, we awaited the outcome of the Part B de novo RCT to confirm an effect of 










































































































































































































nmol/L nmol/L (Mos) reported 
1 Finland 61 8-10 (9)3 45 56 24 400 2005 600 10925 49.2 ± 19.04 77.9 ± 23.74 Jan-
Mar 
Y N N CPBA 
      27 0 2005 200 10925 45.9 ± 15.5 43.2 ± 19.5     
2 Germany 52 70+ (74) 0 8 74 800 1286 928 21906 25.7 ± 13.6 64.8 ± 27.4 Mar-
May 
Y N Y RIA 
      77 0 1286 128 21906 24.6 ± 12.1 44.4 ± 27.4     
3 UK 55 18-27 (21) 50 8 15 600 65 665 2249 47.9 ± 16.0 85.6 ± 24.5 Jan-
Mar 
Y N N EIA 
      12 0 96 96 2383 55.5 ± 18.6 48.3 ± 16.8     
4 Finland 61 65-85 (71) 0 12 13 800 388 1188 1152 44.1 ± 13.5 70.2 ± 13.5 Jan-
Apr 
Y N N HPLC 
      11 400 424 824 911 46.5  ± 10.2 60.4 ± 10.2     
      13 200 388 588 1225 46.0 ± 10.2 55.0 ± 10.2     
      12 0 436 436 946 52.2 ± 19.9 43.9 ± 19.9     




Y Y Y EIA 
      57 400 140 540 976 72.2 ± 26.8 60.0 ± 13.4     
      48 200 172 372 905 60.0 ± 29.4 49.7 ± 11.4     
      57 0 136 136 924 65.7 ± 26.5 37.4 ± 12.2     




Y Y Y EIA 
      53 400 168 568 751 54.3 ± 21.8 69.5 ± 17.0     
      48 200 164 364 866 51.8 ± 22.1 53.2 ± 17.0     
      55 0 188 188 976 58.8 ± 25.9 41.6 ± 17.1     
7 Antartica 78 42 59 20 18 2000 302 2302  45.0 ± 14.0 71.0 ± 23.0 Mar-
Aug 
Y Y Y RIA 
      19 1000 329 1329  44.0 ± 19.0 63.0 ± 25.0     
      18 400 356 756  44.0 ± 18.0 57.0 ± 15.0     






Abbv: years, y; months, mos; weeks, wks; days, d; international units, IU; January, Jan; March, Mar; April, Apr; September, Sept; October, Oct. 
*List of references: 1) Ala-Houhala et al., 1988. 2) Pfeifer et al., 2001. 3) Barnes et al., 2006. 4) Viljakainen et al., 2006 5) Cashman et al., 2008. 6) Cashman et al., 2009. 7) Smith et al., 2009. 
8) Viljakainen et al., 2009. 9) Cashman et al., 2011. 10) Cashman et al., 2012. 11) Logan et al., 2012. 
1Dose of vitamin D confirmed independently by analysis. 
2Analytical method for circulating 25(OH)D: enzyme linked immune assay, EIA; radioimmunoassay, RIA; competitive binding protein assay, CBPA; high performance liquid 
chromatography, HPLC. 
3Mean age is depicted in parentheses, and on its own in the case that an age range is not given. 
4Mean ± standard deviation. 
5 Intake estimated from Andersen et al., 2006. 
6 Intake estimated from Flynn et al., 2009. 
7Intake estimated from Nowson et al., 2012. 
8An average latitude was taken from Helsinki, Finland (61N) and Copenhagen, Denmark (55°N). 
8 Finland 61 21-49 (29) 100 25 16 800 34 1144 1510 60.3 ± 11.6 90. ± 11.6 Nov-
Apr 
Y Y Y EIA 
      16 400 304 704 1260 62.3 ± 13.6 75.6 ± 13.6     




588 11.4 0 52 49 400 156 556 1197 58.4 ± 13.9 58.8 ± 10.9 Sept-
Mar 
Y Y Y HPLC 
     49 200 156 356 1158 57.4 ± 12.4 47.6 ± 8.0     
     46 0 148 148 1052 54.5 ± 14.8 31.0 ± 10.0     
10 Ireland 51 50+ (57) 45 10 13 800 304 1104 1114 49.7 ± 16.2 69.0 ± 8.7 Jan-
Mar 
Y Y Y ELISA 












+ tandom MS 
      25 0 1007 100 869 81.0 ± 21.7 37.0 ± 16.6    






Figure 1. The relationship between total vitamin D intake and achieved serum 25(OH)D 
during winter stratified by category of calcium intake (dashed line representing data from 
RCTs with mean intakes below median [1092 mg/d]; full line representing data from 




3.2.4  Discussion of Part A findings 
 
Overall, the post hoc analysis of data from the four individual vitamin D RCTs in Part A 
may suggest very little, if any, effect of habitual calcium intake on the response of serum 
25(OH)D to vitamin D intake (and thus vitamin D requirements). This is caveated by the 
fact that the four vitamin D RCTs used in the present analysis were not designed to test 
the effect of calcium intake on dietary vitamin D requirements. The mean habitual calcium 
intake in the three population groups investigated were relatively good (mean/median 
1122, 976 and 874 mg/d, for girls, young adults and older adults, respectively) and thus 
the numbers with calcium intakes below the lower cut-offs (550 and 700 mg/d), which are 
important public health-related intakes, were relatively low (n typically in range of 1 to 
~20).  This is an important limitation in terms of drawing conclusions on the impact of 
dietary calcium on response of serum 25(OH)D and thus dietary requirement estimates 
for vitamin D. Using data from all subjects within an age-group, regression analysis also 
suggested no interaction between habitual calcium intake on the response of serum 
25(OH)D to vitamin D intake.   
 
The interaction between vitamin D and dietary calcium was also tested using existing RCT 
data but from a wider selection of vitamin D RCTs in the meta-regression approach.  The 
data used in the meta-regression was a mix of winter-based RCTs in children (n 2), adults 
(up to 50 y; n 4) and older adults (>50 y; n 5) and the analysis suggested an interaction 
between the response of winter serum 25(OH)D to total vitamin D and dietary calcium 
category (mean < and ≥ 1092 mg/d). Using a target serum 25(OH)D of 50 nmol/L (which 
the IOM suggest covers the needs of 97.5% of the population in terms of bone health), 
then those with a higher mean calcium intakes (≥1092 mg/d) required a lower vitamin D 
intake compared to those lower mean intakes (<1092 mg/d). It is important to stress that 
the cut-off was a median of group mean calcium intakes and thus reflected more a 
delineation of high calcium intake from lower intake. It is possible that the significant 
interaction in this meta-regression approach may be related to the relatively unadjusted 
analysis. In the analysis of our individual vitamin D RCTs some of the significant 
differences in response of serum 25(OH)D to different doses of vitamin D, especially in 
64+ year olds became non-significant when adjusted for smoking, BMI, age and gender. 
Data on possible confounding variables were  not sufficient in all the RCTs selected for 
the meta-regression such that they could to be included. 
 
Overall, the data from Part A underscored the need for the hypothesis that calcium intake 
modifies vitamin D requirement be tested more vigorously in a RCT specifically designed 
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to address this question. This is Part B of the present work, and we indicated that should 
the hypothesis be confirmed by the new RCT, we would return to the individual data from 
our previous vitamin D RCTs and generate RNI estimates for those with moderate-low 
and high calcium intakes.  
3.3 Part B -De novo Vitamin D  Calcium RCT 
 
3.3.1  Specific objective 
 
To conduct a randomised, placebo-controlled, single-dose vitamin D3 RCT in apparently 
healthy, free-living adults (aged 50+ years) to investigate whether different levels of 
habitual calcium intake ranging from low-moderate to high (<EU EAR [550 mg/d] and 
>US RDA [1000 mg/d, dependent on age]), influence serum 25(OH)D concentrations, 
and also indices of vitamin D activation and catabolism as explanatory variables, during 
winter, when vitamin D intake is adequate versus inadequate. 
 
3.3.2  Subjects and methods 
 
3.3.2.1  Recruitment of study subjects 
A total of 125 apparently healthy, free-living adults aged ≥50 years were recruited to this 
15-week vitamin D3 intervention trial. Subjects were recruited following a strong 
advertising campaign in the Cork catchment area, which included adverts on both radio 
and newspaper and also through the placement of posters on the campus of University 
College Cork and across the location. The recruitment phase began in September 2012. 
We aimed to recruit a ratio of approximately 2.5:1 women to men, as this was reflective 
of the ratio of women to men with a ‘moderate-low’ (<700 mg/d) habitual dietary calcium 
intake as reported in the National Adult Nutrition Survey in Ireland (IUNA, 2011) and 
also the National Diet and Nutrition Survey, UK (Henderson et al, 2003). Adults that were 
interested in participating in this study contacted a research nutritionist in the Cork Centre 
for Vitamin D and Nutrition Research who explained in detail the purpose of the study 
and what would be required of the participant for the duration of the trial should they 
decide to participate. Potential volunteers were also assessed for inclusion and exclusion 
criteria as follows: 
White men and women aged ≥50 years that provided consent were included in the study. 
Those who were not willing to suspend the consumption of vitamin D supplements for the 
4 weeks prior to the first visit and throughout the study period were excluded. Volunteers 
were also excluded if they planned to take a winter vacation to a location of either low 
latitude or high altitude (e.g., a winter sun or a mountain ski holiday) at which it would be 
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expected that there would be significant dermal production of vitamin D due to exposure 
to UVB radiation. Other exclusion criteria included a severe medical illness, 
hypercalcaemia, a known intestinal malabsorption syndrome, use of tanning facilities of 
any type, excessive alcohol use or the use of contraindicated medications known to alter 
the metabolism of vitamin D. 
The study was approved by the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals, University College Cork. All participants gave their written consent according 
to the Helsinki Declaration. This trial was registered at clinicaltrials.gov as 
NCT01990872. 
3.3.2.2  Design and conduct of study 
This study was a double-blind, randomised, placebo-controlled vitamin D intervention 
trial. Subjects’ habitual calcium and vitamin D intakes were assessed initially during the 
recruitment phase using a validated food frequency questionnaire that was administered 
by a research nutritionist. Subjects were stratified according to their habitual calcium 
intake, in this case a habitual calcium intake of <700 mg/d was considered to be 
‘moderate-low’ and >1000 mg/d to be ‘high’ and subjects were then randomised to receive 
either placebo or 20 µg vitamin D3 daily for 15 weeks throughout winter. Supplements 
were identical in appearance and taste. The contents of supplements used were confirmed 
using an in-house laboratory high performance liquid chromatography (HPLC) analysis 
at University College Cork.  
The Reference Nutrient Intake and Population Reference Intake value for calcium is 700 
mg/d in the UK and EU, respectively. According to the NDNS, approximately 49% men 
and 69% women (aged 50-64y) in the UK have calcium intakes below this reference intake 
level. The EAR for calcium in the EU is 550 mg/d, in the UK population there is 
approximately 5% men and 15% women with intakes below this intake level. In relation 
to the high calcium intake, North American IOM guidelines have suggested the EAR and 
RDA for calcium for women (>50 y) and men (>70 y) are 1000 mg/d and 1200 mg/d 
respectively.  For men (aged 50-70 y), the RDA for calcium is 1000 mg/d (IOM, 2011). 
In addition for the purposes of informing the design of the present RCT, we used the data 
from Part A. Stratification of the RCTs by the median (1092 mg/d) of the reported average 
calcium intakes in these studies showed that there was a significant (P<0.05) interaction 
between calcium intake (above or below 1092 mg/d) and vitamin D intake such that those 
with lower calcium intakes had a less steep slope (response of serum 25(OH)D) compared 
to those with a higher calcium intake (the two slopes were significantly different; 0.030 
versus 0.044, respectively; P=0.023).  Therefore, achievement of a serum 25(OH)D of 50 
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nmol/L required a lower vitamin D intake in those with a higher calcium intakes (>1092 
mg/d) than those with the lower intake (<1092 mg/d). 
To maximise subject recruitment in the study, any subject (n 38) whose habitual calcium 
intake was above 700 mg/d but did not reach the >1000 mg/d target was asked during 
recruitment if they would take additional calcium. Subjects were given a choice as to 
whether they wished consume the additional calcium in the form of a supplement (one 
Calcichew tablet containing 500 mg calcium alone [Shire Pharmaceuticals Ireland Ltd, 
Citywest Business Campus, Dublin 24, Ireland]; n 36 opted for this route) or as additional 
milk in their diet (n 2 for this route), so that their calcium intake would be greater than 
1000 mg/d for the duration of the intervention phase. This additional calcium intake was 
started four weeks before the intervention phase commenced to allow for normalisation 
of calcitropic hormone levels (Dawson-Hughes et al, 1993).  
The IOM have suggested that the ‘RDA-like’ serum 25(OH)D concentration required to 
meet the needs of 97.5% of the population aged 1 year + is 50 nmol/L (IOM, 2011). On 
the basis of this serum concentration of 25(OH)D, the IOM has established the RDA for 
vitamin D at 15 and 20 μg vitamin D daily for those aged 1-70 years and >70 years, 
respectively, in North America (IOM, 2011). We have previously reported that a vitamin 
D RDA estimate of 24.7 μg/d was needed to maintain wintertime serum 25(OH)D over 
50 nmol/L in 97.5% of adults aged 64+ y residing in Ireland (51-55oN) (Cashman et al, 
2009), and confirmed again recently in our RCT with vitamin D versus 25-
hydroxyvitamin D in those aged 50+ years (Cashman et al, 2012). Therefore, we choose 
to use 20 μg/d supplemental vitamin D3, which together with a habitual intake of vitamin 
D of ~5 μg/d in Irish adults (IUNA, 2011), would provide about 25 μg/d in the present 
study.  
The randomisation of subjects to treatment groups was centralised and computer 
generated, and habitual calcium intake grouping (as per above) and sex were controlled 






Figure 2.  Flow of subjects through the study. 
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3.3.2.3  Laboratory analysis 
 
Serum 25-hydroxyvitamin D.  
 
The concentrations of total 25-hydroxyvitamin D [25(OH)D] (i.e., 25(OH)D2 plus 25(OH)D3) 
in all serum samples were measured by the Vitamin D Research Group at University College 
Cork using a liquid chromatography-tandem mass spectrometry (LC-tandem MS) method, 
described in detail elsewhere (Cashman et al, 2013).  The quality and accuracy of serum 
25(OH)D analysis by the LC-tandem MS in our laboratory is monitored on an ongoing basis 
by participation in the Vitamin D External Quality Assessment Scheme [DEQAS, Charing 
Cross Hospital, London, UK]. In addition, the Vitamin D Research Group is a participant in 
the Vitamin D Standardization Program (VDSP) (Sempos et al, 2012) and Vitamin D 
Standardization Certification Program (VDSCP) (Rahmani et al, 2013). 
 
Serum intact parathyroid hormone. 
 
Serum PTH concentrations were measured at University College Cork in all serum samples 
using an ELISA [Intact parathyroid hormone, MD Biosciences Inc., St. Paul, MN 55108].  The 
intra- and inter-assay CV was 3.4% and 3.8%, respectively. 
 
Serum total calcium.  
Total calcium and albumin concentrations in all serum samples were measured at Cork 
University Hospital, Cork, Ireland.  Serum calcium concentrations were adjusted for albumin 
concentration. 
 
Serum 1,25-dihydroxyvitamin D.  
 
1,25-dihydroxyvitamin D [1,25(OH)2D] concentrations were measured at University College 
Cork in baseline and endpoint serum samples using an ELISA [IDS 1,25-dihydroxyvitamin D 
EIA, Immuno Diagnostic Systems, Ltd., Boldon, UK].  The intra- and inter- assay CV for the 
ELISA method was 10.5% and 17.1%, respectively.   
 
Serum 24,25-dihydroxyvitamin D. 
 
The concentrations of 24,25(OH)2D in baseline and endpoint serum samples were measured 
by the Vitamin D Research Group at University College Cork using an in-house LC-tandem 
MS method which was a modification of the method for measurement of 25(OH)D as 
described elsewhere (Cashman et al, 2013).  The following summarized the modifications 
made to the original LC-tandem MS method for serum 25(OH)D. 24,25(OH)2D3 and stable 
isotope labelled d6-24,25(OH)2D3 were purchased from Isosciences (4667 Somerton Road, 
Trevose, PA 19053, USA).  In-house serums were used for low and high QC materials.  The 
chromatographic column was a Supelco Ascentis Express F5 (10cm x 2.1mm, 2.7m) 
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available from Sigma-Aldrich. Following addition of internal standard to the sample and 
adequate mixing, an aqueous solution of zinc sulphate was added to aid in the release of 
analytes from the vitamin D binding protein. Methanol was used to precipitate the proteins 
while a hexane/ethyl acetate (50:50) was the extraction solvent. Following extraction, samples 
were dried and reconstituted in UPLC mobile phase. Quality control serums were extracted 
and analysed in parallel to samples and were strategically placed close to the beginning, 
middle and end of the analysis on the LC-tandem MS instrument.  Chromatographic resolution 
of 24,25(OH)2D3 was achieved on an Ascentis Express F5 column using an isocratic mixture 
of 32:68 A:B at 0.45 ml/min (where mobile phase A was 0.1% formic acid + 2 mM ammonium 
acetate in water and B was 0.1% formic acid + 2 mM ammonium acetate in methanol). A 
gradient with increased organic composition was applied towards the end of the 10 minute 
chromatographic run to wash out organic materials followed by a re-equilibration to initial 
conditions. MS detection was achieved on the Waters Acquity triple quadrupole detector 
through electrospray ionisation in positive ion multiple reaction monitoring (MRM) mode. 
Nitrogen was the desolvation gas and high purity Argon (BOC Ltd, Ireland) was the collision 
gas. 
 
The ion MRM transition monitored for d6-24,25(OH)2D3 was m/z 417.3 → m/z 121.1.  The 
quantifier transition for 24,25(OH)2D3 was m/z 417.3 → m/z 363.3 with m/z 417.3 → m/z 
121 being used as a confirmatory transition. The inter-assay CV of the method was <5%, while 
the intra-assay CV was <12%.   
 
Serum vitamin D binding protein.  
 
Vitamin D Binding Protein (DBP) concentrations were measured at University College Cork 
in baseline and endpoint serum samples using an ELISA [Human Vitamin D BP Quantikine 
ELISA Kit, R&D Systems, USA]. The intra- and inter- assay CV for the ELISA method was 
6.2% and 7.4%, respectively.   
 
Estimation of serum free 25(OH)D concentrations and 24,25(OH)2D:25(OH)D ratio 
 
It has been suggested that free bioavailable 25(OH)D may provide for a more meaningful 
marker of vitamin D function (Chun et al, 2014). For example, an individual with inadequate 
serum total 25(OH)D (<50 nmol/L), might nevertheless have adequate levels of free 25(OH)D 
if serum levels of DBP are low (Chun et al, 2014).  Therefore, we calculated the concentration 
of free 25(OH)D using a previously described equation (Bolland et al, 2007).  The ratio of 
24,25(OH)2D to 25(OH)D has also been suggested as possible sensitive marker of vitamin D 
status and possess clinical utility as a marker for vitamin D catabolism because its production 
is reduced in the early stages of vitamin D deficiency and may be increased when vitamin D 
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supply is high, as the first step in the catabolic pathway of 25(OH)D (Schoenmakers et al., 
2010; Wagner et al. 2011). 
 
3.3.2.4  Statistical analysis 
Berlin & Björkhem (1988) reported a mean difference in winter serum 25(OH)D of 17 nmol/L 
in Swiss men supplemented compared to un-supplemented with calcium.  Stratification of 
vitamin D RCTs included in a previous meta-analysis by the Cork Centre for Vitamin D and 
Nutrition Research of functional markers of vitamin D status by whether vitamin D was 
administered alone or in conjunction with calcium (Seamans & Cashman, 2009) suggested a 
difference in average group mean serum 25(OH)D between groups receiving vitamin D alone 
compared with calcium plus vitamin D of ~13 nmol/L. Therefore, we used a more 
conservative 10 nmol/L difference as what we would need to be able to detect between 
calcium intake groups. On the basis of the distribution of winter time serum 25(OH)D data 
from older adults from a previous study by the Cork Centre for Vitamin D and Nutrition 
Research (Cashman et al. 2012), a study design recruiting 30 volunteers/group (which 
included 20% to cover potential drop-outs) will have 90% power to detect a 10 nmol/L 
difference in serum 25(OH)D between groups at α=0.5. 
Statistical analysis of the data was conducted using SPSS© for WindowsTM Version 22.0 
(SPSS, Inc., Chicago, IL, USA).  The distributions of all variables were tested with 
Kolmogorov-Smirnov tests. Descriptive statistics (means ± SD or medians and interquartile 
range [IQR], when appropriate) were determined for all variables.  Dietary vitamin D, serum 
PTH, 24,25(OH)2D, free 25(OH)D, and 1,25(OH)2D were not normally distributed and thus 
were either log or square root transformed to achieve near-normal distributions. Serum 
concentrations of 25(OH)D, albumin-corrected calcium, DBP, 24,25(OH)2D:25(OH)D ratio 
as well as age, weight, height, BMI and dietary calcium were normally distributed. Baseline 
characteristics of male and female subjects were compared using unpaired Student’s t tests.  
Baseline characteristics of subjects in the different intervention groups were compared using 
Chi-square (for ratio of men to women) and one-factor analysis of variance (ANOVA). Linear 
models of the response in a repeated measures analysis for the differences in serum 25(OH)D, 
albumin-corrected calcium, PTH, 24,25(OH)2D, 1,25(OH)2D, 24,25(OH)2D:25(OH)D, free 
25(OH)D, and DBP concentrations were constructed. The linear models included three- and 
two-way interactions between the main effects (calcium intake grouping and vitamin D 
treatment) and these were reported.  If no significant calcium intake grouping × vitamin D 
treatment × time interaction was observed, then calcium intake grouping × time and vitamin 
D treatment × time interactions were explored.  The models were also run to include sex as an 
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additional factor.  Bonferroni-adjusted t tests were used for post hoc analysis to the ANOVA.  
A P-value of <0.05 was taken as being statistically significant.  
3.3.3. Results of Part B 
3.3.3.1 Baseline characteristics of subjects in de novo RCT 
Of 125 subjects recruited onto the study, 121 subjects completed the intervention.  The 
progress of these subjects through the trial is shown in Figure 2. The baseline characteristics 
of those subjects who entered the intervention are shown in Table 8. While women were, on 
average, lighter and smaller than men (both P<0.0001) and had lower serum 1,25(OH)2D 
concentrations (P<0.05), there was no difference (P>0.1) in mean age, BMI, habitual intakes 
of vitamin D and calcium, serum 25(OH)D, albumin-corrected calcium, PTH, 24,25(OH)2D, 
DBP, or free 25(OH)D concentrations between men and women (data not shown).  
 
3.3.3.2 Effects of intervention with vitamin D3 in moderate-low- and high- calcium intake 
groups 
There was no difference (P>0.3) in mean age, weight, height, or BMI at baseline among the 
four treatment groups (placebo and vitamin D3 with moderate-low calcium intake groups; 
placebo and vitamin D3 with high calcium intake groups) (data not shown).  Similarly, there 
was no significant difference in the proportion of men to women among the treatment groups 
(Table 9). Mean habitual dietary vitamin D was significantly (P=0.01) higher in the group 
with ‘high calcium’ intake who were randomised to receive vitamin D supplementation 
compared to the ‘moderate-low’ calcium intake group who were randomised to receive 
placebo, but otherwise there was no significant difference (Table 9). Mean habitual dietary 
calcium was similar among the two ‘moderate-low’ calcium intake groups and similar among 
the two ‘high calcium’ intake groups, with the latter two groups significantly higher calcium 
intake (P<0.0001) than the former two groups (Table 9).  The mean total calcium intakes 
(habitual intake plus additional calcium intakes) for the two ‘high calcium’ intake groups are 
shown in Table 9, and these were similar (P>0.7).  
 
There were no adverse events reported during the study. Of the 4 dropouts, two subjects were 
in the period between baseline and midpoint sampling (one subject was from the ‘moderate-
low’ calcium intake plus 20 g vitamin D3/d group, one from the ‘high calcium’ intake plus 
placebo group), and two subjects (both from the ‘high calcium’ intake plus 20 g vitamin D3/d 
group) were in the period between midpoint and endpoint sampling.  Dropout during the 
intervention phase was for reasons of unavailability or loss of interest, and in no instance was 
dropout related to the intervention.  
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Table 8.  Baseline characteristics of the subjects who entered the intervention study1. 
n 125 
Male:Female 35:90 
Age (y) 59.9  6.5  
Weight (kg) 72.5  13.3 
Height (m) 1.64  0.11 
BMI (kg/m2) 26.7  4.2 
Dietary calcium (mg/d) 814  413  
Dietary vitamin D (µg/d) 4.4 [2.9, 6.8] 
Serum 25(OH)D (nmol/L) 55.1  20.4 
Serum calcium (mmol/L)2 2.3  0.1 
Serum PTH (pg/mL) 46.1 [35.9, 60.3] 
Serum 1,25(OH)2D (pmol/L) 77.6 [56.9, 99.6] 
Serum 24,25(OH)2D (nmol/L) 2.23 [1.24, 3.39] 
Serum DBP (mg/L) 216  74  
Serum free 25(OH)D (pmol/L) 17.3 [13.2, 24.7] 
 
DBP, vitamin D binding protein. 
1Values represent means  SD or medians [interquartile range] in the case of non-









Table 9. Dietary intakes of vitamin D and calcium and serum 25(OH)D; calcium and, PTH concentrations among treatment groups at baseline, mid-point and 
end-point of the 15 week-intervention in apparently healthy older adults1 
 
Calcium intake group  Low Calcium (<700 mg/d) High Calcium (>1000 mg/d) Repeated measures ANOVA 
Vitamin D3 treatment groups  Placebo 20 µg Vitamin D3/d Placebo 20 µg Vitamin D3/d P
5 P6 P7 
n (at endpoint) 28 27 32 34    
Sex (male:female)2 8:20 8:19 8:24 10:24    
Habitual dietary vitamin D (g/d)2,3 3.0 [2.2, 5.5]a 4.0 [2.8, 6.6]ab 3.8 [3.2, 6.1]ab 6.1 [4.3, 9.2]b - - - 
        
Dietary calcium (mg/d) 2,4:        
     Habitual 514  156a 479  169a 1061  373b 1072    389b - - - 
     Habitual + supplemental 514  156a 479  169a 1358  254b 1337  258b - - - 
        
Serum 25(OH)D (nmol/L):        
     pre-intervention8,9,10 58.3   16.7 54.3    25.1 54.3   16.7 54.3    22.3    
     mid-intervention 44.3   15.8 76.1    16.4 43.4   16.0 73.0    14.9    
     post-intervention 42.1   14.8 80.4    18.7 41.4   16.3 74.3    15.4 0.202 0.840 <0.0001 
        
Serum calcium (mmol/L)11:        
     pre-intervention8,9 2.3  0.1 2.3  0.1 2.3  0.1 2.3  0.1    
     mid-intervention 2.4  0.1 2.4  0.1 2.3  0.1 2.4  0.1    
     post-intervention 2.3  0.1 2.4  0.1 2.3  0.1 2.3  0.1 0.494 0.971 0.310 
        
Serum PTH (ng/mL):        
     pre-intervention8,9,12 47.0 [35.6, 59.9] 53.7 [38.2, 70.5] 43.1 [35.0, 52.2] 42.8 [33.3, 59.9]    
     mid-intervention 45.0 [40.5, 65.2] 52.9 [41.4, 64.4] 45.2 [39.2, 55.6] 43.0 [32.1, 54.3]    







Table 9 continued… 
 
125(OH)D, 25-hydroxyvitamin D; PTH, parathyroid hormone. 
2Chi-square test was used to test differences for between-group differences in case of sex (P>0.9) and ANOVA was used in the case of dietary calcium  
(both P<0.0001) and vitamin D (P<0.01).  a,bDifferent superscript letters represent significant differences among group means: P<0.05 (Bonferroni-adjusted t test).   
3Medians [interquartile range] of non-normally distributed variable (all such values) 
4Mean    SD (all such values) 
5Repeated-measures ANOVA was used to test the time × vitamin D treatment × calcium intake grouping interaction effect. 
6Repeated-measures ANOVA was used to test the time × calcium intake grouping interaction effect. 
7Repeated-measures ANOVA was used to test the time × vitamin D treatment interaction effect. 
8There were no significant differences in baseline concentrations across the four groups (P>0.4 in all cases). 
9All baseline blood samples taken between 5th and 23th November 2012 and all endpoint blood samples taken between 18th February and 14th March 2013. 
10Mean (± SD) serum 25(OH)D concentrations in the combined 20 µg Vitamin D3/d groups (n 64), irrespective of calcium intake grouping, increased significantly from baseline by 
week 8 (P<0.0001; via Bonferroni-adjusted t test) and further  by week 15 (P=0.005) (54.3 ± 23.4 to 74.3 ± 15.5 to 76.9 ± 17.1 nmol/L, respectively).   Conversely, mean (± SD) 
serum 25(OH)D concentrations in the combined Placebo groups (n 61), decreased significantly from baseline by week 8 (P<0.0001) and further  by week 15 (P=0.002) (56.1 ± 16.7 
to 43.8 ± 15.8 to 41.7 ± 15.5 nmol/L, respectively). 
11Albumin corrected. 
12Median [interquartile range] baseline serum PTH in the two ‘moderate-low calcium’ intake groups combined (n 56) was significantly higher than that in the two ‘high calcium’ 




There was good supplement adherence on the basis of the pill count (median [IQR] 
compliance was 98.6% [94.3; 100%], and compliance was similar among the 4 treatment 
groups; P=0.9). 
 
The effect of vitamin D treatment in the two calcium intake groupings (‘moderate-low’ 
versus ‘high’) on serum 25(OH)D, albumin-corrected calcium and PTH at baseline, 
midpoint and endpoint is shown in Table 9.  There was no significant difference in pre-
intervention serum 25(OH)D concentrations among the treatment groups (Table 9).  
Repeated measures ANOVA showed that there was no significant (P=0.2) time × vitamin 
D treatment × calcium intake grouping interaction effect on mean serum 25(OH)D 
concentration over the 15-wk intervention period (Table 9).  Likewise, there was no 
significant (P=0.8) time × calcium intake grouping interaction effect, but there was a 
significant (P≤ 0.0001) time × vitamin D treatment interaction effect on mean serum 
25(OH)D concentration over the 15-wk intervention period (Table 9).  As calcium intake 
grouping had no effect, the mean (± SD) baseline serum 25(OH)D of the two groups 
combined who received 20 µg/d of vitamin D3 (54.3 ± 23.4 nmol/L; n 64) was similar 
(P>0.6) to that of the two groups combined who received placebo  (56.1 ± 16.7 nmol/L; 
n 61).  Mean (± SD) serum 25(OH)D concentrations in the combined groups who received 
20 µg/d of vitamin D3, irrespective of calcium intake grouping, increased significantly (to 
74.3 ± 15.5 nmol/L; P<0.0001) by approximately midpoint (week 8), and there was a 
modest, but significant (P=0.005), further increase (to 76.9 ± 17.1 nmol/L) by week 15.  
Conversely, mean (± SD) serum 25(OH)D concentrations in the combined groups who 
received placebo, irrespective of calcium intake grouping, decreased significantly (to 43.8 
± 15.8 nmol/L; P<0.0001) by week 8, and there was a modest, but significant (P=0.002), 
further decrease (to 41.7 ± 15.5 nmol/L) by week 15. 
 
There was no significant interaction between time × vitamin D treatment × calcium intake 
grouping (or time × vitamin D treatment or time × calcium intake grouping) and sex (all 
P>0.4) in the response of serum 25(OH)D to intervention (data not shown). 
 
There was no significant difference in pre-intervention serum albumin-corrected calcium 
concentrations among the treatment groups (Table 9).  There was no significant time × 
vitamin D treatment × calcium intake grouping interaction effect or time × vitamin D 
treatment or time × calcium intake grouping interaction effects (all P>0.3) on mean serum 




Repeated measures ANOVA showed that there was a significant (P<0.05) difference in 
pre-intervention serum PTH concentrations among the groups stratified by calcium intake.  
The two ‘moderate-low calcium’ groups combined (n 56) had a modest, but significantly 
(P=0.037), higher median (IQR) baseline serum PTH compared to that of the two groups 
combined (n 69) who had a ‘high calcium’ intake (50.2 [38.2, 67.6] versus 43.9 [34.7, 
55.9] pg/mL, respectively).  There was no significant (P=0.3) time × vitamin D treatment 
× calcium intake grouping interaction effect on median (IQR) serum PTH concentration 
over the 15-wk intervention period (Table 9).  Likewise, there was no significant (P=0.7) 
time × calcium intake grouping interaction effect, but there was a significant (P=0.013) 
time × vitamin D treatment interaction effect on median (IQR) serum PTH concentration 
over the 15-wk intervention period (Table 9). Median serum PTH concentrations in the 
two groups who received 20 µg/d of vitamin D3, irrespective of calcium intake grouping, 
remained unchanged (P>0.3) over the 15 weeks, whereas median serum PTH 
concentrations in the two groups who received placebo, irrespective of calcium intake 
grouping, remained unchanged (P>0.7) over the first 8 weeks but had increased 
significantly (P=0.034) by week 15 (44.8 [35.2, 56.9], 45.1 [40.1, 58.4], and 47.8 [49.0, 
57.1] pg/mL, respectively).   
 
The effect of vitamin D treatment in the two calcium intake groupings (‘moderate-low’ 
versus ‘high’) on serum 24,25(OH)2D, ratio of 24,25(OH)2D:25(OH)D, 1,25(OH)2D, free 
25(OH)D or DBP concentrations at baseline and endpoint is shown in Table 10.  There 
was no significant difference in pre-intervention concentrations for any of these variables 
among the treatment groups (Table 10). Repeated measures ANOVA showed that there 
was no significant (P>0.1 for all) time × vitamin D treatment × calcium intake grouping 
interaction effect on mean serum 24,25(OH)2D, ratio of 24,25(OH)2D:25(OH)D, 
1,25(OH)2D, free 25(OH)D, or DBP concentration over the 15-wk intervention period 
(Table 10). Likewise, there was no significant (P>0.1 for all) time × calcium intake 
grouping interaction effect on mean serum 24,25(OH)2D, ratio of 24,25(OH)2D:25(OH)D, 
1,25(OH)2D, free 25(OH)D and DBP concentration over the 15-wk intervention period 
(Table 10).  While there was no significant (P=0.7) time × vitamin D treatment interaction 
effect on mean serum DBP, there were significant (P≤ 0.0001 for all) time × vitamin D 
treatment interaction effects on mean serum 24,25(OH)2D, ratio of 
24,25(OH)2D:25(OH)D, 1,25(OH)2D, and free 25(OH)D concentrations over the 15-wk 
intervention period (Table 10). 
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As calcium intake grouping had no effect, the mean baseline 24,25(OH)2D, ratio of 
24,25(OH)2D:25(OH)D, 1,25(OH)2D, and free 25(OH)D of the two groups combined who 
received 20 µg/d of vitamin D3 (n 61) was similar (P>0.2 for all) to that of the two groups 
combined who received placebo (n 60) (data not shown). The two placebo groups 
combined (n 60) had a significantly (P<0.0001) lower median (IQR) serum 24,25(OH)2D 
at endpoint compared to that of the two vitamin D3-supplemented groups combined (n 61) 
(1.14 [0.59, 1.85] versus 3.54 [2.87, 4.54] nmol/L, respectively). The two placebo groups 
combined (n 60) had a significantly (P≤0.0001) lower mean (± SD) serum 
24,25(OH)2D:25(OH)D ratio at endpoint compared to that of the two vitamin D3-
supplemented groups combined (n 61) (0.030 ± 0.014 versus 0.048 ± 0.014, respectively). 
The two placebo groups combined (n 60) had a significantly (P≤0.0001) lower median 
(IQR) serum 1,25(OH)2D at endpoint compared to that of the two vitamin D3-
supplemented groups combined (n 61) (65.0 [48.2, 91.4] versus 99.7 [65.7, 119.1] pmol/L, 
respectively).  The two placebo groups combined (n 60) had a significantly (P≤0.0001) 
lower median (IQR) serum free 25(OH)D at endpoint compared to that of the two vitamin 
D3-supplemented groups combined (n 61) (2.93 [2.16, 4.65] versus 6.42 [4.77, 9.40] 
pmol/L, respectively). In terms of the within combined treatment group changes from 
baseline to endpoint, mean/median serum 24,25(OH)2D, ratio of 24,25(OH)2D:25(OH)D, 
and free 25(OH)D concentrations in the combined groups who received placebo (n 60), 
irrespective of calcium intake grouping, decreased significantly from week 0 to 15  (by 
54.5, 28.6, and 24.3%, respectively; P≤0.0001 for all), whereas there was no significant 
change (P=0.4) in median serum 1,25(OH)2D concentration over the 15 weeks. 
Mean/median serum 24,25(OH)2D, ratio of 24,25(OH)2D:25(OH)D, 1,25(OH)2D, and 
free 25(OH)D concentrations in the combined groups who received 20 µg/d of vitamin D3 
(n 61), irrespective of calcium intake grouping, increased significantly from week 0 to 15 







Table 10. Serum 24,25(OH)2D, 1,25(OH)2D, free 25(OH)D and vitamin D binding protein concentrations and serum 24,25(OH)2D: 25(OH)D ratio among 
treatment groups at baseline and end-point of the 15 week-intervention in apparently healthy older adults1. 
 
Calcium intake group  Low Calcium (<700 mg/d) High Calcium (>1000 mg/d) Repeated measures ANOVA 
Vitamin D3 treatment groups  Placebo 20 µg Vitamin D3/d Placebo 20 µg Vitamin D3/d P
4 P5 P6 
n (at endpoint) 28 27 32 34    
  Serum 24,25(OH)2D (nmol/L)
2:        
   pre-intervention7,8 2.3 [1.8, 3.7] 1.5 [1.2, 4.0] 2.4 [1.3, 3.3] 1.9 [0.9, 2.8]    
   post-intervention 1.3 [0.7, 1.9] 3.5 [2.7, 4.9] 1.0 [0.5, 1.7] 3.5 [2.9, 4.4] 0.794 0.769 <0.0001 
        
Serum 24,25(OH)2D:25(OH)D ratio
3:        
   pre-intervention7,8 0.041   0.017 0.041   0.021 0.043   0.017 0.042   0.020    
   post-intervention 0.031   0.014 0.047   0.013 0.030   0.014 0.049   0.014 0.532 0.739 <0.0001 
        
Serum 1,25(OH)2D (pmol/L):        
   pre-intervention7,8 79.9 [64.4, 103.6] 82.0 [60.5, 108.8] 59.5 [48.8, 82.8] 79.6 [57.0, 93.5]    
   post-intervention 69.2 [52.1, 91.5] 103.9 [70.4, 122.6] 64.2 [46.4, 91.4] 96.2 [61.7, 109.8] 0.143 0.109 <0.0001 
        
Serum free 25(OH)D (pmol/L):        
   pre-intervention7,8 20.3 [15.6, 26.0] 17.5 [11.3, 28.1] 16.2 [11.5, 23.1] 17.3 [13.1, 25.65]    
   post-intervention 15.1 [10.9, 20.5] 30.6 [22.1, 42.6] 11.5 [8.2, 18.0] 25.1 [19.7, 34.1] 0.160 0.819 <0.0001 
        
Serum DBP (mg/L):        
   pre-intervention7,8 211.4   62.5 198.5   77.2 242.5   75.1 211.3   75.8    









Table 10 continued… 
 
124,25(OH)2D, 24,25-dihydroxyvitamin D; 1,25(OH)2D, 1,25-dihydroxyvitamin D;  25(OH)D, 25-hydroxyvitamin D; VBP, vitamin D binding protein 
2Medians [interquartile range] of non-normally distributed variable (all such values) 
3Mean    SD (all such values) 
4Repeated-measures ANOVA was used to test the time × vitamin D treatment × calcium intake grouping interaction effect. 
5Repeated-measures ANOVA was used to test the time × calcium intake grouping interaction effect. 
6Repeated-measures ANOVA was used to test the time × vitamin D treatment interaction effect. 
7There were no significant differences in pre-intervention concentrations across the four groups (P>0.1 in all cases). 
8All baseline blood samples taken between 5th and 23th November 2012 and all endpoint blood samples taken between 18th February and 14th March 2013. 
.   
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3.3.3.2 Effects of intervention with vitamin D3 in ‘low’ calcium versus ‘high’ calcium intake 
groups; secondary analysis of serum 25(OH)D 
A secondary analysis of the data in which subjects with ‘low’ calcium intakes (i.e., cut-off set 
at <550 mg/d [mean ± SD, 391 ± 136 mg/d]; n 32) were compared with those with ‘high’ 
calcium intake (i.e., cut-off also set at >1000 mg/d but which was achieved from habitual 
intake alone and without any additional calcium needed in study period [mean ± SD, 1376 ± 
371 mg/d]; n 31) showed that there was no significant (P=0.2) time × vitamin D treatment × 
calcium intake grouping interaction effect on mean serum 25(OH)D concentration over the 
15-wk intervention period.   
 
3.3.3.3 Effects of intervention with vitamin D3 in ‘moderate-low’ calcium and ‘high’ calcium 
intake groups stratified by adequacy of baseline serum 25(OH)D concentration; secondary 
analysis of serum 25(OH)D 
Further secondary analysis of the data was performed to see whether adequacy of baseline 
serum 25(OH)D concentrations influenced the main outcome. All subjects were stratified on 
the basis of baseline serum 25(OH)D concentrations (< and >40 nmol/L, a cut-off suggested 
by the IOM as the estimated average requirement (EAR)-like concentration). Mean (± SD) 
baseline serum 25(OH)D of the resulting subgroups was 31.1 ± 4.6 nmol/L (n 30) and 62.8 ± 
17.2 nmol/L (n 92) for < and >40 nmol/L, respectively.  Repeated measures ANOVA showed 
that there was no significant (P>0.2 for both) time × vitamin D treatment × calcium intake 
grouping interaction effect on mean serum 25(OH)D concentration over the 15-week 
intervention period in either subgroup (data not shown).
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3.3.4 Discussion of Part B findings 
 
Recent dietary requirement estimates for vitamin D from both sides of the Atlantic have 
prioritized winter-time as a critical period during which intakes of vitamin D should 
maintain serum 25(OH)D concentrations above chosen cut-offs (IOM, 2011; German 
Nutrition Society, 2012; Nordic Nutrition Recommendations, 2012). The IOM while 
setting their most recent DRI for vitamin D highlighted uncertainty and gaps in the 
available data about the influence of calcium intake on the regulation of vitamin D 
activation and catabolism (IOM, 2011). Thus, while as per convention the vitamin D DRI 
was established by the IOM on the assumption that the requirement for dietary calcium is 
being met (IOM, 2011), inadequacy in calcium intake could cause changes in the efficient 
handling of, or physiological response to, vitamin D that might not otherwise be present. 
A significant portion of adult populations in Europe and North America fail to meet 
respective dietary calcium requirements (Flynn et al, 2009; IOM, 2011; IUNA, 2011). In 
fact, the 2010 Dietary Guidelines Advisory Committee identified four nutrients of public 
health concern with calcium being one of them. Thus, clarifying whether low intakes of 
calcium increase the dietary requirement for vitamin D is important from a public health 
perspective and also in devising preventative strategies for vitamin D deficiency. Using a 
15 week winter-based vitamin D3 intervention study in 125 apparently healthy, free-living, 
white adults aged ≥50 years at a latitude of 51oN, it was possible to examine the potential 
interactions of dietary calcium intake on both the decline of serum 25(OH)D over winter 
whilst on a habitual inadequate vitamin D intake as well as on the response of serum 
25(OH)D to an intake aimed at achieving at least the IOM suggested ‘RDA-like’ 25(OH)D 
concentration of 50 nmol/L (IOM, 2011). It was found that responses in serum 25(OH)D 
(bound and free) concentrations throughout winter, as well as indices of vitamin D 
activation and catabolism as potential explanatory variables, were similar in older adults 
irrespective of whether they were on relatively low or high habitual calcium intakes. 
 
These data would suggest that recently proposed dietary requirement estimates for vitamin 
D (IOM, 2011; German Nutrition Society, 2012; Nordic Nutrition Recommendations, 
2012; Weggemans et al., 2013; UK Scientific Advisory Committee on Nutrition [SACN] 
2016) will ensure the adequacy of serum 25(OH)D concentrations in older adults even 
when the calcium intakes of these adults are in the inadequate range (<700 mg/d, and 
possibly even <550 mg/d).  The winter-based, 2 × 2 factorial design of the present vitamin 
D3 intervention study differs from those of the limited number of previous RCTs in this 
area (Berlin & Björkhem, 1988; Goussous et al, 2005; McCullough et al, 2009). It allowed 
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for  the examination of the possible interaction effect of two different nutritionally and 
public health relevant calcium intake bands (i.e., <550/<700 versus >1000 mg/d) on the 
natural decline in serum 25(OH)D concentrations due to absent or markedly diminished 
UVB sunlight as well as on the potential of an adequate vitamin D intake in maintaining 
serum 25(OH)D concentrations ≥ 50 nmol/L (Holick et al., 1973) during winter. Berlin & 
Björkhem (1988) reported that supplementation of healthy young adult men (n 14/group) 
with 2000 mg of calcium per day in addition to the usual diet for 6- to 7-weeks during late 
autumn/early winter in Sweden led to a significant increase in serum 25(OH)D 
concentrations (by 30%) relative to that in a control group on a normal diet. Unfortunately, 
the habitual dietary intake of calcium was not assessed in the study but the authors worked 
on the assumption that it was about 800 mg/d (Berlin & Björkhem, 1988). While none of 
the subjects received vitamin D supplementation, serum 25(OH)D concentrations 
increased in both the calcium and control group over the 6- to 7-week study period 
(increasing from a mean of 67 to 71 nmol/L in the control group) which was from late 
October to early December. Of note, the authors suggest that unpublished data of theirs 
on an identical trial, but one conducted from February to March, still suggested an 
elevatory effect of additional calcium on serum 25(OH)D (mean decrease in serum 
25(OH)D of 21% versus 9% in control and calcium-supplemented groups, respectively 
P<0.002 [actual data not provided].  McCullough et al, (2009) also performed a 
randomized 2 × 2 factorial design pilot intervention study with vitamin D and/or calcium 
supplements in US-based (42oN) previous adenomatous colonic polyp patients (aged 30-
74 y; 70% were men), as part of a chemoprevention trial of biomarkers of risk of colorectal 
adenoma. Four groups of patients, with group mean habitual calcium intakes in the range 
of 625-753 mg/d, were randomized to receive daily either placebo, an additional 2000 mg 
calcium, an additional 20 g vitamin D3, or an additional 2000 mg calcium plus 20 g 
vitamin D3 for 6 months (n 22/23 per group) (McCullough et al, 2009).  The additional 
calcium did not influence the response of serum 25(OH)D to vitamin D supplementation. 
Baseline blood sampling occurred throughout the year, with only 26% during winter. 
Consequently, there was no significant reduction in mean serum 25(OH)D concentrations 
over the intervention period in the two groups not randomized to receive vitamin D 
supplements, whereas there was the expected significant increases in mean serum 
25(OH)D in the two vitamin D-supplemented groups.  Goussous et al, (2005) performed 
a RCT in which healthy older men and women (aged 50+ years; 74% female on average; 
mean habitual calcium, 577 mg/d) were randomized to receive calcium supplements (1000 
mg/d) or placebo (n 23/29 per group) for 90 days throughout winter. However, as all 
participants received vitamin D3 (20 µg/d) over the intervention period, neither group had 
a decline in mean winter serum 25(OH)D concentrations but instead had the expected 
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increase. The response of serum 25(OH)D to vitamin D3 supplementation did not differ 
between the calcium or placebo group (Goussous et al, 2005).   
 
The IOM used data from winter-based RCTs with vitamin D alone to establish the DRI 
for vitamin D (IOM, 2011). This is because of the concern that altering calcium intake as 
well as vitamin D intake in RCTs may impact on serum 25(OH)D concentration due to 
altered regulation of vitamin D activation and catabolism. All of the calcium-
supplemented subjects in the three RCTs above (Berlin & Björkhem, 1988; Goussous et 
al., 2005; McCullough et al, 2009) had increases in their usual calcium intake of the order 
of an additional 1000 to 2000 mg of calcium per day, likely bringing their total mean 
calcium intakes into the range of >1500 to >2700 mg/d. This perturbation in calcium 
intake alone may have altered calcitropic hormone levels from baseline to end-point.  One 
study found a significant reduction in serum 1,25(OH)2D (but not PTH) upon calcium 
supplementation (Berlin & Bjorkhem, 1988), while 1,25(OH)2D (Goussous et al, 2005; 
McCullough et al, 2009) and surprisingly PTH (Goussous et al, 2005) were unaffected by 
calcium supplementation in the other studies. The response of these hormones to 
intervention are variable (Goussous et al, 2005). In the present study, we tried to minimize 
the perturbation of usual calcium intake and possible knock-on effects on calcitropic 
hormones, by stratifying at recruitment by habitual calcium intake and then only in those 
(n 38) falling short of the high calcium intake cut-off (>1000 mg/d) did we add 
supplemental calcium to meet this target (started four weeks prior to baseline to facilitate 
normalisation of calcitropic hormone levels (Dawson-Hughes et al, 1993). In the 
comparison of subjects with <550 mg/d and >1000 mg/d, there was no perturbation as 
these were all habitual intakes of calcium. Thus, the declines and increases in serum 
25(OH)D over winter which were associated with inadequate and adequate dietary 
vitamin D, respectively, were compared in subjects on their habitual low calcium intakes 
and on their habitual, or as close as, high calcium intakes.  
 
Using 24,25(OH)2D concentration and the ratio of 24,25(OH)2D:25(OH)D as markers for 
vitamin D catabolism (Schoenmakers et al, 2010; Wagner et al, 2011; Jones, 2013), the 
lack of effect of level of habitual intake of calcium on response of both during the present 
study is in keeping with the main findings of a lack of interaction between calcium and 
vitamin D on response of serum 25(OH)D. In contrast, supplementation with vitamin D3 
significantly increased serum 24,25(OH)2D concentration and the ratio of 
24,25(OH)2D:25(OH)D, as well as serum 25(OH)D, suggesting induction of the catabolic 
pathway via increased 24-hydroxylase activity. Serum 1,25(OH)2D has been suggested as 
a key regulator of catabolism of 25(OH)D ( Clements et al, 1987; Clements et al, 1992;) 
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whereas it appears less clear whether or not PTH itself has an independent effect on 
catabolism of 25(OH)D (Clements et al, 1987).  Vitamin D3 supplementation during 
winter had no effect on serum PTH in the present study, but significantly increased serum 
1,25(OH)2D concentrations.  While serum 1,25(OH)2D was not increased by vitamin D 
supplementation in some RCT (Goussous et al, 2005; McCullough et al, 2009), it has in 
others (Harris & Dawson-Hughes, 2002).  Interestingly, serum 24,25(OH)2D 
concentration and the ratio of 24,25(OH)2D:25(OH)D were significantly reduced during 
winter in the placebo groups, suggesting a possible a 24-hydroxylase mediated sparing 
effect aimed at maintaining serum 25(OH)D; even though concentrations, as expected, 
did decrease during winter.  While serum PTH was significantly increased over winter-
time in the placebo groups, serum 1,25(OH)2D was unchanged. 
 
While the present study did not include an entire group of subjects with extremely low 
calcium intakes where perhaps an effect on serum 25(OH)D catabolism may occur, and 
thus may be a potential limitation, 50% of subjects in the low-moderate calcium intake 
grouping had intakes <550 mg/d and 25% had intakes <400 mg/d, and all had <700 mg/d.  
At a population level, only 3% and 13% of Irish adults have calcium intakes <400 and 
<550 mg/d, respectively (IUNA, 2011). 
 
In conclusion, the findings of the Part B of the present work suggest that responses in 
serum 25(OH)D (both bound and free) concentrations throughout winter, as well as 
indices of vitamin D activation and catabolism, were similar in older adults irrespective 
of whether they were on relatively low or high habitual calcium intakes. Thus, recent 
dietary vitamin D requirement estimates will cover the vitamin D needs of even those in 




3.4 Part C - Vitamin D-Calcium associations with serum 24,25(OH)2D in a 
subset of a representative adult population 
 
3.4.1 Specific objective 
 
 To assess the impact of low and high habitual calcium intakes in the absence and 
presence of low and high serum 25(OH)D status on serum 24,25(OH)2D3 
concentration, as an index of vitamin D catabolism and potentially higher 
requirement, using data and bio-banked serum samples from a subset of adults from 
the representative National Adult Nutrition Survey (NANS) in Ireland.  
 
Rationale  
In the RCT in Part B, relative to >1000 mg/d, calcium intakes <550 mg/d [(5-13% of Irish 
and UK adults have calcium intakes below 550 mg/d (Henderson et al, 2004; IUNA, 2011)] 
did not influence the response of serum 25(OH)D or serum 24,25(OH)2D3 over winter in 
older adults. This was a secondary analysis however and numbers of subjects were 
relatively low (n 32 in total with intakes <550 mg/d). Therefore, we used data and 
biobanked sera from specific subsets of participants in the NANS so as to extend this 
analysis with greater numbers and in a wider age group (18-84 years). Those NANS 
participants with calcium intakes below 550 mg/d and with biobanked serum (n 64) were 
matched with those with intakes above 1000 mg/d, and stratified by low and high serum 
25(OH)D. Biobanked sera was then used to measure the concentration of 24,25(OH)2D3, 
as an index of vitamin D catabolism and potentially higher requirement. 
 
3.4.2 Subjects and methods 
 
Subject sampling and recruitment procedures and methods of data collection 
A detailed description of the methodology used in the NANS, including the sampling 
procedure as well as sample recruitment has been reported elsewhere (IUNA 2011; 
Cashman et al, 2013). Briefly, the fieldwork phase of NANS was carried out between 
October 2008 and April 2010, providing a seasonal balance to the data and biological 
sample collection. To achieve a nationally representative sample of community-dwelling 
adults aged 18 years and over, a quota sampling approach was adopted using data from the 
2006 Census (Cashman et al, 2013). A sample of 1500 free-living adults to represent a 
population of ~4.2 Million participated in the dietary survey. There were few exclusion 
criteria, other than pregnancy/lactation and inability to complete the survey due to 
disability.  The study was approved by the Clinical Research Ethics Committee of the Cork 
Teaching Hospitals, University College Cork and the Human Ethics Research Committee 
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of University College Dublin. All eligible and willing participants gave their written 
consent according to the Helsinki declaration.   
  
Analysis of the demographic features in this sample has shown it to be a representative 
sample of Irish adults with respect to age, gender, social class and geographical location 
when compared to Census data (IUNA, 2011; Cashman et al, 2013). While participation in 
the survey did not require provision of a blood sample as an eligibility criteria, all 
participants were asked if they were willing to provide a blood sample. Of the total group 
of respondents, 75.5% (n=1132) provided a blood sample. The demographic features of the 
group of participants who provided a blood sample and those in the entire sample have been 
described elsewhere (IUNA, 2011; Cashman et al, 2013). Seasonality was based on the date 
the respondents provided the blood sample – November to March (representing the ‘winter’ 
period) or April to October (representing the ‘summer’ period)  – consistent with studies 
based on NHANES in the US and the recent analysis of Canadian Health Measures Survey 
for vitamin D status.   
 
The approach to food intake data collection, food quantification and estimation of vitamin 
D and calcium intake in NANS has been provided in detail elsewhere (IUNA, 2011; 
Cashman et al, 2013). Of note, food intake data were analysed using WISP© V3.0 (Tinuviel 
Software, Anglesey, UK), which uses data from McCance and Widdowson’s The 
Composition of Foods, fifth and sixth editions plus all nine supplemental volumes to 
generate nutrient intake data, as described elsewhere (IUNA, 2011). Information on social 
class and education level, smoking status, alcohol intake and, medication usage (including 
those which contained nutrients) was also collected (IUNA, 2011). Anthropometric 
measures including height, weight, waist and hip circumference and measures of body 
composition were taken in the respondents homes, as described previously (IUNA, 2011). 
The approach towards assessment of vitamin D- and calcium-containing supplement 
consumption has been provided elsewhere (IUNA, 2011; Cashman et al, 2013). 
 
Blood collection 
Blood samples were collected by venepuncture into a vacutainer tube by a qualified nurse 
at designated centres within the survey area or in the respondents’ home if the respondent 
could not travel. Bloods were transported to the laboratory for further processing and serum 
was stored at -80ºC until required for analysis.  
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Selection of four subgroups within NANS as required for the present project on impact 
of dietary calcium on serum 24,25(OH)2D3 concentration  
Subjects that fit with the following four subgroupings were identified within the NANS 
database using existing data on dietary calcium intake estimates and serum total 25(OH)D 
concentrations: 
 
1. Low calcium intake (<550 mg/d), low serum 25(OH)D (<40 nmol/L) 
2. Low calcium intake (<550 mg/d), high serum 25(OH)D (>70 nmol/L) 
3. High calcium intake (>1000 mg/d), low serum 25(OH)D (<40 nmol/L) 
4. High calcium intake (>1000 mg/d), high serum 25(OH)D (>70 nmol/L) 
 
Subjects within these four subgroupings were broadly matched for sex and age to provide 
a balance across groups (n 31/43 per group).   
 
3.4.2.1 Laboratory analysis 
 
Serum total 25-hydroxyvitamin D 
The concentrations of total 25(OH)D (i.e., 25(OH)D2 plus 25(OH)D3) in serum samples for 
the subgroup of subjects (n 141) were measured previously by the Vitamin D Research 
Group at University College Cork using a liquid chromatography-tandem mass 
spectrometry (LC-tandem MS) method, described in Part B above and in detail elsewhere 
(Cashman et al., 2014). 
 
Serum 24,25-dihydroxyvitamin D 
The concentrations of 24,25(OH)2D3 in serum were measured in bio-banked samples using 
the liquid chromatography-tandem mass spectrometry (LC-tandem MS) method described 
in Part B above and in detail elsewhere (Cashman et al, 2014). 
 
3.4.2.2 Statistical analysis 
 
Differences in baseline characteristics between genders and between the four groupings 
were investigated by t-tests, ANOVA and chi-square tests, as appropriate. Two-way 
ANOVA was used to investigate the association between habitual calcium intake and serum 
25(OH)D concentration groupings, and their interaction, on serum 24,25(OH)2D3 
concentration. Linear regression models were also ran to adjust for potential confounding 
effects of age, gender and BMI.
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3.4.3 Results of Part C 
 
The characteristics of the subsample of adults from NANS used for the present analysis of 
the associations between dietary calcium, vitamin D status (as reflected by serum 
25(OH)D) and serum 24,25(OH)2D3 concentration are shown in Table 11. There was no 
significant difference between males and females in terms of age, serum 25(OH)D or 
24,25(OH)2D3 concentration (P>0.4 in all cases), males had a borderline (P=0.073) higher 
calcium intake than females and had a higher mean BMI (P=0.032). The characteristics of 
the subsample stratified by dietary calcium and serum 25(OH)D status are shown in Table 
12. The age distribution among the subsample and entire NANS was closely related. The 
percentage of adults from each of the age categories (18-50 years, 51-64 years and 65+ 
years) was 67%, 21% and 12%, respectively, in the NANS dataset compared to 66%, 18% 
and 16%, respectively, in the present subsample. Owing to the need for individuals with 
calcium intakes below 550 mg/d, there was a higher proportion of females to males 
(n=84:47) in the present subsample as compared to the entire NANS. There were, however, 
no significant differences between the four groups of the subsample in terms of proportion 
of females to males (P=0.3), mean age (P=0.4), mean BMI (P=0.1), or distribution of 
season of sampling (P=0.07). Even though <500 mg/d and >1000 mg/d calcium intake were 
used as the threshold bands in the present work, the mean intakes within the groups were 
427/463 mg/d and 1232/1391 mg/d for the two low (low calcium, low serum 25(OH)D and 
low calcium, high serum 25(OH)D, respectively) and two high calcium intake groups (high 
calcium, low serum 25(OH)D and high calcium, low serum 25(OH)D, respectively), 
respectively. 
 
Two-way ANOVA showed that there was no main effect of calcium intake (<500 mg/d 
versus >1000 mg/d) on serum 24,25(OH)2D3 concentration (P=0.6), no significant 
interaction between calcium intake grouping and serum 25(OH)D concentration grouping 
(<40 nmol/L versus >70 nmol/L) (P=0.8), but a significant main effect of serum 25(OH)D 
concentration grouping (P<0.01) (see Figure 3). Irrespective of habitual calcium intake 
grouping, individuals with a high serum 25(OH)D concentration (>70 nmol/L) had a 
significantly higher mean serum 24,25(OH)2D3 concentration than individuals with a low 
serum 25(OH)D concentration (<40 nmol/L) (4.12 ± 1.62 versus 1.23 ± 0.64 nmol/L, 
respectively; P<0.01). Serum 25(OH)D was strongly correlated with serum 24,25(OH)2D3 
(r=0.76; P<0.0001, n 141). Regression analysis showed that habitual dietary calcium 
grouping remained a non-significant (P=0.6) determinant of serum 24,25(OH)2D3 even 




Table 11. Characteristics of the subsample of adults for the National Adult Nutrition 
Survey used for the present analysis of associations between dietary calcium intake, vitamin 
D status and serum 24,25(OH)2D3.
1 
 
 Total Men Women 
n 131 47 84 
Age 44.0 (17.8) 43.0 (17.5) 44.5 (18.0) 
BMI 26.4 (6.1) 28.2 (7.3) 25.2 (4.9) 
Dietary Calcium (mg/d) 911 (485) 1033 (488) 842 (473) 
Serum 25(OH)D (nmol/L) 55.3 (24.8) 54.1 (24.4) 56.0 (25.2) 
Serum 24,25(OH)2D3 (nmol/L) 2.68 (1.90) 2.75 (1.74) 2.64 (1.99) 





Table 12. Characteristics of the subsample of adults for the National Adult Nutrition 
Survey used for the present analysis of associations between dietary calcium intake, vitamin 
D status and serum 24,25(OH)2D3 stratified by calcium intake/serum 25(OH)D status. 
 
Grouping:     
(Calcium intake/vitamin D status) High/Low High/High Low/Low Low/High 
  Calcium intake threshold >1000mg/d <500mg/d 
  Serum 25(OH)D threshold <40nmol/L >70nmol/L <40nmol/L >70nmol/L 
n 34 37 31 29 
Sex, n (%)     
  Female 19 (55.9) 22 (59.5) 21 (67.7) 20 (69.0) 
  Male 15 (44.1) 15 (40.5) 10 (32.3) 9 (24.1) 
Age, n (%)     
  18-50 years 21 (61.8) 24 (64.9) 21 (67.7) 20 (69.0) 
  51-64 years 8 (23.5) 9 (24.3) 2 (6.5) 5 (17.2) 
  ≥65 years 5 (14.7) 4 (10.8) 8 (25.8) 4 (13.8) 
BMI (kg/m2)1 28.6 (7.1) 26.1 (4.1) 24.5 (8.3) 26.4 (4.2) 
Season of sampling, n (%)     
  Extended summer 13 (38.2) 26 (70.3) 16 (51.6) 15 (51.7) 
  Extended winter 21 (61.8) 11 (29.7) 15 (48.4) 14 (48.3) 
Mean calcium intake (mg/d)1 1232 (177) 1376 (346) 427 (96) 457 (82) 
Mean serum 25(OH)D (nmol/L)1 33.0 (5.5) 77.2 (9.2) 30.2 (6.6) 80.6 (8.9) 






Figure 3. Serum 24,25(OH)2D3 concentration in a subsample of adults for the National 
Adult Nutrition Survey stratified by dietary calcium intake and serum 25(OH)D grouping.  
High calcium intake = >1000 mg/d; low calcium intake = <500 mg/d; High serum 
25(OH)D = >70 nmol/L; low serum 25(OH)D = <40 nmol/L. n =31/43 per group. *Means 
significantly different from low vitamin D status group within a calcium intake grouping; 


































3.4.4 Discussion of Part C findings 
 
 
The finding of this associational analysis which showed that serum 24,25(OH)2D3, an index 
of vitamin D catabolism, was unaltered in a subset of adults from a nationally representative 
sample with habitually low and high calcium intakes, with either low or high serum 
25(OH)D concentrations, further support the findings of the new RCT in Part B.  Moreover, 
as the low calcium intake group had habitual intakes below 550 mg/d (and a mean of 445 
mg/d, on average), these findings extend and support the secondary analysis of the RCT in 
which <700 mg/d versus >1000 mg/d was the primary analysis, and <550 mg/d versus 
>1000 mg/d was the secondary analysis. All subjects with calcium intake below 550 mg/d 
(and who had an available biobanked serum sample) within the entire NANS were used in 
the present analysis and thus this result is of public health significance and relevance. 
Increasing serum 25(OH)D concentration was shown to be the strongest predictor of serum 
24,25(OH)2D3, and in this case unlike the high concentrations of serum 25(OH)D achieved 
through supplementation with vitamin D3, the high serum 25(OH)D concentrations were 
mostly from those subjects sampled in summer-time. Both sets of findings are consistent 
with the concept that 24-hydroxylation of 25(OH)D represents the first step in the pathway 
of deactivation when status is good, albeit that there still remains the possibility that 
24,25(OH)2D3 itself may have some biological activity.  
3.5. Concluding discussion and remarks 
 
 
While as per convention the vitamin D DRI was established by the IOM on the assumption 
that the requirement for dietary calcium is being met (IOM, 2011), a convention followed 
by most authorities briefed with setting nutrient requirement values, inadequacy in calcium 
intake could cause changes in the efficient handling of, or physiological response to, 
vitamin D that might not otherwise be present. A significant portion of adult populations in 
Europe and North America fail to meet respective dietary calcium requirements (Henderson 
et al, 2004; Flynn et al, 2009; IOM, 2011; IUNA, 2011). In fact, the 2010 and 2015 Dietary 
Guidelines Advisory Committees in the US identified four nutrients of public health 
concern with calcium being one of them. Thus, clarifying whether low intakes of calcium 
increase the dietary requirement for vitamin D is important from a public health perspective 
and also in devising preventative strategies for vitamin D deficiency. This knowledge gap 
about the influence of calcium intake on the regulation of vitamin D activation and 
catabolism has been highlighted and prioritized by the IOM (2011) and ourselves (Cashman 
& Kiely, 2011), as well as forming one of the central basis of the UK Department of Health 
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research call tenders in which this work was funded in 2012, and which was intended to 
inform the Vitamin D DRV re-evaluation process in the UK. 
 
While the data from the post hoc analyses suggested little, if any, interaction between 
dietary calcium and vitamin D requirements, it should be acknowledged that none of the 
four previously-funded vitamin D RCTs were specifically designed to investigate the  
impact of dietary calcium level and accordingly had relatively small numbers of subjects 
with calcium intakes which might be considered as being low. To counter this potential 
limitation the project also conducted a 15 week winter-based vitamin D3 intervention study 
in 125 apparently healthy, free-living, white adults aged ≥50 y at a latitude of 51oN in which 
the potential interactions of dietary calcium intake on both the decline of serum 25(OH)D 
over winter whilst on a habitual inadequate vitamin D intake as well as on the response of 
serum 25(OH)D to an intake aimed at achieving at least the IOM suggested ‘RDA-like’ 
25(OH)D concentration of 50 nmol/L (IOM, 2011) were examined.  Recent dietary 
requirement estimates for vitamin D from both sides of the Atlantic have prioritized winter-
time as a critical period during which intakes of vitamin D should maintain serum 25(OH)D 
concentrations above chosen cut-offs (IOM, 2011; German Nutrition Society, 2012; Nordic 
Nutrition Recommendations, 2012; UK SACN, 2016). A key finding of this new RCT is 
that the responses in serum 25(OH)D concentrations throughout winter, as well as indices 
of vitamin D activation and catabolism as potential explanatory variables, were similar in 
older adults irrespective of whether they were on relatively low (<550/700 mg/d) or high 
habitual (>1000/1200 mg/d) calcium intakes. Data from NANS also showed a lack of 
association between calcium intake and serum 24,25(OH)2D in adults aged 18-84 years. 
Thus, these new data would suggest that recently proposed dietary requirement estimates 
for vitamin D in North America (IOM, 2011) and then in a number of European member 
states (German Nutrition Society, 2012; Nordic Nutrition Recommendations, 2012; 
Weggemans et al, 2013; UK SACN 2016) will ensure the adequacy of serum 25(OH)D 
concentrations in older adults even when the calcium intakes of these adults are in the 
inadequate range (<700 mg/d, and even <550 mg/d). 
 
It is also interesting to note that when the four new RCT arms (placebo and vitamin D3 with 
low habitual calcium intake and placebo and vitamin D3 with high habitual calcium intake) 
from the present Part B RCT were included in the RCT database and the meta-regression 
analysis in Part A was re-performed using with this additional data, there was no overall 
significant interaction between the response of winter serum 25(OH)D to total vitamin D 
and dietary calcium category. 
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These new findings also are important from a policy perspective in terms of devising 
preventative strategies for vitamin D deficiency. Strategies for bridging the gap between 
RDA/RNI estimates and current intake of vitamin D in the UK, Ireland, US and other 
populations (be it dietary advice, and/or supplementation and/or food fortification) will not 
be dependent on habitual calcium intakes, at least for those with intakes >550 mg/d. While 
the present study did not include an entire group of subjects with extremely low calcium 
intakes where perhaps an effect on serum 25(OH)D catabolism may occur, and thus may 
be a potential limitation, 50% of subjects in the low-moderate calcium intake grouping had 
intakes <550 mg/d and 25% had intakes <400 mg/d, and all had <700 mg/d.  At a population 
level, only 3% and 5-13% of Irish and UK adults have calcium intakes <400 and <550 
mg/d, respectively (Henderson et al. 2004; IUNA, 2011). 
 
Likewise, it is possible that the high calcium intake in the present project wasn’t high 
enough to provide the protective effect on serum 25(OH)D. Berlin & Björkhem (1988) 
reported that supplementation of healthy young adult men (n 14/group) with 2000 mg of 
calcium per day in addition to the usual diet for 6- to 7-weeks during late autumn/early 
winter in Sweden led to a significant increase in serum 25(OH)D concentrations (by 30%) 
relative to that in a control group on a normal diet. The authors also suggest that 
unpublished data of theirs on an identical trial, but one conducted from February to March, 
still suggested an elevatory effect of additional calcium on serum 25(OH)D (mean decrease 
in serum 25(OH)D of 21% versus 9% in control and calcium-supplemented groups, 
respectively P<0.002). Unfortunately, the habitual dietary intake of calcium was not 
assessed in the study but the authors worked on the assumption that it was about 800 mg/d 
(Berlin & Björkhem, 1988), which would likely bring their total mean calcium intakes into 
the range of >2800 mg/d. The upper 2.5 percentile of calcium from all sources in adults in 
the UK has been reported to be 1794 mg/d and 1550 mg/d for men and women, respectively. 
Thus, the levels of calcium used by Berlin & Björkhem (1988) are beyond those of a public 
health relevance, and furthermore two other RCTs found that subjects who had increases 
in their usual calcium intake of the order of an additional 1000 to 2000 mg of calcium per 
day (Goussous et al, 2005; McCullough et al, 2009), likely bringing their total mean 
calcium intakes into the range of >1500 to >2700 mg/d, did not have a sparing effect on 
their serum 25(OH)D concentrations over those not supplemented with calcium. 
 
Overall, the data from the present work would suggest dietary requirements for vitamin D 
are not impacted by calcium intakes, ranging from low to high, and which covers the vast 
majority of Irish or UK adults. The data will inform the UK and Irish government policy 
on vitamin D supplementation and fortification of foods. This data will not only be of 
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importance and relevance to the UK and Ireland, but also internationally as existing vitamin 
D recommendations/reference intake values are being actively re-evaluated in several 
European member states as well as in parts of Asia, and possibly elsewhere. The data will 
also be of interest to the North American IOM in relation to filling one of its identified key 
knowledge gaps from its recent vitamin D and calcium DRI panel exercise. Thus, the data 
will contribute to a sound scientific basis for development of nutrition policy and 
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Recent data from a pan-European study by Cashman et al. (2016) have shown that one in eight 
Europeans have serum 25-hydroxyvitamin D [25(OH)D] concentrations <30 nmol/L 
(reflective of vitamin D deficiency) and furthermore, 40% have concentrations  less than 50 
nmol/L, which the Institute of Medicine (IOM) and others suggest are needed to cover the 
needs of the majority of the population from a bone health perspective (IOM, 2011; Norden, 
2015; EFSA, 2016). While summer ultraviolet B (UVB) sunlight enables cutaneous vitamin 
D biosynthesis, and thus is a key contributory source of vitamin D for many, excessive 
exposure is the principal risk factor for the majority of skin cancers, which continue to rise in 
white populations. Hence, public education campaigns in relation to skin cancer recommend 
limiting exposure to sunlight. In addition, most European countries experience a vitamin D 
winter of about 4 to 5 months (Webb et al. 2006), during which dermal synthesis of vitamin 
D is extremely limited due to low UVB availability. Thus, absence of sufficient UVB sunlight 
for dermal synthesis places increased importance on the vitamin D food supply.  As it stands, 
dietary vitamin D intakes in the population are typically between 3-7 µg/day (Kiely & Black, 
2012) and most are not achieving the recently suggested Estimated Average Requirement 
(EAR) value of 10 µg/day (IOM, 2011). Vinas et al. (2011) recently showed that of European 
national nutrition surveys reporting vitamin D intake data from 2000 onwards, 77-100% and 
55-100% of adults (19-64 y) and elderly (>64 y), respectively, had intakes below the EAR. 
This is not surprising as food sources of vitamin D are few and limited (oily fish, meat, dairy, 
egg yolk and mushrooms) and many are not consumed on a regular basis (Cashman & Kiely, 
2015). In order to improve the dietary supply of vitamin D across the food chain and thus the 
distribution of intakes in the population, evidence-based, food-based strategies are required.  
 
Bio-fortification of foods with vitamin D is one such strategy that may be employed as an 
additional approach to traditional fortification practices as a means of closing the gap between 
current intakes and recommendations. In terms of the present work, bio-fortification refers to 
the addition of vitamin D and/or 25-hydroxyvitamin D (known commercially as HyD®), where 
permissible, to livestock feeds with an aim of improving the vitamin D or 25-hydroxyvitamin 
D contents of the resulting animal produce (e.g., eggs, pork and beef). 
 
Research in this area to date has focused mainly on eggs, but even then the emphasis has been 
as much on the effect that higher levels of vitamin D compounds in animal feeds may have on 
the welfare of the animal itself or the quality of their produce (e.g. egg shell strength, laying 
rate) as on its impact on the vitamin D activity of the resulting eggs. A number of groups have 
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shown that there is a dose response effect in the vitamin D content of the egg yolk when the 
diets of laying hens had incremental levels of vitamin D3 and/or HyD® added (Mattila et al., 
1999; 2003; 2004; 2011; Yao et al., 2013; Browning & Cowieson, 2014). However, several 
of these studies use levels of inclusion above the upper allowable level for feeds in Europe 
[3000 IU/kg diet (EFSA, 2005)]. In addition, the studies which used HyD® included it at levels 
above the upper allowable level [0.080 mg/kg diet (EFSA, 2009)]. Eggs which are produced 
for human consumption must adhere to these regulations. 
 
In countries where mandatory fortification is not in place, meat can be considered a significant 
source of vitamin D in the diet (Hill et al., 2004). The effect of additional vitamin D3 and/or 
HyD® in the diets of pigs and beef cattle, and the resulting vitamin D activity of pork meat and 
beef, has been much less well investigated and generally where it has been investigated it was 
again in relation principally to animal welfare and beef tenderness (Swanek et al., 1999; Foote 
et al., 2004; Montgomery et al., 2004; Sell et al., 2004; Wertz et al., 2004; Rivera et al., 2005; 
Cho et al., 2006; Lawrence et al., 2006; Jakobsen et al., 2007; Carnagey et al., 2008a; 
Carnagey et al., 2008b; Burild et al., 2016). Even in the two studies by the same group which 
investigated the effect of additional vitamin D and HyD® in pigs, the results in relation to 
vitamin D content of pork meat are conflicting (Jakobsen et al., 2007, Burild et al., 2016). 
 
Overall, this study aims to investigate the potential for addition of vitamin D and/or HyD® to 
hen, pig and beef heifer diets, but at levels that do not exceed the respective EU upper levels, 
on increasing the vitamin D activity of the resulting eggs and meat. Such biofortified foods 
may protect against vitamin D deficiency in the general population. 
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4.2 Trials, materials and method 
 
4.2.1 Conduct of layer hen, pig and beef heifer feeding trials at Lyons Research Farm, 
University College Dublin, Newcastle, Co. Dublin 
 
3.2.1.1 Laying hen feeding trial  
A total of sixty laying (Hyline) hens (90% laying), which were receiving standard commercial 
feeding and management and had a mean initial start weight of 1.68 kg at 25 weeks of age, 
were randomly assigned to one of four dietary treatment groups (n 15 hens/group): 
 
Hen treatment 1 – basal diet with vitamin D3 (1500 IU/kg); 
Hen treatment 2 – basal diet with vitamin D3 (3000 IU/kg) [EU Upper limit (EFSA, 2009)]; 
Hen treatment 3 – basal diet with vitamin D3 (1500 IU/kg) and HyD® (37.5 μg/kg diet; 
equivalent to 1500 IU/kg feed) [Total equivalent, 3000 IU/kg feed]; 
Hen treatment 4 – basal diet with HyD® (EFSA, 2009) (75 μg/kg diet; equivalent to 3000 
IU/kg feed). 
 
The experimental diets were based on a basic diet containing crude protein, 155 g/kg, and 
metabolizable energy, 10.44 MJ/kg. Diets were also balanced for amino acid profiles and fatty 
acid content, and were provided in a layer mash form. The vitamin D3  and HyD® for inclusion 
in the experimental diets in this hen trial, and also the pig feeding trial (see Section 3.2.1.2 
below), were provided by DSM Nutritional Products Ltd, Ayrshire, UK. Each experimental 
feed was produced at the beginning of the feeding trial in 100 kg batches. The vitamin D3 and 
25-hydroxyvitamin D3 contents of the experimental diets were determined independently by 
the Danish Technical University (DTU), Denmark, using a modified liquid chromatography 
tandem mass spectrometry (LC-MS/MS) method (Jakobsen et al., 2004, 2007). The DTU 
laboratory has been accredited for vitamin D and 25-hydroxyvitamin D since 1994 and 2004, 
respectively. For the last 15 years, it has performed the analysis for vitamin D and 25-
hydroxyvitamin D in food for the Danish and Norwegian Food Composition Tables.   
 
The hens were housed in a barn system throughout the experiment. All treatment groups 
received a 14-hour lighting pattern, with free access to ten laying boxes per house. All houses 
were bedded in wood shavings; and all treatment groups had adequate perching and scratching 
space.  Birds were fed at a rate of 140 g/per head/day with ad libitum supply of water at all 
times. Water was supplied in round drinkers and hens had adequate space allowance of 2.5 
cm/hen at drinkers. 
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Eggs from the four different treatment groups were collected on two separate days (days 1 and 
3) during the last week of the study (week 6). Eggs were transported to the Food Processing 
Hall, University College Cork (UCC) for processing and storage before vitamin D and sensory 
analysis. The vitamin D3 and 25-hydroxyvitamin D3 content of individual (n 6-8 eggs) as well 
as pooled egg yolk samples (pool of 16 eggs) from each treatment group were analysed by the 
Cork Centre for Vitamin D and Nutrition Research, UCC using an adapted high performance 
liquid chromatography (HPLC) method (See Section 3.2.3 below). A pooled egg yolk sample 
(based on pool of 16 eggs) from each of the dietary treatment groups was sent to DTU, 
Denmark for external analysis of vitamin D compounds by a modified LC-MS/MS method 
(Jakobsen et al., 2004, 2007).  
4.2.1.2 Pig feeding trial 
Twenty four (Large white x Landrace) finisher pigs, which were receiving standard 
commercial feeding and management and with a mean initial starting weight of 60 kg, were 
blocked on the basis of live weight and sex, and allocated at random to one of three dietary 
treatment groups (n 8 pigs/group): 
 
Pig treatment 1 – basal diet with vitamin D3 (2000 IU/kg) [Upper EU limit] (EFSA, 2012); 
Pig treatment 2 – basal diet with HyD® (EFSA, 2009) (50 μg/kg diet; equivalent to 2000 
IU/kg feed); 
Pig treatment 3 – basal diet and vitamin D3 (1000 IU/kg) and HyD® (25 μg/kg diet; 
equivalent to 1000 IU/kg feed) [Total equivalent, 2000 IU/kg feed]. 
 
The experimental diets were based on wheat, barley and soya-bean meal. Diets were fed in 
meal form and formulated to have identical contents of energy (13.8 MJ/kg) and total lysine 
(9.5 g/kg). Each diet was made at the beginning of the experiment in two x 5 tonne batches. 
Feed samples were taken at manufacture and throughout the experimental period for chemical 
analysis. The vitamin D3 and 25-hydroxyvitamin D3 contents of the experimental diets were 
determined independently by DTU (as per Section 3.2.1.1 above). 
 
The pigs were penned in mixed groups of twelve (six males and six females) and were stocked 
at 1.0 m2 per pig per treatment. The house was mechanically ventilated to provide an ambient 
temperature of 18°C. Each pen had a solid floor lying area with access to slats at the rear. 
Individual single space computerised feeders with water nipples were present in all pens 
providing ad libitum supply of both food and water at all times. Animals were individually 
tagged and weighed on days 1, 14, 28 and 42 of the experiment. All pigs were removed on 
day 66 of the experiment for slaughter, at which stage the pigs had live weights of ≥90 kg. 
 
104 
The pigs were slaughtered and processed to meats at Rosderra Irish Meats Group, Co. Offaly, 
which is the largest pork processing company in Ireland. 
 
Blood samples were obtained at slaughter from the vena jugularis, collected in BD 
Vacutainer® blood collection tubes, and processed to serum within 4 hours at Lyons Research 
Farm, Newcastle, Co. Dublin. Serum was frozen at -80°C until analysis. Serum total 25-
hydroxyvitamin D [25(OH)D] concentrations were measured by the Cork Centre for Vitamin 
D and Nutrition Research, UCC using a certified LC-MS/MS method (see Section 3.2.2 
below).  
 
At 24-hours post-mortem, samples of loin and fillet were harvested and transported to the 
Food Processing Hall, UCC for further processing and storage. Upon arrival, sub samples of 
loin and fillet from each animal in each treatment group were collected, packaged according 
to treatment group, and stored at 4oC prior to preparation of pooled samples. The remainder 
of the selected cuts from each animal were individually vacuum packed and labelled 
accordingly. Individual samples were then stored at -20oC for future analysis. The following 
day, the aforementioned sub samples were minced and further mixed using a Buchi blender 
to ensure homogeneity of the pooled sample. This was carried out by treatment group, with 
adequate cleaning of equipment between different treatment groups. The pooled sample was 
then sub-divided into aliquots for both DTU and UCC. Pooled samples from each treatment 
group were stored at -80°C, for future analysis of vitamin D compounds in UCC and prior to 
transport to DTU. Pooled samples of both loin and fillet (based on meat samples from 8 pigs) 
from each treatment group were transported on dry ice to DTU, Denmark for independent 
analysis of vitamin D3 and 25-hydroxyvitamin D3 (as per Section 3.2.1.1). Individual samples 
of loin and fillet from each animal in the treatment groups were also stored for meat quality 
and sensory analysis at UCC. 
4.2.1.3 Beef cattle feeding trial 
Thirty continental beef heifers (Charolais and Limousin cross), with a mean initial weight 600 
kg, were blocked on the basis of breed and body weight, and randomly allocated to one of 
three dietary treatment groups (n 10 cattle/group): 
 
Beef treatment 1 – basal diet with no vitamin D3 added; 
Beef treatment 2 – basal diet with vitamin D3 (2000 IU/kg feed); 





The basal diet consisted of a high-energy, concentrate finishing ration, which was offered to 
heifers in conjunction with their respective dietary treatments on an ad libitum basis. Animals 
were also offered straw as a long fibre source. All dietary treatments had a constant 
forage:concentrate ratio. The vitamin D3 for inclusion in the experiments were provided by 
DSM Nutritional Products Ltd (as per Section 3.2.1.1 above).  Treatments were offered for 
the final three weeks of an 80-day finishing period. Each treatment diet was manufactured at 
the beginning of the experiment in two batches. Feed samples were taken at manufacture and 
throughout the experimental period for chemical analysis. The vitamin D3 and 25-
hydroxyvitamin D3 contents of the experimental diets were determined independently by DTU 
(as per Section 3.2.1.1 above).  
 
For the duration of the 3-week experimental feeding period, the animals were housed indoors 
under normal lighting conditions (i.e., no UVB), with no access to the outside. Individual feed 
intakes were recorded daily using a Calan gate feeding system, where feed was weighed in 
and refusals weighed back to calculate daily feed intakes and dry matter intakes. Heifers were 
weighed on day 0, 7, 14, 21 and day 28 of the experiment to calculate average daily gains.  
 
Prior to slaughter, on day 80 of the finishing period, blood samples were collected by a 
veterinarian and processed to serum at Lyons Research Farm, Newcastle, Co. Dublin.  Sera 
were stored at -80°C until transport to UCC for subsequent analysis of serum 25(OH)D 
concentrations. The animals were slaughtered at Kildare Chilling, Co. Kildare, a long-standing 
Irish beef and lamb processing plant.  At 48-hours post-mortem, primal cuts were harvested 
and transported to the Food Processing Hall, UCC for processing and storage. The meat 
samples were stored at 4°C before the selected cuts of rib-eye were boned and trimmed by a 
craft butcher. Sub-samples of rib-eye from each animal (n 8) in each treatment group were 
minced and further mixed using a Buchi blender to ensure homogeneity of the pooled sample. 
Pooled samples (based on meat samples from 7 heifers per pool) were transported on dry ice 
to DTU, Denmark for independent analysis of vitamin D3 and 25-hydroxyvitamin D3 contents 
(as per Section 3.2.1.1). Individual and pooled samples from each treatment group were stored 
at -20°C and -80°C, respectively, for future analysis of vitamin D compounds in UCC. 
Individual meat samples from each animal were also stored for meat quality and sensory 




4.2.2 Measurement of serum 25(OH)D concentrations  
 
The concentrations of total 25(OH)D (i.e., 25(OH)D2 plus 25(OH)D3) in the porcine and 
bovine serum samples were measured by the Cork Centre for Vitamin D and Nutrition 
Research at UCC using a certified LC-MS/MS method, as has been described in detail 
elsewhere (Cashman et al., 2013). In brief, the LC-MS/MS method measures 25(OH)D2 and 
25(OH)D3 in serum as well as the 3-epimer of 25(OH)D3 (3-epi-25(OH)D3), which is not 
chromatographically resolved from 25(OH)D3 by most routine LC-MS/MS methods.  The 
presence of 3-epimers of 25(OH)D can pose problems for LC-MS/MS methods because the 
precursor ion and fragmentation patterns are the same as 25(OH)D, thus failure to account for 
these metabolites can result in overestimation of 25(OH)D3 in particular as the quantitatively 
more abundant metabolite.  The intra-assay CV of the method was <5% for all 25-
hydroxyvitamin D metabolites, while the inter-assay CV was <6%. The Cork Centre for 
Vitamin D and Nutrition Research is a participant in the VDSP (Sempos et al. 2012) and is 
certified by Centers for Disease Control and Prevention’s Vitamin D Standardization 
Certification Program (Rahmani et al. 2013). The inter-assay CV for total 25(OH)D was 3.6%. 
Both the VDSP and the certification program reports total 25(OH)D as well as 25(OH)D2 and 
25(OH)D3 using the higher order reference laboratories.  In addition, the quality and accuracy 
of human serum total 25(OH)D analysis by the LC-MS/MS in our laboratory is monitored on 
an ongoing basis by participation in the Vitamin D External Quality Assessment Scheme 
[DEQAS, Charing Cross Hospital, London, UK]. 
 
All solvents and mobile phase additives were MS grade and purchased from Sigma-Aldrich 
(Wicklow, Ireland). Zinc sulphate was sourced from Sigma-Aldrich while stable isotope 
labelled d3-25(OH)D2, d3-25(OH)D3 and d3-3-epi-25(OH)D3 were purchased from Isosciences 
(4667 Somerton Road, Trevose, PA 19053, USA).  Certified calibrators for 25(OH)D2 and 
25(OH)D3 were bought from the National Institute of Standards and Technology (NIST), USA 
(SRM 2972) while a CertiMass reference standard for 3-epi-25(OH)D3 was sourced from 
Isosciences. Low and High serum QC materials were commercially available from 
Chromsystems (Munich, Germany). The chromatographic column was a Supelco Ascentis 
Express F5 available from Sigma-Aldrich. 
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4.2.3 Determination of vitamin D compounds and total activity in pork, beef and egg 
yolk 
 
4.2.3.1 Egg yolk sample preparation (Pooled and individual)  
Whole eggs were stored for a maximum of two weeks in the cold storage room (4°C) at the 
Food Processing Hall, UCC prior to sample preparation. The whole egg was weighed using a 
standard balance. Egg yolk and albumin (white) were separated. The egg yolk and wet 
eggshell were weighed individually. Egg albumin weight was determined using the following 
equation: 
 
 Albumin (g) = whole egg (g) – [wet egg shell (g) + egg yolk (g)] 
 
The weight of each component was recorded for individual egg samples. Individual egg yolks 
were added to plastic containers (Sarstedt, 50 ml, polypropylene container) that were labeled 
accordingly, blanketed with nitrogen gas and stored at -80°C until analysis. 
 
Egg yolks were pooled according to dietary treatment. Pooled samples were added to plastic 
containers that were labeled accordingly, mixed to ensure homogeneity, blanketed with 
nitrogen gas and stored at -80°C until analysis or transport to DTU, Denmark. 
 
4.2.3.2 Measurement of vitamin D compounds and total activity in pooled egg yolk and meat 
samples via LC-MS/MS at DTU, Denmark 
 
Vitamin D2/3 and 25(OH)D2/3 content of pooled egg yolk, pork and beef samples were analysed 
in DTU, Denmark using a modification of a sensitive LC-MS/MS method, as described in 
detail elsewhere (Jakobsen et al, 2004, 2007). 
 
The vitamin D analysis performed at DTU on pooled samples was in order to expedite a 
decision on which of the various treatment might be used in further feeding trials for ultimate 
supply of eggs for a randomised controlled trial in Irish adults (see Chapter 5).  However, this 
pooled analysis only provided very limited data on the variability around the mean vitamin D 
and metabolite content. Therefore, analysis of vitamin D and 25(OH)D was conducted on 
individual egg samples from the various treatment groups at UCC using an in-house HPLC 
method (see Section 3.2.3.3 below).  The data from this method was aligned with that from 




4.2.3.3 Measurement of vitamin D metabolites in pooled and individual egg yolk and meat 
samples via HPLC at UCC  
All work was carried out under amber light where possible. Vitamin D and 25-hydroxyvitamin 
D were purchased from Sigma-Aldrich Ireland Ltd. (Arklow, Ireland).  Heptane, 2-propanol, 
acetonitrile and methanol were HPLC grade.  All other reagents were analytical grade. 
 
Saponification: Raw egg yolk (individual sample) or approximately 16 g of pooled egg yolk 
sample (representative of average yolk weight) was thawed at room temperature and 
transferred into appropriately labeled 250 ml Erlenmeyer flasks. Internal standards were added 
using a calibrated pipette, 50 μl 10 μg/ml vitamin D2 and 25 μl of 10 μg/ml 25-hydroxyvitamin 
D2. Ethanol (100 ml) was added to all samples.  Ascorbic acid was prepared freshly on the day 
(10% w/v) and 20 ml of this solution and 50 ml of KOH (50%, w/v) were added to each flask 
and mixed. All samples were blanketed with nitrogen, sealed with parafilm and saponified 
overnight on a magnetic stirring block. 
 
Extraction: The extraction procedure was adapted from Jakobsen et al., (2004).  In brief, the 
contents of the Erlenmeyer flask were transferred into 500 ml separating funnels and extracted 
with diethyl ether (130 ml) and petroleum ether (130 ml). The extract was washed 3 times by 
inversion with 50 ml of ultrapure water.  Residual water was removed from the extract by 
adding a small amount of anhydrous sodium sulphate. The extract was evaporated on a rotary 
evaporator until approx. 5 ml remained.  The residue was transferred to a small tube and the 
remaining ether evaporated under nitrogen.  The residue was reconstituted in 5 ml of heptane. 
Solid phase extraction was carried out using Mega Bond-Elut silica columns (2 g) (Agilent 
Technologies); Samples were dried in a vacuum centrifuge (miVac Quattro concentrator, 
Genevac) and reconstituted in 1.5 ml of 2-propanol (1%) in heptane. The extract was then 
transferred to a centrifugal spin filter (0.45 µm nylon membrane) and centrifuged at 2500 rpm 
for five minutes before the semi-preparative HPLC stage.  
 
Standards: Standards for semi-preparative HPLC were prepared from solid vitamin D3 and 
25-hydroxyvitamin D3.  Stock solutions were prepared in heptane (1 mg/ml), stored at -20°C 
and diluted as required for retention time checks.  Working standard solutions (10 µg/ml) for 
analytical HPLC were prepared from certified solutions of vitamin D3 (1 mg/ml ethanol) and 
25-hydroxyvitamin D3 (100 g/ml) and stored at -80°C. Concentrations were checked every 
six months by measuring the absorbance of stock solutions at 265nm.  The molar extinction 
coefficients used were 18,466 (D3) and 18,584 (25OHD3). Calibration curves were prepared 
in acetonitrile:methanol (90:10) (20-200 ng/ml vitamin D3) or methanol:water (50:50) (3-50 




HPLC: The same HPLC system was used for semipreparative and analytical HPLC (Shimadzu 
Corporation, Kyoto, Japan).  The system consisted of two LC20ADXR pumps, SIL-30AC 
autosampler, CTO-20AC column oven, SPD-30MA PDA detector, FRC-10A fraction 
collector and CBM-20A system controller.  Labsolutions Lite software was used for system 
control and data acquisition and processing.  Semi-preparative steps were based on the 
methods of Jakobsen et al., (2004, 2007).  The first semi-preparative step used two columns 
in series (Lichrospher Si-60, 5m, 250mm x 4.6mm i.d.; Lichrospher Amino, 5m, 150 x 
4.6mm i.d., both supplied by Sigma-Aldrich Ireland Ltd.).  Gradient elution using 2-propanol 
(solvent A) and n-heptane (solvent B) was as follows: 96% solvent B for 10 min.; 92% B for 
15 min.; 96% B for 10 min.  The flow rate was 1 ml/min.  The collected vitamin D and 25OHD 
fractions were further purified using a cyano column (Supelco LC-CN, 5um, 150mm x 4.6mm 
i.d.).  The mobile phase was 2-propanol:heptane (1:99) at 1 ml/min.  Vitamin D was analysed 
using a Vydac 201TP C18 column (250 x 3mm i.d., 5µm, Grace Davison Discovery Sciences, 
Hesperia, California, USA).  The mobile phase was acetonitrile:methanol (90:10) at a flow 
rate of 0.25 ml/min.  Column temperature was 30°C.  25-Hydroxyvitamin D3 was analysed 
using an Ascentic Express C18 column (100 x 4.6mm i.d., 2.7µm, Sigma-Aldrich Ireland 
Ltd.).  The mobile phase was methanol:water (86:14) at a flow rate of 1ml/min.  Column 
temperature was 45°C.  The injection volume was 45 l.  The PDA detector was set to scan 
from 200-500nm and spectra were extracted at 265nm.  Concentrations were calculated based 
on external calibration and adjusted for percent recovery of the internal standard.  Following 
correction, results were within 92% of expected values for vitamin D3 and 25-hydroxyvitamin 
D3. 
 
In all cases, total vitamin D activity was calculated as the content of vitamin D3 plus the content 
of 25(OH)D3  5, which is the calculation used in McCance & Widdowson’s, food 
composition tables. The conversion factor of 5 is consistent with the findings from our 
randomized controlled trial of older adult Irish men and women which showed that 
supplemental 25-hydroxyvitamin D3 was 5 times more potent in raising winter serum 





4.2.4 Sensory analysis of vitamin D-enhanced eggs, pork and beef  
 




Whole eggs were placed in a saucepan of cold water and boiled for 10 minutes on a 
conventional cooker hob. Following cooking, eggs were cooled in cold water, the shells were 
removed and each boiled egg was cut in half (longitudinally) prior to presentation to sensory 




Eggs were cracked open and cooked (5 minutes in vegetable oil) within stainless steel cooking 
rings placed in a frying pan, to ensure uniformity and consistency of fried eggs for sensory 
evaluation. Fried eggs were cut in half and re-heated for 20 seconds in a microwave prior to 
presentation to sensory panelists (see below). 
 
Sensory evaluation of eggs 
 
Sensory evaluation of boiled and fried eggs was carried out in two separate sensory analysis 
sessions using 18-22 naïve assessors where four egg samples (one from each dietary 
treatment), identified with random three digit codes, were presented to each panelist in 
duplicate. Sample presentation order was randomised to prevent any flavour carryover effects. 
Sensory analysis was undertaken in the panel booths at the sensory laboratory, UCC, in 
accordance with ISO (1988) international standard regulations. Assessors were also provided 
with water and crackers to cleanse their palates between samples. 
 
Hedonic (appearance, liking of flavour, liking of texture and overall acceptability) 
(dislike/like, unacceptable/acceptable) and intensity sensory analysis descriptors (yolk colour 
(yellow/orange), egg white (white/grey), sulphur flavour (none/extreme), sour (not/very), 
sweet (not/very), salty (not/very), odour (weak/strong) and off-flavour (none/extreme)) were 
determined where assessors were asked to indicate their rating on a 10 centimetres (cm) 





4.2.4.2 Preparation and sensory evaluation of pork loin for sensory trials 
Pork loin slices (2.5 cm in thickness) from each dietary treatment were covered with 
aluminium foil and cooked in an oven (Zanussi Professional, Model 10 GN1/1, Conegliano, 
Italy) at 180ºC until an internal meat temperature of 72ºC was reached. Following cooking 
and cooling, pork was cut into 2 cm x 2 cm cubes, pooled for each treatment group and 
identified with random three-digit codes. Sample presentation order was randomised to 
prevent any flavour carryover effects (MacFie et al., 1989). Prior to serving to panellists, pork 
samples were re-heated in a microwave for 20 seconds to release the meat odour and flavour. 
 
Sensory evaluation of pork loin 
 
Sensory analysis of cooked pork loin was performed in duplicate by a total of 20 naïve 
assessors, as described by O’Sullivan et al. (2003). Sensory analysis was undertaken in the 
panel booths at the sensory laboratory, UCC in accordance with the ISO (1988) international 
standard regulations. Assessors were provided with water to cleanse their palates between 
samples.  
 
Hedonic sensory analysis descriptors were appearance, odour, liking of texture, liking of 
flavour and overall acceptability. Off-flavour was selected as an intensity sensory analysis 
descriptor. Assessors were asked to indicate their opinions on a 10 cm continuous line scale 
ranging from 0 (extremely dislike / none) to 10 (extremely like / extreme). Results for sensory 
analysis scores were measured in cm. 
 
4.2.4.3 Preparation and sensory evaluation of beef steaks for sensory trials 
 
Beef steaks from each dietary treatment were covered with aluminium foil and cooked in an 
oven (Zanussi Professional, Model 10 GN1/1, Conegliano, Italy) at 200ºC until an internal 
meat temperature of 72ºC was reached.  Following cooking, steaks were cooled, cut into 2 cm 
x 2 cm cubes, pooled for each treatment group and identified with random three-digit codes. 
Sample presentation order was randomised to prevent any flavour carryover effects (MacFie 
et al., 1989). Prior to serving to panellists, beef samples were re-heated in a microwave for 20 




Sensory evaluation of beef steaks 
 
Sensory analysis of cooked beef steaks was performed in duplicate by a total of 40 naïve 
assessors over two analysis days, as described by O’Sullivan et al. (2003). Sensory analysis 
was undertaken in the panel booths at the sensory laboratory, UCC in accordance with the ISO 
(1988) international standard regulations. Assessors were provided with water to cleanse their 
palates between samples. 
 
Hedonic sensory analysis descriptors were appearance, odour, liking of texture, liking of 
flavour and overall acceptability. Off-flavour was selected as an intensity sensory analysis 
descriptor. Assessors were asked to indicate their opinions on a 10 cm continuous line scale 
ranging from 0 (extremely dislike / none) to 10 (extremely like / extreme). Results for sensory 
analysis scores were measured in centimetres (cm). 
 
4.2.5 Statistical analysis 
 
Data and statistical analysis on egg and meat (pork and beef) vitamin D3, 25- hydroxyvitamin 
D3 and total vitamin D activity as well as serum 25(OH)D concentrations for pigs and beef 
cattle was conducted using SPSS© Version 22.0 for WindowsTM (SPSS Inc. Chicago, IL, 
USA). Data was tested for normality and Ln transformed as required (serum 25(OH)D2 in 
pigs). Differences in mean serum 25(OH)D variables and vitamin D3, 25- hydroxyvitamin D3 
and total vitamin D activity across groups were analysed by one-way ANOVA followed by 
Tukey’s post hoc tests.  
 
Statistical analysis of the sensory score data, via analysis of variance (ANOVA)-partial least 
squares regression (APLSR), was conducted using Unscrambler software (Version 10.3, 
CAMO ASA, Trondheim, Norway). Statistical significance was defined as a P <0.05. For the 
pork loin and beef steak sensory evaluation, in order to investigate the predictive ability of the 
dietary treatment received on the sensory score outcome, the X-matrix was designated as 0/1 
for the dietary treatment and the Y-matrix designated as the sensory descriptors. To derive 
significance indications for the relationships determined in the quantitative APLSR, 
regression coefficients were analysed by jack-knifing which is based on cross-validation and 
stability plots (Martens & Martens, 2001). Results were presented as significance of 
regression coefficients.  From these, the significances (P<0.05) of the variable relationships 







4.3.1. Vitamin D content of vitamin D-enhanced eggs 
 
The vitamin D3, 25-hydroxyvitamin D and total vitamin D activity in the pooled raw egg yolk 
samples derived from egg collections from hens fed four experimental diets are shown in 
Table 1. Within treatment groups, estimates for all three vitamin D-related measures were 
variable across the two pools made from two separate collection days (d1 and d3) of the same 
week. For example, the percentage difference in egg vitamin D3 content, 25-hydroxyvitamin 
D content, and vitamin D activity results ranged from 10.4-41.0%, 0.4-22.4%, and 9.7-24.0%, 
respectively. Thus, data from the pools from both days were combined to provide an average 
for each treatment group, and the means of each vitamin D content-related measure were 
compared across groups. One-way ANOVA showed that vitamin D3, 25-hydroxyvitamin D 
and total vitamin D activity in the combined pools differed by treatment (P<0.05, in all cases).  
 
The vitamin D3 contents of raw egg yolk pools in the three 3000 IU/kg treatment groups were 
similar to that in the 1500 IU/kg group. Within the three 3000 IU/kg treatment groups, the 
vitamin D3 content of egg yolk pools from the 3000 IU vitamin D3/kg group were significantly 
(P=0.022) higher than that from the 3000 IU HyD®/kg group; with no other significant 
differences observed. The 25-hydroxyvitamin D3 contents were significantly higher in the 
3000 IU combination group (1500 IU vitamin D3 + 1500 IU HyD®/kg) and the 3000 IU 
HyD®/kg group in comparison to the 1500 IU/kg group (P<0.05, in both cases). Within the 
3000 IU/kg equivalent groups, the 3000 IU vitamin D3/kg group contained significantly lower 
25-hydroxyvitamin D3 than the other two treatment groups (P<0.05, in both cases). The 
vitamin D activity of the pooled egg sample from the 3000 IU HyD®/kg group was 
significantly higher than the 1500 vitamin D3/kg group (P=0.05). No other significant 
differences were observed between treatment groups.  
 
Total vitamin D activity was prioritized as it takes account of vitamin D3 and 25-
hydroxyvitamin D as well as fact that the latter is 5 times more effective in raising serum 
25(OH)D than the former.  The eggs from hens fed the 3000 IU HyD®/kg diet had the highest 
numerical mean total vitamin D activity, followed by the 3000 IU combination group, 3000 
IU vitamin D3/kg group and the 1500 IU vitamin D3/kg group, in that order. However, it should 
be stressed that the mean total vitamin D activity in the 3000 IU HyD®/kg egg pool was not 
statistically different to that found in the egg pools from the other 3000 IU equivalent treatment 








Table 1. Vitamin D3, 25-hydroxyvitamin D3 and total vitamin D activity of pooled egg yolk samples from eggs collected from hens fed the four experimental 
vitamin D diets: as determined via LC-MS/MS at the Danish Technical University.  
 
Egg vitamin D content 
Treatment groups [additional vitamin D compounds/kg feed] 
P-value2 
1500 IU vitamin D3 3000 IU vitamin D3 3000 IU combination




µg/100g raw egg yolk 
 
    
Vitamin D3:      
      Pooled Day 1 7.85 13.44 9.14 4.12 - 
      Pooled Day 3 4.63 10.96 7.27 3.69 - 
      Mean (SD) 6.24 (2.28) 12.20 (1.75)a 8.21 (1.32)ab 3.91 (0.30)b 0.026 
      
   25-hydroxyvitamin D3:      
      Pooled Day 1 2.48 2.31 4.92 5.85 - 
      Pooled Day 3 2.15 2.32 3.82 5.29 - 
      Mean (SD) 2.32 (0.23) 2.32 (0.01)a 4.37 (0.78)*,b 5.57 (0.40)*,b 0.005 
      
   Total vitamin D activity:3      
      Pooled Day 1 20.2 25.0 33.7 33.4 - 
      Pooled Day 3 15.4 22.6 26.4 30.1 - 
      Mean (SD) 17.8 (3.4) 23.8 (1.7) 30.1 (5.2) 31.8 (2.3)* 0.047 
      
 HyD® =25-hydroxyvitamin D 
n per treatment = 16 egg yolks/pool for day 1 and also for day 3. 
13000 IU combination = 1500 IU vitamin D3 + 1500 IU HyD
® 
2One–way ANOVA followed by Tukey’s; *Significant differences (P≤0.05) between group means of 1500 IU/kg diet and the three different 3000 IU/kg diet 
groups;  a,bDifferent supercript letters represent significant (P≤0.05) differences among group means of three groups receiving 3000 IU/kg diet.  
3Total vitamin D activity calculated as vitamin D3 plus 25-hydroxyvitamin D3 × 5 (Cashman et al., 2012)
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The vitamin D3, 25-hydroxyvitamin D and total vitamin D activity in eggs from hens fed four 
experimental diets, based on individual analysis of eggs (n 6-8/group) rather than pooled 
samples, are shown in Table 2. One-way ANOVA showed that mean vitamin D3, 25-
hydroxyvitamin D and total vitamin D activity in the groups of individual eggs differed by 
treatment (P<0.001 in all cases).  
 
The 1500 IU vitamin D3/kg and 3000 IU HyD®/kg treatment groups produced eggs with 
similar vitamin D3 contents; the vitamin D3 content of eggs from these groups were 
significantly lower than eggs produced from either the 3000 IU vitamin D3 or 3000 IU 
combination groups (P<0.01, in both cases). The 3000 IU vitamin D3 group produced eggs 
with the highest vitamin D3 content of all groups (P<0.01, in all cases). The 25-
hydroxyvitamin D3 contents were significantly higher in eggs from the 3000 IU combination 
group and 3000 IU HyD® group than the eggs produced from the 2 groups with additional 
vitamin D3 only (P<0.01, in all cases). The 25-hydroxyvitamin D3 content of eggs from the 
3000 IU combination group and 3000 IU HyD® group were not statistically different from 
each other (P>0.1). Eggs from the 3000 IU HyD® had higher total vitamin D activity than eggs 
from the 1500 IU vitamin D3 group (P=0.0001); whereas eggs from the 3000 IU combination 
group were statistically higher than eggs from both of the additional vitamin D3 only groups 
(P<0.01).  The percentage coefficient of variation (CV) for vitamin D activity in each of the 
treatment groups were 18.4%, 12.3%, 14.7% and 27.6% for 1500 IU vitamin D3, 3000 IU 
vitamin D3, 3000 IU combination, and 3000 IU HyD®, respectively. 
 
In terms of vitamin D activity, eggs from the 3000 IU combination and 3000 IU HyD® groups 
were not statistically different from each other; however, individual egg analysis showed that 
the eggs from hens fed the 3000 IU combination diet had the highest numerical mean total 
vitamin D activity, followed by the 3000 IU HyD®/kg group, 3000 IU vitamin D3/kg group 










Table 2. Vitamin D3, 25-hydroxyvitamin D3 and total vitamin D activity of individual eggs (n 6-8/group) collected from hens fed the four experimental vitamin 
D diets:  as determined via HPLC at University College Cork1  
HyD® =25-hydroxyvitamin D 
1Values represent means (SD). 
23000 IU combination = 1500 IU vitamin D3 + 1500 IU HyD
® 
3One–way ANOVA followed by Tukey’s; *Significant differences (P≤0.01) between group means of 1500 IU/kg diet and the three different 3000 IU/kg diet 
groups; a,b,cDifferent supercript letters represent significant (P≤0.01) differences among group means of three groups receiving 3000 IU/kg diet.  
4Total vitamin D activity calculated as vitamin D3 plus 25-hydroxyvitamin D3 × 5 (Cashman et al., 2012) 
 
Egg vitamin D content… 
Treatment groups [additional vitamin D compounds/kg feed] 
 
P-value3 1500 IU vitamin D3 3000 IU vitamin D3  3000 IU combination
2 3000 IU HyD® 
 µg/100g raw egg yolk  
   Vitamin D3 3.0 (1.6) 10.2 (2.3)*,a 6.7 (0.9)*,b 2.6 (1.7)c <0.0001 
   25-hydroxyvitamin D3 3.0 (0.8) 3.2 (0.8)a 6.7 (1.1)*,b 6.2 (2.1)*,b <0.0001 
   Total vitamin D activity4 18.1 (3.4) 26.1 (3.3)a 40.4 (6.0)*,b 33.4 (9.2)*,ab <0.0001 
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4.3.2 Sensory analysis of fried and boiled eggs across vitamin D dietary treatment groups 
 
The average sensory scores of boiled and fried eggs from each vitamin D dietary treatment 
group are shown in Table 3 and 4, respectively. There were no significant positive or negative 
correlations between vitamin D dietary treatments and the sensory descriptors in resulting eggs 
when boiled (Table 3) or fried (Table 4) (P <0.05).  
 
4.3.3. Serum 25(OH)D concentration and total vitamin D content of meat from pigs 
and beef heifers from vitamin D treatment groups 
 
Serum 25(OH)D concentrations and the vitamin D3 and 25-hydroxyvitamin D3 contents of 
pork meat based on pooled (n 7/8 per group) and individual analysis (n 7/group) from pigs fed 
the three different vitamin D experimental diets are outlined in Table 5. Serum total 25(OH)D 
and 25(OH)D3 concentrations were significantly different across the treatment groups 
(P=0.001, for both). Serum 25(OH)D3 and total 25(OH)D concentrations (see Figure 1) were 
significantly higher (P=0.001) in pigs that received the 2000 IU HyD® compared to those in 
the 2000 IU vitamin D3 group, but no other group differences were observed. There were no 
significant differences (P>0.4) in serum 25(OH)D2 concentrations between the treatment 
groups.  
 
The vitamin D3 contents of the pork meat were significantly different between the three 
different treatment diet groups. The vitamin D3 content of the pork meat was highest from pigs 
fed the 2000 IU vitamin D3 diet, followed by the 2000 IU combination diet and the 2000 IU 
HyD® diet, respectively. Within the three different diet treatment groups, the 25-
hydroxyvitamin D3 content of the pork meat was significantly higher  in pigs fed the 2000 IU 
HyD® diet in comparison to the 2000 IU vitamin D3 group (P = 0.001); with no other 
significant differences observed. In terms of the vitamin D activity of the pork meat, pork meat 
from the group that was fed 2000 IU HyD diet, had the highest total vitamin D activity, 
followed by the 2000 IU combination group and the 2000 IU vitamin D3 group in that 
order.Vitamin D activity of the pork meat was significantly higher in pigs fed the 2000 IU 
HyD® diet in comparison to the 2000 IU vitamin D3 group (P = 0.01); with no other significant 








Table 3. Average sensory scores (cm) for boiled eggs from each dietary treatment; values represented as mean (S.D.) Samples were presented in duplicate (n 22)1 
 
HyD® =25-hydroxyvitamin D 
1P>0.05 for all. 



































































1500 IU vit D3  6.70 (1.13) 6.73 (1.20) 6.88 (1.20) 6.90 (0.93) 3.80 (1.84) 3.73 (1.81) 2.40 (1.89) 1.15 (1.21) 2.03 (1.70) 1.69 (1.53) 3.43 (1.77) 1.25 (1.19) 
3000 IU vit D3  6.19 (1.39) 6.25 (1.40) 6.52 (1.39) 6.36 (1.11) 3.81 (1.77) 3.83 (1.84) 2.44 (1.68) 1.22 (1.25) 2.27 (1.75) 1.78 (1.93) 2.76 (1.34) 1.21 (1.34) 
3000 IUcombo2 6.69 (1.41) 6.77 (1.13) 7.16 (1.14) 6.89 (0.81) 4.76 (1.96) 3.52 (1.80) 2.13 (1.68) 1.22 (1.25) 2.11 (1.97) 1.90 (1.99) 3.32 (1.80) 1.10 (1.36) 







Table 4. Average sensory scores (cm) for fried eggs from each dietary treatment; values represented as mean ± S.D. Samples were presented in duplicate (n 18)1 
 
HyD® =25-hydroxyvitamin D 
1P>0.05 for all. 



































































1500 IU vit D3  6.61 (1.38) 6.73 (1.17) 5.91 (1.40) 6.40 (1.35) 4.78 (1.92) 2.69 (0.98) 1.38 (1.21) 0.76 (0.89) 1.89 (1.85) 1.71 (1.31) 2.78 (1.22) 0.44 (0.78) 
3000 IU vit D3  6.35 (1.64) 6.59 (1.44) 5.89 (1.50) 6.29 (1.37) 4.75 (2.11) 2.68 (1.49) 0.88 (0.77) 0.91 (1.03) 1.61 (1.79) 1.47 (1.52) 2.77 (1.60 0.75 (1.30) 
3000 IUcombo2 6.47 (1.23) 6.53 (1.18) 6.26 (1.06) 6.36 (1.04) 5.30 (2.40) 2.64 (1.19) 0.93 (1.33) 0.92 (1.50) 1.93 (1.92) 1.47 (1.39) 2.55 (1.75) 0.87 (1.49) 







Table 5. Serum 25(OH)D concentrations and content of vitamin D3 and 25-hydroxyvitamin D3 in pork meat from pigs (n 7/8 per group) fed the three experimental vitamin 
D diets1 
 
 Treatment group [Additional vitamin D compounds/kg feed]  
2000 IU vitamin D3 2000 IU combination
2 2000 IU HyD® P-value7 
Porcine serum (nmol/L)3:     
      25(OH)D2 0.08 (0.20) <LOD* 0.42 (0.48) 0.403 
      25(OH)D3 69.3 (12.8)a 104.9 (32.9)ab 147.1 (46.6)b 0.001 
      Total 25(OH)D  69.4 (12.9)a 104.9 (32.9)ab 147.5 (46.9)b 0.001 
Meat (μg/100g)     
Pooled (n 8 )4     
      Vitamin D3 0.17 (0.01) 0.09 (0.01) 0.03 (0.01) -8 
      25(OH)D3 0.14 (0.00) 0.22 (0.02) 0.33 (0.02) - 
      Total vitamin D activity 5 0.89 (0.00) 1.17 (0.09) 1.70 (0.12) - 
Individual (n 7) 6     
      Vitamin D3 0.20 (0.02)a 0.12 (0.04)b 0.04 (0.02)c < 0.0001 
      25-hydroxyvitamin D3 0.13 (0.03)a 0.18 (0.05)ab 0.29 (0.09)b 0.001 
      Total vitamin D activity 5 0.87 (0.19)a 1.03 (0.27)ab 1.49 (0.44)b 0.01 
 
HyD® =25-hydroxyvitamin D 
1Values represent mean (S.D.) 
22000 IU combination = 1000 IU vitamin D3 + 1000 IU1 25(OH)D3 
3Determined via LC-MS/MS at University College Cork; Total 25(OH)D = 25(OH)D2 + 25(OH)D3. 
4Determined via LC-MS/MS at Danish Technical University; representing combined data from pooled samples of loin and fillet cuts (each containing an n 8) 
5Total vitamin D activity = vitamin D3 + 25(OH)D3 × 5 
6Determined via LC-MS/MS at University College Cork; representing data from individual samples (n 7) 
7One–way ANOVA followed by Tukey’s; a,b Groups with different superscript letters are statistically different from each other; P=0.001 
8These data did not undergo a statistical comparison, as they are pooled data.  






Figure 1. Serum total 25(OH)D concentrations (nmol/L) for pigs fed the three dietary vitamin 
D experimental diets. Bars and error bars represent mean (SD (n 7/ 8 per group). Bars with 
different lower case letters are significantly different to each other (P = 0.001; via ANOVA 
and Tukey’s). ‘2000 IU combination’ represents the treatment diet of 1000 IU vitamin D3 + 












































Serum 25(OH)D concentrations and the vitamin D3 and 25-hydroxyvitamin D3 contents of 
beef based on pooled and individual analysis (n 7/group) from heifers fed the three different 
vitamin D experimental diets are outlined in Table 6. Serum total 25(OH)D and 25(OH)D3 
concentrations were significantly different across the treatment groups (P<0.001, for both). 
Serum 25(OH)D3 and total 25(OH)D concentrations (see Figure 2) were significantly higher 
(P<0.05, for both) in heifers that received the 2000 and 4000 IU vitamin D3/kg compared to 
those in no vitamin D3 group, with no differences between the 2000 and 4000 IU vitamin D3 
groups (P>0.05). There were no significant differences (P>0.9) in serum 25(OH)D2 
concentrations between the treatment groups.  
 
The vitamin D3 and 25- hydroxyvitamin D3 contents of the beef were significantly different 
between the three different treatment diet groups (P < 0.0001). The vitamin D3 content of the 
beef was highest in the group fed 4000 IU vitamin D3/ kg, followed by the 2000 IU- and 0 IU 
vitamin D3/kg groups, respectively. Likewise, the 25-hydroxyvitamin D content was highest 
in the beef from heifers that received the 4000 IU vitamin D3/ kg, followed by the 2000 IU- 
and 0 IU vitamin D3/kg groups, respectively. In terms of the vitamin D activity of the beef, 
beef from heifers fed the 4000 IU vitamin D3 /kg diet had the highest total vitamin D activity 
followed by the  2000 IU vitamin D3/ kg and the 0 IU vitamin D3/ kg group in that order..4.3.4 
Sensory analysis of pork loin across vitamin D dietary treatment groups 
 
The mean sensory scores for pork loin from each vitamin D dietary treatment group are shown 
in Table 7.  The regression coefficients as shown in Table 8 were derived from jack-knife 
uncertainty testing (as described in section 3.2.5). No significant differences existed across 





Table 6. Serum 25(OH)D concentrations and content of vitamin D3 and 25-hydroxyvitamin D3 in tissue from beef heifers (n 7/group) fed the three experimental 
vitamin D3 diets1 
  
 Treatment group [Additional vitamin D3/kg feed]  
0 IU vitamin D3 2000 IU vitamin D3 4000 IU vitamin D3 P-value5 
Bovine serum (nmol/L)2     
      25(OH)D2 22.1 (9.9)  21.4 (6.7) 20.9  ( 6.1 0.960 
      25(OH)D3 67.5 (8.9)a 118 (12.8)b 158 (50.3)b <0.001 
      Total 25(OH)D 89.5 (15.7)a 139 (18.7)b 179 (52.7)b <0.001 
Meat (μg/100g)     
Pooled3     
      Vitamin D2 <0.1 <0.1 <0.1 -6 
      Vitamin D3 0.019 0.045 0.067 - 
      25(OH)D2 0.024 0.027 0.022 - 
      25(OH)D3 0.083 0.168 0.172 - 
      Total vitamin D activity  0.55  1.02 1.04 - 
Individual4     
      Vitamin D3 0.01(0.01)a 0.04 (0.01)b 0.10 (0.02)c <0.0001 
      25-hydroxyvitamin D3 0.11 (0.02)a 0.18 (0.02)b 0.25 (0.05)c <0.0001 
      Total vitamin D activity 0.55 (0.09)a 0.95 (0.10)b 1.35 (0.28)c <0.0001 
 
HyD® =25-hydroxyvitamin D 
1values represent mean (S.D).  
2Determined via LC-MS/MS at University College Cork; Total 25(OH)D = 25(OH)D2 + 25(OH)D3. 
3Representing data from pooled samples rib-eye (each containing an n 7); determined via LC-MS/MS at Danish Technical University; Total vitamin D activity = vitamin D2 + D3 + 
[25(OH)D2 × 5] + [25(OH)D3  × 5]; no vitamin D2 estimates included as below level of quantification. 
4Representing data from individual samples (n 7); determined via LC-MS/MS at University College Cork; Total vitamin D activity = vitamin D3 + [25(OH)D3  × 5] 
5One–way ANOVA followed by Tukey’s; a,b Groups with different superscript letters are statistically different from each other; P<0.005 






Figure 2. Serum total 25(OH)D concentrations (nmol/L) for beef heifers fed the three different 
vitamin D experimental diets. Bars and error bars represent mean (SD) (n 10, 11 per group). 
Bars with different lower case letters are significantly different to each other (P<0.05; via 


































































2000 IU vitamin D3 6.41 (1.86) 6.06 (1.95) 5.37(2.34) 5.48 (2.00)  5.92 (1.83) 2.08 (2.41) 
1000 IU vitamin D3 + 
1000 IU HyD® 
5.94 (2.37) 6.28 (1.64) 6.09 (2.49) 6.15 (1.99) 6.38 (1.85) 1.66 (2.15) 



























2000 IU vitamin D3 0.555 -0.415 -0.469 -0.250 -0.206 0.271 
1000 IU vitamin D3 + 
1000 IU HyD® 
-0.441 0.327 0.437 0.141 0.156 -0.153 
2000 IU  HyD® 0.367 -0.354 -0.339 -0.131 -0.194 0.210 
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4.3.5 Sensory analysis of beef steak across vitamin D dietary treatment groups 
 
The average sensory scores for beef steak from each vitamin D dietary treatment group are 
shown in Table 9. The regression coefficients as shown in Table 10 were derived from jack-
knife uncertainty testing (as described in section 3.2.5). Overall acceptability was found to be 
significantly lower for beef steaks from the 0 IU treatment diet group in comparison to beef 
steaks from the treatment groups that received additional vitamin D3 via jack knife testing. 
There were no significant differences in overall acceptability between the 2000 IU and 4000 
IU vitamin D3 dietary treatment groups. No further significant differences existed across the 

























0 IU vitamin D3 6.18 (1.84) 5.84 (1.85) 5.47 (2.36) 5.88 (2.06) 5.72 (2.04) 1.50 (2.15) 
2000 IU vitamin D3 6.46 (1.84) 6.10 (1.94) 6.07 (2.27) 6.17 (2.08) 6.42 (1.76)  1.71 (2.24) 







Table 10. Regression coefficients from the analysis of variance (ANOVA)-partial least squares regression analysis of beef steaks, as derived by jack-knife 
uncertainty testing 
 
















0 IU vitamin D3 -0.134 -0.062 -0.093 -0.139 -0.024* 0.982 
2000 IU vitamin D3 0.974 0.624 0.352 0.931 0.178 -0.337 





The low dietary vitamin D intakes in European populations, as outlined comprehensively by 
Vinas et al. (2011), highlights the fact that the current food supply (even including current 
food fortification and vitamin D supplementation practices) are not enough to prevent wide-
scale low vitamin D status in Europe (Cashman et al. 2016). This is particularly the case during 
the months of the year where UVB availability is inadequate for dermal synthesis of vitamin 
D (Webb et al., 2006) and where individuals follow recommendations to limit summer sun 
exposure for the prevention of skin cancer (NICE, 2016). The present work has focused on 
bio-fortification of eggs, pork and beef with vitamin D as a method of improving the dietary 
availability of vitamin D from the current food supply and in an effort to reduce the 
discrepancy that exists between typical dietary intakes of vitamin D and recently established 
recommendations.  
 
Eggs are a widely consumed food and therefore potentially an ideal vehicle to target as a 
vitamin D-biofortified food. Previous studies have demonstrated the effectiveness of 
additional vitamin D3 and/or HyD® in the feed of laying hens in terms of improving the vitamin 
D3 and 25-hydroxyvitamin D contents of the resulting eggs (Mattila et al., 1999; 2003; 2004; 
2011; Yao et al., 2013; Browning & Cowieson, 2014).  However, the majority of these studies 
have included levels of vitamin D and/or HyD® in the feed which exceed the EU allowable 
maximum levels for use in laying hen feed (equivalent to 3000 IU/kg feed; EFSA, 2009, 
EFSA, 2012).  Figure 4 below shows the data on vitamin D3 content of the eggs from these 
published studies, and has also included data from the current study for reference. Studies 
which used feed levels of vitamin D and/or HyD® in excess of the maximum allowable levels 
are shown in the graph using red bars, those which have used permissible levels are shown 
using blue bars and the present study is indicated using the green bars.  Likewise, Figure 5 
below shows available data on 25-hydroxyvitamin D content of the eggs from these published 
studies, and has also included data from the present study.  Prior to the present study, data on 
vitamin D, and especially the metabolite, content of eggs from hens provided with feed 
containing permissible levels of vitamin D and/or HyD® were limited and, moreover, the 
available data were quite variable (Figure 4 and 5). This is particularly the case for 25 
hydroxyvitamin D data in eggs (Figure 5), and yet knowledge of the 25-hydroxyvitamin D 
content is vital in determining the total vitamin D activity (i.e., which accounts for the vitamin 










Figure 4.  The achieved vitamin D3 content of egg yolk (µg/100g) reported from published studies of the effect of different vitamin D and/or HyD® 
supplementation in laying hen feeds. The first number in parenthesis in the X axis denotes the study from which this data is derived as follows: 1) Mattila et al., 
1999; 2) Mattila et al., 2003; 3) Mattila et al., 2004; 4) Mattila et al., 2011; 5) Yao et al., 2013; 6) Browning & Cowieson, 2014.  *Pooled results from the 









































Current study (within EU regulation)









Figure 5.  The achieved 25-hydroxyvitamin D content of egg yolk (µg/100g) reported from published studies of the effect of different vitamin D and HyD® 
supplementation in laying hen feeds.  The first number in parenthesis in the X axis denotes the study from which this data is derived as follows: 1) Mattila et 
al., 1999; 2) Mattila et al., 2003; 3) Mattila et al., 2011; 4) Browning & Cowieson, 2014. *Pooled results from the current study (as determined via LC-MS/MS 










































Current study (within EU regulation)
In breach of EU regulation
 
133 
In general, the measurement of 25 hydroxyvitamin D in food is limited due to the small 
number of research groups who undertake its measurement. In addition, even in the 
laboratories that undertake this analysis, the variability in estimates of 25 hydroxyvitamin D 
in food can be large.  For example, the inter-lab coefficient of variation (CV) for vitamin D3 
and 25 hydroxyvitamin D3 analysis of whole egg powder by five different labs participating 
in an inter-laboratory trial was 10% and 16%, respectively.  The equivalent CVs for vitamin 
D3 and 25 hydroxyvitamin D3 analysis of ground beef was 8% and 24%, respectively (Personal 
communication from Jette Jakobsen, DTU). This situation will be helped by the fact that the 
National Institute of Standards and Technology (NIST) in the US will soon include a value 
for 25 hydroxyvitamin D content in some food standard reference materials. This needs to be 
borne in mind when making comparisons of vitamin D content or total activity in eggs coming 
from different studies, even when the levels of vitamin D compound included in the hen feeds 
are comparable.  The present study used the National Food Institute, Technical University of 
Denmark for the principal vitamin D3 and 25 hydroxyvitamin D analysis, and then the data 
from our in house HPLC was aligned with that method to ensure comparability.  The National 
Food Institute laboratory has been accredited for vitamin D and 25-hydroxyvitamin D since 
1994 and 2004, respectively.  For the last 15 years, it has performed the analysis for vitamin 
D and 25-hydroxyvitamin D in food for the Danish and Norwegian Food Composition Tables.   
 
Mattila et al. (2011), in a feeding trial similar to the present one, used levels of vitamin D and 
HyD® for inclusion in the hen feeds which were allowable by EU regulations, except for one 
high dose HyD® level (at 4800 IU HyD®/kg feed).  The other three levels of vitamin D and/or 
HyD® used by Mattila et al. (2011) (i.e., 1720 IU vitamin D/kg feed; 1240 IU vitamin D and 
1200 IU HyD®/kg feed; and 2200 IU HyD® /kg feed) are lower than that used in our study 
which limits a direct comparison of final egg vitamin D and 25-hydroxyvitamin D contents 
from the two studies.  Of note, however, Mattila et al. (2011) found that hens receiving 
additional HyD® alone produced eggs with a very low vitamin D3 content (<0.2 µg/100 egg 
yolk), despite a clear increase in 25-hydroxyvitamin D content. In contrast, our present 
findings show that hens receiving additional HyD® alone (and albeit at slightly higher levels 
3000 IU/kg feed versus 2200 IU/kg in Mattila et al. 2011 study) had relatively good vitamin 
D3 content (3.9 µg/100 egg yolk) as well as the expected increase in 25-hydroxyvitamin D 
content.  This also translated into total vitamin D activity being much higher in our HyD®-
biofortified eggs compared to that in the Mattila et al. (2011) study (~5 v. ~2 µg/whole egg, 
respectively).  A key difference between the two studies, besides being analysed in different 
laboratories, is that the hens in the Mattila et al. (2011) study were provided with HyD® in 
their feeds throughout their laying lifespan, whereas in our study they received HyD®-
containing feed for 6 weeks of the experimental diet period, following consumption of a 
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typical commercial diet for several months prior to that.  This may have facilitated the higher 
vitamin D of the egg, unlike that in Mattila et al. (2011) study.  Thus, it may be that use of 
HyD® in hen diets should be used in a fashion almost akin to a ‘finisher’ style diet in heifers, 
so as to achieve optimal content of both vitamin D compounds in the egg.   
 
Studies on the sensory acceptability of vitamin D3-biofortified eggs to date have been on eggs 
in which the hens received well above the European allowable upper level (Mattila et al., 2003, 
Yao et al., 2013), and HyD® eggs have not been tested. The findings of our study suggest that 
consumer acceptability of eggs from hens fed 3000 IU vitamin D3/kg diet or 3000 IU  HyD®/kg 
diet did not differ from each other, or from hens fed the 50:50 vitamin D3:HyD® diet 
(equivalent to 3000 IU/kg) or control diet (3000 IU vitamin D3/kg).  That the HyD®- or vitamin 
D3-derived eggs had equal consumer acceptability profiles based on the present sensory 
evaluation was important, as any alteration to a sensory perception of a food that may be 
deemed negative by the consumer will affect their decision to consume the product.   
 
Overall, the findings of our study suggest that the addition of vitamin D and/or HyD® at levels, 
that adhere to the EU maximum allowable levels set by EFSA, can increase the total vitamin 
D activity of an egg to ~5 µg/whole egg, whilst maintaining good consumer acceptability 
profiles.  Thus, from a content perspective, these vitamin D-biofortified eggs can provide 
about half of the EAR value of 10 µg/day (IOM, 2011).  Of key importance in terms of 
informing the potential of vitamin D-biofortified eggs as a food-based solution for prevention 
of vitamin D deficiency, is the need to test and illustrate the effect of consumption of such 
biofortified eggs on vitamin D status of healthy human subjects in a randomized controlled 
trial setting, which is the focus of Chapter 5. 
 
In terms of the evidence-base for vitamin D-biofortified pork, there have been a number of 
pig studies (Wiegand et al., 2002; Swigert et al., 2004; Wilborn et al., 2004) which included 
vitamin D3 in the feed but at supra-nutritional levels, that exceed the current EU maximum 
allowable level of 2000 IU/kg feed (EFSA, 2009).  Three studies have reported the effect of 
inclusion of vitamin D and/or HyD® in pig feedstuffs, at or below the current EU allowable 
levels, on vitamin D3 and 25-hydroxyvitamin D content of pork meat (Jakobsen et al. 2007, 
Höller et al. 2010, Burild et al. 2016).  Burild et al. (2016) have stressed an important 
consideration in comparing absolute levels of vitamin D compounds in pork meat from these 
different studies, due to differences in study design and experimental animals, but also 
importantly analytical methods. As mentioned above, variability among labs in the assessment 




In a study design very similar to the present pig study, Jakobsen et al. (2007) reported that 
while use of vitamin D3 or HyD® alone, or both in combination (all at circa 2000 IU 
equivalent/kg feed), for 16 weeks prior to slaughter led to minimal differences in plasma 
25(OH)D concentrations in pigs, there was a clear dose-related increments in vitamin D3 
content of lean pork (loin) meat with increasing vitamin D3 level in the three feeds (i.e., from 
0 to 1000 to 2000 IU/kg in the HyD®, 50:50 vitamin D3:HyD® and vitamin D3 feed, 
respectively).  The 25-hydroxyvitamin D content of pork meat was variable, with no difference 
between pigs fed the vitamin D3 alone and HyD® alone feeds, but was significantly higher in 
pigs fed the vitamin D3+HyD® feed (Jakobsen et al. 2007). This led the authors to suggest that 
HyD® in pig feed leads to meat with a lower vitamin D nutritional value compared to feeds 
containing vitamin D3.  While not reported in the paper, comparison of total vitamin D activity 
(using the meat vitamin D and metabolite data and a factor of 5 for the 25-hydroxyvitamin D) 
of pork meat from animals fed HyD® or vitamin D3 (2000 IU per kg diet) showed only a slight 
difference (4.1 versus 5.6 g/kg meat, respectively).  More recently, however, another pig 
study from the same Danish group showed that serum 25(OH)D concentration, and the 
contents of vitamin D3 and 25-hydroxyvitamin D in lean pork (loin) meat, all increased in a 
linear manner in pigs fed increasing levels of vitamin D3 in feeds (5-50 g/kg) over 7 weeks 
prior to slaughter (Burild et al. 2016).  Similarly, while serum 25(OH)D concentration and the 
25-hydroxyvitamin D content of lean pork meat increased in a linear manner in pigs fed 
increasing levels of HyD® in the feeds (5-50 g/kg diet), the increase in pork meat vitamin D3 
content was relatively weak, if not absent altogether (Burild et al. 2016). Again while not 
reported in the paper, comparison of total vitamin D activity (again using the meat vitamin D 
and metabolite data and a factor of 5 for the 25-hydroxyvitamin D) of pork meat from animals 
fed HyD®- or vitamin D3-containing feed (2000 IU per kg) showed a two-fold higher activity 
in the former compared to the latter (14.2 versus 6.5 g/kg meat, respectively). Likewise, 
serum 25(OH)D concentration was over twice as high in the animals fed the HyD®- versus 
vitamin D3-containing feed (67.1 v. 27.2 ng/mL, respectively) (Burild et al. 2016). These agree 
well with the findings of the present study which showed that serum 25(OH)D concentration 
and total vitamin D activity of lean pork (loin and fillet) meat from pigs fed HyD® was double 
that from pigs fed vitamin D3, whereas the pigs provided with feeds containing 50:50 
HyD®:vitamin D3 had intermediate serum 25(OH)D concentrations and total vitamin D 
activity in pork meat.   
 
The total vitamin D activity of lean pork meat appears to be in the range 1.0 to 2.9 g/170 g 
meat (average serving size) based on the present data and that of Burild et al. (2016). The total 
vitamin D activity of less lean pork products could be even higher, as Burild et al. (2016) have 
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shown that the total vitamin D activity of fat from animals fed HyD® or vitamin D3 (2000 
IU/kg feed) was 24.0 and 17.7 g/kg, respectively. 
 
Sensory data in this study show that there was no significant difference in sensory descriptors 
of the pork loin from any of the treatment groups. This highlights that the addition of vitamin 
D3 and HyD® to the diets of pigs did not alter the consumer acceptability of the resulting pork 
loin from the treatment groups. 
 
In terms of the evidence-base for vitamin D-biofortified beef, again there have been a number 
of beef heifer studies (Swanek et al., 1999; Foote et al., 2004; Montgomery et al., 2004; Sell 
et al 2004) but which included vitamin D3 in the finisher feed or as a single oral bolus dose at 
supra-nutritional levels, that exceed the current EU allowable level of 4000 IU/kg feed (EFSA, 
2009).  In addition, as the focus of these studies was primarily on the effect of the additional 
vitamin D on tenderness of beef cuts, only two reported data on the vitamin D and 25-
hydroxyvitamin D content of the resulting beef, both of which increased with increasing feed 
vitamin D content but well above allowable levels at up to 5 million IU vitamin D (Foote et 
al., 2004, Montgomery et al., 2004). While a number of other studies have tested the impact 
of HyD® added to the feed, again with the aim of improving meat quality/tenderness (Wertz 
et al., 2004; Rivera et al., 2005; Cho et al., 2006; Lawrence et al., 2006; Carnagey et al., 
2008a; 2008b), HyD® is not currently permitted for use in feed of beef heifers in the EU 
(EFSA, 2009, 2012). It is for these reasons, we tested the effect of vitamin D3 at the EU 
maximum allowable level of inclusion, and half that, versus no additional vitamin D3 added 
to the finisher diet of beef heifers for 4 weeks.  Not unsurprisingly, vitamin D3 content of the 
beef steak increased in a dose-related manner with increasing feed level. Interestingly, pooled 
sample data indicated that the 25-hydroxyvitamin D content of the beef steak appeared to 
increase about 2-fold when the feed content of vitamin D3 was increased from 0 to 2000 IU/kg, 
but then with no further increment at 4000 IU/kg feed, whereas individual sample data showed 
there was a further significant increase in the 25 hydroxyvitamin D content of the beef from 
heifers fed the 4000 IU/kg diet in comparison to the 2000 IU/kg data, highlighting the potential 
requirement for more extensive analysis of food samples in terms of vitamin D food analytics 
due to the presence of individual differences. This was also the trend for total vitamin D 
activity.  The present data suggests that the total vitamin D activity of beef (rib eye) steak 
appears to be around 1.5 g/144 g meat (average serving size).  
 
The present sensory data suggest that there was no significant difference in the overall 
acceptability of the beef steak from heifers that received the 2000 IU vitamin D3/kg diet or 
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4000 IU vitamin D3/kg treatment diets.  However, 0 IU vitamin D3/kg treatment group had 
significantly lower overall acceptability scores compared to both vitamin D treatments groups. 
A 0 IU vitamin D3/kg treatment group was included in this study as a reference group, but in 
practise it is unlikely there would be zero addition to finishing feed. Thus, the addition of 
vitamin D3 to the diets of beef heifers did not negatively impact the consumer acceptability of 
the resulting beef steak from the 2000 IU and 4000 IU vitamin D3/kg dietary treatment groups. 
 
Public health strategies to date have largely focused on supplementation as a means to prevent 
vitamin D deficiency; however, this only works for those who consume vitamin D 
supplements, of which consumption can be inconsistent across sex, age group, and area of 
residence (Calvo et al., 2005). The most recent NHANES data brief showed that supplemental 
vitamin D usage increases with increasing age; 26.5% and 33.8%, 38% and 45%, and 44% 
and 56.3% in males and females, respectively, in the age groups, 20-39 years, 40-59 years, 
and >60 years, respectively (Gahche et al., 2011).  Importantly, the most recent data for 
vitamin D status in the US population indicated that 24% of individuals over 1 year have a 
serum 25(OH)D <50 nmol/L (Schleicher et al, 2016).  So, while the report indicated that 
supplement use in the population was common, there is still a high proportion of the 
population who do not take a vitamin D supplement and in addition, approximately one third 
of the population with a low vitamin D status. Thus, it is important to consider further options 
in addition to supplementation policies when aiming to improve vitamin D status in the 
population. Similarly, mandatory fortification of one staple food does address those which are 
non-consumers or low consumers of that food (Cashman & Kiely, 2011). Hence, it becomes 
important to consider the diversity that exists in dietary patterns and careful consideration 
must be placed on the choice of foods to fortify in order to best meet the needs of the 
population and also to ensure safety (Cashman, 2015). The present work shows that small to 
moderate increases can be made to the total vitamin D activity of eggs, pork and beef, 
following the addition of vitamin D3 and/or HyD® to animal feedstuffs, where permissible, 
and at levels that adhere to current EU regulations. This work adds to the evidence-base that 
vitamin D biofortified eggs and meats can be produced with enhanced vitamin D content and 
also maintain consumer acceptability.  Evidence of the effectiveness of vitamin D biofortified 
foods in terms of preventing vitamin D deficiency is a clear priority to bring their concept 
closer to more widespread availability and use.
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Vitamin D intakes are lower than dietary recommendations in most populations and 
increasing evidence suggests that the current dietary supply is unable to offset the lack of 
cutaneous production of vitamin D throughout the winter months in northerly latitudes 
(Kiely & Black, 2012). Recent data suggest that one in eight Europeans are vitamin D 
deficient (Cashman et al, 2016), thus strategies to improve the vitamin D status of the 
general population are urgently required. The fortification of food with vitamin D has 
been suggested as a strategy with potentially widest reach and impact in the population in 
terms of enhancing vitamin D intakes and minimizing risk of vitamin D deficiency.  
 
Traditional fortification practices in which exogenous vitamin D is added to foods has 
been and will continue to be an important approach for increasing the content of vitamin 
D. For example, Black et al. (2012) in their systematic review and meta-analysis of 
vitamin D fortified foods and vitamin D status in randomised controlled trials (RCTs), 
highlighted the efficacy of vitamin D food fortification in increasing serum 25-
hydroxyvitamin D [25(OH)D] concentrations in a dose-dependent manner.  However, the 
authors also suggested that the RCTs included were not primarily designed to assess the 
impact of food fortified with vitamin D on serum 25(OH)D concentrations or prevention 
of vitamin D deficiency. It has also been suggested that food fortification strategies should 
account for diversity in the diet (Cashman & Kiely, 2015). Thus, the use of a ‘bio-
fortification’ (also referred to as ‘bio-addition’ [Calvo & Whiting, 2013]) approach to 
enhance the vitamin D content of foods also merits serious attention not only as it may 
hold more consumer appeal in some cases, but also as it may increase other metabolites 
of vitamin D which would boost the overall relative effectiveness of these foods in raising 
vitamin D status (Cashman, 2015). For example, as outlined in Chapter 4, there have been 
several reports illustrating that the vitamin D3 content of eggs can be significantly 
increased by the greater addition of vitamin D3 to the feed of hens (Mattila et al, 1999; 
2003; 2004; 2011; Yao et al, 2013; Browning & Cowieson, 2014 and Cashman et al, 
2015), albeit several of the studies (Mattila et al, 2003; 2004; Yao et al, 2013 and 
Browning & Cowieson, 2014) use levels of inclusion above the upper allowable level for 
feeds in Europe [3000 IU/kg diet; European Union Register of Feed Additives pursuant 
to Regulation (EC) 1831/2003)]. Addition of commercially available 25-hydroxyvitamin 
D3 (HyD®) to the diet of hens has also been shown to increase egg 25-hydroxyvitamin D3 
content (Mattila et al, 2011; Browning & Cowieson, 2014; Cashman et al, 2015), albeit 






There are however several additional factors to acknowledge when examining the 
effectiveness of bio-fortified foods as opposed to fortified food and supplements, such as 
the food matrix where the vitamin D compounds are bound and any impact this may have 
on their bioavailability once consumed, and also any effect that processing or cooking 
may have on the retention of vitamin D and 25-hydroxyvitamin D in these foods before 
consumption (Jakobsen et al, 2014; Taylor et al, 2014). In order to provide proof of 
efficacy of these foods and to address these considerations, such foods should be 
examined in a specifically designed food-based intervention trial. Therefore, the objective 
of the present work was to investigate the effect of consumption of vitamin D3- or HyD® 
-biofortified eggs on winter serum 25(OH)D concentrations in adults using an 8-week 
RCT.  
5.2 Subjects and Methods  
 
5.2.1 Subjects for RCT 
 
A total of 55 apparently healthy, free-living adults aged 45-70 years were recruited to this 
eight-week food-based vitamin D intervention trial. Subjects were recruited in the Cork 
area through the use of advertisements placed around University College Cork and across 
the location. We aimed to recruit approximately equal numbers of men and women.  
Inclusion criteria were consenting white men and women aged 45-70 y. Volunteers were 
excluded if they were unwilling to discontinue consumption of vitamin D-containing 
supplements for four weeks before initiation of the study and throughout the study. 
Volunteers were also excluded if they planned to take a winter vacation (during the course 
of the eight-week intervention) to a location at which either the altitude or the latitude 
would be predicted to result in significant cutaneous vitamin D synthesis from solar 
radiation (e.g. a winter-sun coastal resort or a mountain ski resort) or if they used tanning 
facilities of any type. A severe medical illness, allergy to egg products, medically advised 
to limit egg intake in relation to managing hypercholesterolemia, hypercalcaemia, known 
intestinal malabsorption syndrome, excessive alcohol use, the use of medications known 
to interfere with vitamin D metabolism also were reasons for exclusion. The study was 
approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals, 
University College Cork. All participants gave their written informed consent according 






5.2.2 Rationale and design of RCT 
 
The study was a controlled, food-based intervention trial in which adults (aged 45-70 y) 
were randomized to three groups: a control group who habitually consumed only two eggs 
or less per week and who agreed to do so for the duration of the RCT; and two vitamin D 
groups, who were habitual egg consumers and willing to consume seven eggs per week, 
who received either seven vitamin D3-enhanced eggs (Vitamin D3-eggs group) or seven 
HyD®-enhanced eggs (HyD® eggs group) a week for eight weeks. The rationale for the 
inclusion of a control group was to show that serum 25(OH)D concentration decreased 
over the eight weeks of the winter RCT, akin to a placebo group in our previous vitamin 
D RCTs (Cashman et al, 2008; 2009; 2011). Our initial hen feeding trial showed that even 
using only half the upper allowable level of vitamin D in feeds led to eggs with 
considerable total vitamin D activity (2.8 μg/egg) (Cashman et al, 2015), thus, it wasn’t 
feasible to supply seven eggs a week and not impact on vitamin D status of the control 
group. Therefore, we chose to limit the egg consumption to a maximum of two per week 
(and participants were not required to consume these two eggs but rather if they did 
consume eggs to limit them to two per week), and in terms of feasibility we selected 
habitual low consumers of eggs for this control group to enhance compliance over eight 
weeks. We felt this was a more feasible approach than requesting participants who were 
habitual egg consumers but then stratified to the control group to limit their egg intake to 
two maximum over eight weeks, which could be challenging. The two vitamin D groups 
were egg consumers willing to consume seven eggs per week.  Seven and 1-2 eggs a week 
(including eggs in dishes) is consistent with that consumed in the highest and lowest tertile 
of adult egg consumers in Ireland, respectively, based on data from the National Adult 
Nutrition Survey (NANS, 2011). From a dietary guideline perspective, the general 
population can include up to seven eggs a week in their diet (Eckel et al, 2013). The 
random assignment of subjects in the two vitamin D-enhanced eggs groups was 
centralised and computer-generated, and accounted for sex.   
 
The vitamin D intake from food sources in the control group would be expected to be 
close to that in general adult population aged 50-70 y (median ~5 μg/d; Black et al, 2012), 
whereas the intakes in the two vitamin D-enhanced eggs groups were expected to be ~10 
μg/d, based on the additional vitamin D activity provided by these eggs.  The ~10 μg/d in 
HyD®-eggs group, however, is based on an assumption that the 25-hydroxyvitamin D in 
the eggs will behave in a similar manner to synthetic 25-hydroxyvitamin D used by us in 
our previous RCT of older adults and which was seen to increase serum 25(OH)D more 




consumed; Cashman et al, 2012), and for which some Food Composition tables assume it 
does (FSA, 2008; Saxholt et al, 2008; Zurich, 2010). However, as mentioned above, it 
may be that the bioavailability of 25-hydroxyvitamin D means that at worst it will only 
be of equivalence to vitamin D3, as suggested by some researchers (Jakobsen et al, 2007). 
Thus, intakes of vitamin D may be only 6.5 μg/d in the HyD®-eggs group.  
 
5.2.3 Eggs for RCT 
 
Both forms of vitamin D are approved by the European Commission expert group (Panel 
on Additives and Products or Substances used in Animal Feed) for inclusion in animal 
feedstuffs [European Union Register of Feed Additives pursuant to Regulation (EC) 
1831/2003; EFSA, 2005], and the vitamin D3/HyD®-enhanced eggs for the RCT were 
supplied on a weekly basis by the School of Agricultural and Food Science, University 
College Dublin. The experimental vitamin D3- and HyD®-containing hen diets, each 
produced at the beginning of the feeding trial in 100 kg batches, were based on a basic 
diet containing crude protein, 155 g/kg, and metabolisable energy, 10.44 MJ/kg.  The diets 
were also balanced for amino acid profiles and fatty acid content, and were provided in a 
layer mash form. Information on the composition of the hen diet used in production of 
commercially available eggs was not known to us. 
 
The eggs were placed in specifically purchased cardboard egg boxes, labelled with ‘use 
by date’, and the subject IDs, all by staff not involved in the conduct of the RCT.  The 
control (non-vitamin D-enhanced) eggs were purchased locally at a major retail store and 
were provided to all in the control group for consistency. The vitamin D3 and 25-
hydroxyvitamin D3 contents of the three types of eggs used in this trial (i.e., commercially 
available [control] eggs, the vitamin D3-enhanced eggs and the HyD®-enhanced eggs) 
were assessed by in-house HPLC analysis within the Cork Centre for Vitamin D and 
Nutrition Research (CCVDNR), University College Cork.  
 
5.2.4 Conduct of RCT 
 
The study was carried out in Cork, Republic of Ireland (latitude: 51ºN). All subjects were 
screened, recruited, and commenced the intervention study between the 5th to 30th January 
2015, and finished the study eight weeks later between 3rd and 30th March, 2015, during 
which the vitamin D status would be expected to decline to a nadir (Webb et al, 1988). 
During the intervention phase, researchers met each participant on two sampling 
occasions at the human dietary studies unit at the CCVDNR, once each at baseline (week 




was taken from each participant between 08.30 and 10.30 hours by a clinical research 
nurse. Blood was collected by venepuncture into an evacuated tube with no additive and 
processed to serum, which was immediately stored at -80ºC until required for analysis.  
Anthropometric measures, including height and weight, were taken as described 
previously (Lucey et al, 2008). Habitual intake of vitamin D (and calcium) was estimated 
via a validated food-frequency questionnaire (FFQ) (Collins, 2006; Kiely et al, 2016) that 
was administered by a research nutritionist at baseline. This FFQ, which has been tailored 
using national food consumption survey data obtained from Irish adults (aged 18-64 y) so 
as to identify foods that contribute 95% of vitamin D intake, has been shown to have a 
generally good level of agreement with a 14 day diet history method, and without 
significant levels of overall bias or proportional bias (Kiely et al, 2016). It is important to 
note that the FFQ was not designed to measure energy or other nutrient intakes and is 
designed to be administered by a trained researcher in association with validated methods 
of estimating portion size (Kiely et al, 2016). In addition, a health and lifestyle 
questionnaire, which assessed physical activity, general health, smoking status and 
alcohol consumption, was completed at baseline.  
 
Participants either collected their weekly/fortnightly allocation of fresh eggs at the human 
dietary studies unit or in some cases where this was not feasible, the eggs were delivered 
to them. This regular contact also served to promote compliance and encourage 
completion of the study protocol. The participants were asked to use the study provided 
eggs in place of their normally purchased eggs for the duration of the study period. 
Subjects were requested to use the whole egg, in light of the fact that egg white is low in 
vitamin D content (Fraser & Emtage, 1976). Subjects were provided with cooking 
suggestions and meal ideas for incorporation of their vitamin D-enhanced whole eggs into 
their weekly diet. Compliance was assessed by an egg diary. While the control group were 
aware of their allocation by virtue of being limited to 2 eggs per week, the allocation of 
the two vitamin D-enhanced egg groups remained concealed from both participants and 
staff involved in the conduct of the RCT until the final analyses was complete. The 
biochemical outcome measures were reported by people who were masked to all subjects’ 




5.2.5. Laboratory analysis  
 
High performance liquid chromatography analysis of RCT eggs.  
 
The separated yolks from six individual eggs per treatment were analysed for vitamin D3 
and 25-hydroxyvitamin D by using an in-house high performance liquid chromatography 
(HPLC) method at the CCVDNR. The extraction procedure was adapted from Jakobsen 
et al. (2004), and following semi-preparative steps also described elsewhere (Jakobsen et 
al, 2004; 2007), vitamin D3 and 25-hydroxyvitamin D were quantified using a HPLC 
system (Shimadzu Corporation, Kyoto, Japan) consisting of two LC20ADXR pumps, 
SIL-30AC autosampler, CTO-20AC column oven, SPD-30MA PDA detector, FRC-10A 
fraction collector and a CBM-20A system controller. Concentrations of vitamin D3 and 
25-hydroxyvitamin D3 were calculated based on external calibration and adjusted for 
percent recovery of the internal standard. In addition, as the eggs from our original hen 
feeding trial were analysed by a liquid chromatography-tandem mass spectrometry (LC-
MS/MS) method at the National Food Institute, Technical University of Denmark (Burild 
et al, 2014), the data were aligned with that method to ensure comparability. The National 
Food Institute laboratory has been accredited for vitamin D and 25-hydroxyvitamin D 
since 1994 and 2004, respectively. For the last 15 years, it has performed the analysis for 
vitamin D and 25-hydroxyvitamin D in food for the Danish and Norwegian Food 
Composition Tables.  
 
Serum 25-hydroxyvitamin D.  
 
Concentrations of total 25(OH)D [i.e., 25(OH)D2 plus 25(OH)D3] in all serum samples 
were measured by the CCVDNR by using a LC-MS/MS method that has been described 
in detail elsewhere (Cashman et al, 2103). The intra-assay CV of the method was <5% for 
all 25-hydroxyvitamin D metabolites, while the inter-assay CV was <6%. The CCVDNR 
is a participant in the Vitamin D Standardization Program (Sempos et al, 2012) and is 
certified by the Centers for Disease Control and Prevention’s Vitamin D Standardization 
Certification Program (Rahmani et al, 2013). In addition, the quality and accuracy of the 
serum 25(OH)D analysis by using the LC-MS/MS in our laboratory is monitored on an 
on-going basis by participation in the Vitamin D External Quality Assessment Scheme 




Serum intact parathyroid hormone. 
 
Serum PTH concentrations were measured at CCVDNR in all serum samples by using an 
ELISA [Intact parathyroid hormone, MD Biosciences Inc., St. Paul, MN 55108]. The 
intra- and inter-assay CVs were 3.4% and 3.8%, respectively.  
 
Serum total calcium and cholesterol.  
 
Total calcium, albumin and cholesterol concentrations were measured at the CCVDNR in 
all serum samples by using a fully automated clinical analyser (RX Monaco Randox 
Laboratories Ltd., Co. Antrim, UK). The inter-assay CVs were 2.2%, 1.9% and 2.2%, for 
total calcium, albumin and cholesterol, respectively. Serum calcium concentrations were 
adjusted for albumin concentrations. 
 
5.2.6 Sample size estimation  
 
We wished to be able to compare the endpoint (March) serum 25(OH)D concentration 
between the control group and that in both of the vitamin D-enhanced egg groups, which 
were predicted to have ~5 μg/d additional vitamin D. Our previous vitamin D RCTs in 
young and older adults (Cashman et al, 2008; 2009) have shown that there was a 12 
nmol/L, on average, higher endpoint serum 25(OH)D concentration in the 5 μg/d vitamin 
D treatment groups compared to respective placebo groups. On the basis of the 
distribution of serum 25(OH)D data from our previous study of older adults which was at 
the same time of year (Cashman et al, 2012), our power estimates based on a 12 nmol/L 
difference in serum 25(OH)D between the control group and either of the vitamin D-
enhanced eggs groups indicated a need for 17 volunteers/group (n 51 in total) for 90% 
assurance at α=0.05. We did not power the study to detect differences between the two 
vitamin D-enhanced egg groups, as this was not the primary objective. 
 
5.2.7 Statistical analysis 
 
Statistical analysis of the RCT data was conducted using SPSS© for WindowsTM Version 
20.0 (SPSS, Inc., Chicago, IL, USA). The distributions of all variables were tested with 
Kolmogorov-Smirnov tests. Descriptive statistics (means ± SD or medians and 
interquartile range [IQR]; when appropriate) were determined for all variables. One-factor 
ANOVA was used to compare mean total vitamin D activity of three types of RCT eggs. 
Dietary calcium and serum PTH were not normally distributed and thus were log 
transformed to achieve near-normal distributions. Serum concentrations of 25(OH)D, 
albumin-corrected calcium, and total cholesterol as well as age, weight, height, BMI and 




subjects were compared using unpaired Student’s t tests. Baseline characteristics of 
subjects in the different intervention groups were compared using Chi-square (for ratio of 
men to women) and one-factor ANOVA. Analysis of covariance (ANCOVA) (with 
adjustment for baseline parameter being tested) was used to test between intervention 
group effects of treatment on weight as well as serum 25(OH)D, PTH, albumin-corrected 
calcium, and total cholesterol concentrations, and the Tukey’s test was used for post hoc 
analysis. Linear models of the response in a repeated measures analysis for the differences 
in weight as well as serum 25(OH)D, PTH, albumin-corrected calcium, and total 
cholesterol concentrations were also constructed.  Main effects included dietary treatment 
and sex.  Linear models also included two-way interactions between the main effects. 
Paired t-tests were used to test within intervention group changes from pre- to post-
intervention concentrations of serum 25(OH)D, PTH, albumin-corrected calcium, and 
total cholesterol concentrations. Subjects included in the analyses and those not included 
(i.e., dropouts) were compared on selected characteristics with two sample t-tests 
(continuous variables) and χ2-tests (categorical variables). A P-value of <0.05 was taken 
as being statistically significant.  
 
An intention to treat analysis of the serum 25(OH)D data as the primary outcome measure 
was also performed to account for the 4 subjects who dropped out. The 4 missing post-
intervention values for serum 25(OH)D were imputed using the multiple imputation 
function in SPSS (‘k’ = 5), as suggested by Armijo-Olivo et al. (2009). This analysis was 







5.3.1 Vitamin D activity of eggs for RCT 
 
HPLC analysis of the three types of eggs used in the present RCT (n 6 eggs/group) showed 
that the mean ± SD vitamin D3; 25-hydroxyvitamin D3; and total vitamin D activity (i.e., 
vitamin D3 + [25-hydroxyvitamin D3  5]) for vitamin D3-eggs were 1.04 ± 0.54, 0.50 ± 
0.10, and 3.54 ± 1.04 μg/egg, respectively. The mean ± SD vitamin D3; 25-
hydroxyvitamin D3; and total vitamin D activity for HyD® eggs were 0.14 ± 0.08, 0.88 ± 
0.26, and 4.54 ± 1.38 μg/egg, respectively. The mean ± SD vitamin D3; 25-
hydroxyvitamin D3; and total vitamin D activity for the commercially available (control) 
eggs were 0.63 ± 0.22, 0.56 ± 0.22, and 3.43 ± 1.31 μg/egg, respectively. There was no 
significant difference in mean total vitamin D activity across the three types of eggs 
(P=0.13; ANOVA). 
 
5.3.2. Baseline characteristics of subjects in the RCT 
 
Of 55 subjects recruited onto the study, 51 subjects completed the intervention. The 
progress of these subjects through the trial is shown in Figure 1. Baseline characteristics 
of subjects who entered the intervention are shown in Table 1. Although women were, on 
average, lighter and smaller than men (both P<0.0001) and had lower BMI (P<0.05) and 
habitual intake of calcium (P<0.05), there was no difference (P>0.2 for all) in the mean 
age, habitual intake of vitamin D, serum 25(OH)D, PTH, albumin-corrected calcium or 
cholesterol concentrations between men and women at baseline (data not shown). 
 
5.3.3 Effects of intervention with vitamin D-enhanced eggs  
 
There was no difference (P>0.3) in mean age, weight, height, or BMI at baseline in the 3 
treatment groups (control, Vitamin D3-eggs and HyD®-eggs groups) (Table 1 and 2). 
Similarly, there was no significant difference (P>0.9) in the proportion of men to women 
in treatment groups (Table 1). Habitual dietary vitamin D and calcium intakes are shown 





Figure 1.  Flow of subjects through the study 
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n 19 17 19 - 
Sex ( male: female) 9:10 8:9 10:9 0.930 
Age (y) 55.8 (7.5)3 56.2 (5.5) 53.8 (5.8) 0.498 
Height (m) 1.70 (0.12) 1.70 (0.09) 1.71 (0.09) 0.807 
BMI (kg/m2) 25.8 (3.5) 26.5 (5.0) 24.4 (3.7) 0.300 
Habitual dietary vitamin D (μg/d) 6.0 (4.0) 6.7 (3.5) 6.9 (4.0) 0.796 
Habitual dietary calcium (mg/d) 842 [670, 1014]4 961 [764, 1730] 762 [666, 1257] 0.115 
1BMI,body mass index; PTH, Parathyroid hormone; serum 25(OH)D, serum 25-hydroxyvitamin D; HyD®,supplemental 25-hydroxyvitamin D3 
2For baseline comparisons by intervention group: One –way ANOVA 
3 Mean (standard deviation) (all such values) 








Table 2. Weight, serum total cholesterol, 25(OH)D and PTH concentrations in treatment groups at baseline and endpoint of the 8 week intervention study in 
apparently healthy adults1. 
 
Treatment groups Control Vitamin D3 eggs HyD® eggs P-value2 
n (baseline, endpoint) (19,18) (17,16) (19,17) - 
Weight (kg)3:     
   pre-intervention6 75.1 (12.7)4 78.3 (20.1) 73.4 (16.1) 0.654 
   post-intervention7 72.8 (15.6) 78.2 (19.9) 72.3 915.6) 0.387 
Serum total cholesterol (mmol/L)3:     
   pre-intervention6 5.2 (0.8) 5.3 (0.9) 5.5 (0.8) 0.435 
   post-intervention7 5.0 (0.8) 5.2 (0.9) 5.4 (0.6) 0.463 
Serum 25(OH)D (nmol/L)3:     
   pre-intervention6 41.2 (14.1) 48.2 (18.9) 49.4 (15.8) 0.102 
   post-intervention7 34.8 (11.4)a* 50.4( 21.4)b 49.2(16.5)b <0.0001 
Serum PTH (pg/ml)3:     
   pre-intervention6 41.5 [35.0, 62.3]5 48.9 [40.4, 53.9] 43.0 [39.6, 59.5] 0.991 
   post-intervention7 47.0 [39.0, 68.4] 47.7 [36.8, 58.5] 44.9 [37.4, 58.6] 0.606 
1BMI,body mass index; PTH, Parathyroid hormone; serum 25(OH)D, serum 25-hydroxyvitamin D; HyD®,supplemental 25-hydroxyvitamin D3 
2 For endpoint comparison by intervention group: ANCOVA (with adjustment for baseline parameter being tested) followed by Tukeys; a,b Different superscript letters 
represent significant (P ≤ 0.005) differences among group means 
3 Repeated measures ANOVA was also used to test the treatment × time interaction and the same trend was observed for weight (P= 0.38), serum total cholesterol (P=0.86), 
serum 25(OH)D (P = 0.0001), and PTH (P=0.6). There was no significant (P> 0.2)in all cases) interaction with sex.  
4 Mean (standard deviation) (all such values) 
5 Median (interquartile range) of non-normally distributed variables (all such values) 
6 All baseline bloods were taken between 5th to 30th of January, 2015. 
7 All endpoint bloods were taken between 3rd to 30th of March, 2015. 




There were no adverse events reported during the study. Of the four dropouts, one subject 
was from the control group, one subject from the Vitamin D3-eggs group, and two subjects 
from the HyD®-eggs group. Dropout during the intervention phase was for reasons of loss 
of interest or a back injury, and in no instance was dropout related to the intervention. The 
51 subjects who completed the study did not differ from the four subjects who dropped 
out with respect to age, sex, weight, height, BMI, vitamin D intake, calcium intake, or 
baseline serum 25(OH)D, PTH, serum albumin-adjusted serum calcium or total 
cholesterol concentrations (P>0.16). 
 
There was good adherence with egg consumption protocols on the basis of the egg diary 
entries (median [IQR] compliance was 98.2% [93.7; 100%], and compliance was similar 
among the treatment groups; P=0.6). 
 
Data on egg compliance and measured vitamin D and 25-hydroxyvitamin D contents of 
RCT eggs, as well as habitual vitamin D intake data from the FFQ were used to estimate 
daily total vitamin D intakes throughout the study period. Using the factor of 5, the mean 
± SD total vitamin D intake was 9.5 ± 3.5, 10.4 ± 4.0, and 6.6 ± 3.9 µg/d in the Vitamin 
D3-eggs, HyD®-eggs, and control group, respectively.  
 
There was no difference in mean serum total cholesterol or body weight at baseline 
(P>0.4) and no significant change in weight (P=0.39) or serum total cholesterol (P=0.46) 
from pre- to post-intervention in the three treatment groups (Table 2). 
 
Effects of vitamin D egg treatment on serum 25(OH)D and PTH at the baseline and 
endpoint are shown in Table 2. While the pre-intervention serum 25(OH)D concentration 
of the control group was lower than that of the other two groups, it was not significantly 
so (Table 2). Repeated measures ANOVA showed a significant treatment  time effect 
(P=0.0001). Within group analysis showed that while the control group had a significant 
decrease in serum 25(OH)D over the 8 week winter intervention period (mean ± SD: 6.4 
± 6.7 nmol/L; P=0.001), there was no significant change in serum 25(OH)D over the same 
eight week period in the Vitamin D3-eggs and HyD®-eggs groups (P>0.1 for both). 
ANCOVA also showed there was a significant (P=0.001) effect of treatment on post-
intervention serum 25(OH)D concentrations, whereby adjusting for pre-intervention 
serum 25(OH)D concentrations, the Vitamin D3-eggs group and HyD®-eggs group had 
significantly higher  (P≤0.005) post-intervention serum 25(OH)D concentrations relative 
to that in the control group. There was no significant (P>0.3) difference in post-
intervention serum 25(OH)D concentrations between the Vitamin D3-eggs and HyD®-




The percentage (n/total group n) of subjects in each of the three groups that had post-
intervention serum 25(OH)D concentrations <25 nmol/L (the UK and EU threshold of 
vitamin D deficiency; SACN, 2016; Scientific Committee for Food (SCF), 1993) were 
22.2% (4/18), 0% (0/16) and 0% (0/17) for control, Vitamin D3-eggs and HyD®-eggs 
groups, respectively (P=0.019). The percentage (n) of subjects in each of the three groups 
that had post-intervention serum 25(OH)D concentrations <30 nmol/L (the US threshold 
of vitamin D deficiency; IOM, 2011) were 38.9% (7/18), 18.8% (3/16) and 5.9% (1/17) 
for control, Vitamin D3-eggs and HyD®-eggs groups, respectively (P=0.057). 
 
There was no significant difference in pre- or post-intervention serum PTH concentrations 
in the 3 treatment groups (Table 1). Repeated measures ANOVA confirmed a lack of 
significant treatment  time effect (P>0.6).  Within group analysis showed that while there 
was a trend towards a significant increase in serum PTH (P=0.050) in the control group 
over the eight week winter intervention period, there was no significant change in serum 
PTH over the same eight week period in the Vitamin D3-eggs and HyD®-eggs groups 
(P>0.7 for both). 
 
There was no significant interaction between treatment and sex in any of the serum 
25(OH)D or PTH statistical analyses (P>0.18 for both).  
 
An intention to treat analysis of post-intervention serum 25(OH)D (using imputted values 
for the 4 subjects who dropped out during the study) showed similar findings (P≤0.0001), 
and again with a significant decrease in the control group (P≤0.002) but no significant 
difference in either of the two vitamin D-enhanced eggs treatment groups (P>0.17) (data 







Despite numerous vitamin D and/or HyD® hen feeding studies over the last 15 years, which 
collectively have clearly demonstrated the viability of increasing the vitamin D and/or 25-
hydroxyvitamin D content of eggs (Mattila et al, 1999; 2003; 2004; 2011; Yao et al, 2013; 
Browning & Cowieson, 2014; Cashman et al, 2015; Chapter 4), the present study, to our 
knowledge, is the first to investigate the effect of such vitamin D-biofortified eggs on vitamin 
D status in humans. The present RCT showed that consumption of seven vitamin D- or HyD®-
enhanced eggs per week, which were shown to possess consumer acceptability (Chapter 4), 
maintained serum 25(OH)D concentrations in healthy adults and protected against its decline 
during the 8 weeks of winter. Such a decline in serum 25(OH)D concentrations between 
January and March was evident in the control group, which consumed no more than 2 
commercially available eggs per week. This decline in serum 25(OH)D is in line with that 
reported in the placebo groups in our previous RCTs of adults over a similar time-frame during 
winter (Cashman et al, 2012; 2014). Also of note, the vitamin D-biofortified eggs, which 
exhibited these vitamin D status protective effect, were achieved by addition of either vitamin 
D3 (3000 IU/kg diet) or HyD® (0.075 mg/kg diet; equivalent to 3000 IU/kg diet) to the hens’ 
feeds at levels allowable by European Council directives (European Union Register of Feed 
Additives pursuant to Regulation (EC) 1831/2003; EFSA, 2005), whereas the majority of 
previous studies used levels exceeding these maximum allowable contents (Mattila et al, 
1999; 2003; 2004; Yao et al, 2013; Browning & Cowieson, 2014).   
 
The IOM in 2011 set an EAR for vitamin D of 10 μg/day; this was meant to ensure a serum 
25(OH)D concentration above 40 nmol/L in at least half the population when potential for 
UVB-induced dermal synthesis was absent or minimal (i.e., in extended winter). The findings 
of the present study, which was carried out in the winter months in Cork, Ireland (51°N), are 
consistent with this in that consumption of the vitamin D enhanced eggs as part of the 
participants’ usual diet, which led to a mean daily intake (MDI) of vitamin D of ~10 g/d, 
resulted in post-intervention mean serum 25(OH)D concentrations >40 nmol/L. The vitamin 
D MDI of ~10 g/d in both vitamin D enhanced-egg groups was also sufficient to prevent, or 
dramatically diminish, the prevalence of vitamin D deficiency, depending on the selection of 
serum 25(OH)D threshold to define same. For example, none of the participants in either of 
the two vitamin D enhanced-egg groups had post-intervention serum 25(OH)D <25 nmol/L 
[the UK and EU definition of vitamin D deficiency (SCF, 1993; SACN, 2016)], whereas 6-
19% of participants had post-intervention serum 25(OH)D <30 nmol/L [the US definition of 
vitamin D deficiency (IOM, 2011)]. In contrast, the prevalence of serum 25(OH)D 




However, as baseline serum 25(OH)D concentrations were lower, even if not significantly so, 
in this group compared to the two vitamin D-enhanced eggs groups, it may have led to the 
slightly higher endpoint prevalence of vitamin D deficiency compared to that in placebo 
groups in our previous vitamin D RCTs (~33%, on average, with serum 25(OH)D <30 nmol/L; 
Cashman et al, 2008; 2009; 2014). 
 
The use of 25-hydroxyvitamin D, available as HyD®, in animal nutrition allows for an increase 
in the 25-hydroxyvitamin D content in foods of animal origin. It remains to be established if 
the food matrix affects the higher potency of 25-hydroxyvitamin D as discussed earlier. The 
present study did not set out specifically to answer the question of whether the relative potency 
of 25-hydroxyvitamin D to vitamin D3 is 5 or some other factor, as assessed in previous human 
and pig studies (Rossini et al, 2005; Jakobsen et al, 2007; Cashman et al, 2012; Jetter et al, 
2014; Burild et al, 2016), rather it wished to test the impact of vitamin D-enhanced eggs on 
human vitamin D status. That 25-hydroxyvitamin D has a higher effectiveness in terms of 
raising serum 25(OH)D than vitamin D3 is assumed within our study. For example, calculation 
of total vitamin D activity of the eggs applies a conversion factor of 5 for 25-hydroxyvitamin 
D, as reported by us previously (Cashman et al, 2012) and which is used in several Food 
Composition tables (FSA, 2008; Zurich, 2010; Saxholt et al, 2008). Using these total vitamin 
D activity estimates meant that the Vitamin D3-eggs and HyD®-eggs groups received an 
additional 3.5 and 4.5g/d of vitamin D, respectively, which together with the habitual dietary 
vitamin D yielded a MDI of ~10g/d. Of note, the current USDA National Nutrient Database 
for Standard Reference suggests the vitamin D content of 100 g raw egg is 2 g, an estimate 
that does not include 25-hydroxyvitamin D. Accordingly, vitamin D intake estimates from 
NHANES in the US do not account for the contribution of 25-hydroxyvitamin D (Fulgoni et 
al, 2011). Taylor et al. (2014) recently performed some modelling to include food-derived 25-
hydroxyvitamin D in intake estimates for US adults, an effect which would be even more 
pronounced should vitamin D-enhanced eggs become more widespread in the US. For 
example, the total vitamin D content of the eggs used in the analysis by Taylor et al. (2014) 
at 5.7 g/100 g whole egg, and which was very similar to that in the commercial eggs and 
vitamin D3-enhanced eggs in this study (5.7 and 6.0 g/100 g whole egg, respectively), could 
be increased to 7.7 g/100 g whole egg if HyD®-eggs were used. In the US, the FDA 
designated 25-hydroxyvitamin D as having GRAS (generally recognised as safe) status for 
inclusion in chicken feeds (0.069 mg/kg diet) (FDA, 2007).  
 
As there is a persistent public perception that egg consumption is associated with increased 




(Krauss et al. 2000), serum total cholesterol was measured as a secondary outcome in the 
current study. Consumption of 7 eggs a week as part of the current intervention had no effect 
on serum total cholesterol. While the 2010 Dietary Guidelines for Americans suggested to 
keep dietary cholesterol intakes less than 300 mg/d, the more recent this version of the 
guidelines (2015 Dietary Guidelines for Americans) has not included this recommendation. 
Furthermore, recent recommendations have stated that there is insufficient evidence to 
determine whether reducing dietary cholesterol reduces low-density lipoprotein cholesterol 
(Eckel et al. 2013). The present study did not include a wider dietary assessment tool and thus 
did not assess the impact of consumption of 7 vitamin D-enhanced eggs a week on fat or 
energy intake; however, body weight and, as mentioned already, serum cholesterol were 
unaffected over the 8 weeks of the RCT.  
 
A strength of the present study was that it was carried out in free-living adults, providing a 
true to life setting. Participants received cooking suggestions and meal ideas for incorporation 
of their vitamin D-enhanced whole eggs into their weekly diet, and were simply requested to 
ensure that they used the whole egg in their dishes, in order to consume to the full amount of 
vitamin D and that only themselves consumed the dishes to prevent dilution of the treatment 
effect. Cooking methods chosen by the participants appear to have had minimal effect on the 
retention of vitamin D in the egg as the effect of consumption of the additional vitamin D 
received from the treatment eggs on serum 25(OH)D concentrations was evident. Mattila et 
al. (1999) has shown that vitamin D3 and 25-hydroxycholecalciferol retentions in egg yolk 
were good after cooking. Compliance to the egg intervention was also high (98.2%) which 
may be attributed to the weekly or fortnightly collection of fresh eggs, which allowed for 
constant communication with the participants to ensure their satisfaction.   
 
In terms of potential limitations, the purposeful selection of habitual low consumers of eggs 
(≤2 per week) in the control group, while for the pragmatic reasons of feasibility and 
enhancing compliance to a limited egg consumption, may have led to some degree of 
allocation bias. It may have contributed to the lower baseline serum 25(OH)D compared to 
that in the vitamin D-enhanced egg groups, even though it was not significantly so. This, in 
turn, may have contributed to a lower post-intervention serum 25(OH)D in the control group, 
and explain the measured difference of 14.4-15.6 nmol/L between the control and vitamin D 
enhanced eggs groups compared to the more predicted 12 nmol/L difference. The statistical 
analysis, however, took baseline serum 25(OH)D concentration into account, and moreover, 
repeated measures ANOVA and post hoc tests showed that there was no change in serum 
25(OH)D concentration from pre- to post-intervention in either vitamin D-enhanced egg 





In conclusion, weekly consumption of 7 vitamin D-enhanced eggs, which are produced by 
hens provided with feed containing vitamin D (either as vitamin D3 or HyD®) at the allowable 
maximum content, has an important impact on winter vitamin D status in adults. These new 
data have public health relevance in light of the percentage of the population with vitamin D 
deficiency in winter, but also as one in two adults are reported to include eggs or egg dishes 
in their diet on a regular basis (NANS, 2011), vitamin D-biofortified eggs are an important 
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While it has been suggested that vitamin K is arguably the least known member of the fat-
soluble vitamins (Willems et al, 2014), the last decade has seen increasing interest in the 
potential health effects of vitamin K beyond its classical role in blood coagulation.  For 
example, there is evidence of emerging physiological roles for vitamin K in bone biology, 
vascular calcification, energy metabolism and inflammation, all of which have been 
comprehensively reviewed elsewhere (Booth, 2009; Shearer et al, 2012; Beulens et al, 2013; 
Willems et al, 2014). Many of these roles are underpinned by the biochemical function of 
vitamin K, namely to serve as a cofactor for the vitamin K-dependent γ-carboxylase (a 
microsomal enzyme that facilitates the post-translational conversion of glutamyl to γ- 
carboxyglutamyl [Gla] residues) (Esmon et al, 1975). The plasma procoagulant, prothrombin, 
was the first described Gla residue-containing protein, but presently there are at least 14 more 
Gla residue-containing proteins, which collectively are referred to as the vitamin K dependent 
protein (VKDP) family (Willems et al, 2014). There is also, however, an emerging viewpoint 
that the biochemical function of vitamin K may extend beyond that of a cofactor for vitamin 
K-dependent γ-carboxylase (Booth, 2009). 
 
Vitamin K exists naturally in multiple forms, and while not fully reflecting the complexity of 
biological differences among the various forms (Booth, 2009), they can be viewed as 
belonging to either phylloquinone (vitamin K1), menaquinones [vitamin K2; and comprised of 
at least 10 compounds (Shea & Booth, 2016)] or menadione (vitamin K3). Menadione is a 2-
methyl-1,4-napthoquinone ring, which is common to all forms of vitamin K and which fulfils 
the enzyme cofactor role (Booth, 2009). In terms of dietary sources, phylloquinone is the 
primary form in Western diets.  It is a plant-based form which is concentrated in green leafy 
vegetables and certain plant oils (Suttie, 2009). The menaquinones (MKs), which vary in the 
number of repeating isoprenoid units on their side-chain to the core methyl-1,4-napthoquinone 
ring, have a more restricted distribution in the diet (Beulens et al, 2013). While MK7-13 have 
a bacterial origin, being primarily concentrated in animal meats and plant foods, MK4 is not 
produced by bacteria but instead is either formed from phylloquinone or menadione, and is 
concentrated in animal meats and dairy products (Shea & Booth et al, 2016).   
 
While the maintenance of plasma prothrombin concentrations is the basis for the current 
recommended dietary intake value of 1 μg/kg body weight per d in the UK (DOH, 1991) and 
EU (SCF, 1993), the adequate intake (AI) values for vitamin K, established by the US Institute 




intakes from food, as estimated from NHANES III (1988–1994) (IOM, 2001).  There is also 
speculation that these AI values may not be sufficient to attain complete γ-carboxylation of 
all VKDPs (Binkley et al, 2002; Booth et al, 2003). These estimates of dietary requirement 
for vitamin K (DOH, 1991; EC, 1993; IOM, 2001) do not distinguish between phylloquinone 
and menaquinone intakes, but due to the fact that it is the form which predominates in food 
composition databases (Beaulens et al, 2013; Shea & Booth, 2016) used to generate dietary 
intake estimates, they are, by default, based on phylloquinone. 
 
It has been recently suggested that a better understanding of the role of vitamin K in health 
and disease requires the assessment of vitamin K nutritional status in population studies (Shea 
& Booth, 2016). Dietary intake of vitamin K is one of the primary determinants of vitamin K 
status (Booth & Al Rajabi, 2008). While no single biomarker of vitamin K status is a robust 
measure of vitamin K deficiency or sufficiency (Booth & Al Rajabi, 2008), the degree to 
which serum osteocalcin (OC; a VKDP produced by osteoblasts during bone formation and 
the most abundant non-collagenous protein in bone) is undercarboxylated (%ucOC) is 
considered a sensitive indictor of poor vitamin K status in bone (Gundberg  et al, 1998). While 
there are a number of VKDPs in bone, the γ-carboxylation of OC is the primary mechanism 
underpinning the putative protective influence of vitamin K on bone (Booth, 2009).  However, 
vitamin K has also been shown to modulate certain cytokines involved in bone turnover (Shea 
et al, 2008; Katsuyama et al, 2005), which may represent an additional mechanism of action.   
Over a decade ago, we reported that data from our nationally representative nutrition survey 
of adults in Ireland, aged 18-64 y, highlighted low habitual intakes of phylloquinone, which 
we suggested may have had potential implications for bone health (Duggan et al, 2004). The 
adult survey at the time, however, did not include blood sampling in its design and thus we 
had no measure of vitamin K status or biomarker of bone turnover.  In addition, as the survey 
included only adults aged 18-64 y, we have no representative data on older Irish adults (aged 
>64 y), a subgroup potentially at higher risk of low phylloquinone intakes (IOM, 2001) and 
who have higher rates of bone turnover and loss (Cashman & Flynn, 1999). 
 
Therefore, the objectives of the present study, based on the most recent national nutrition 
survey in Ireland [the National Adult Nutrition Survey (NANS; IUNA, 2011)], were to 
estimate the mean daily intake of phylloquinone, the adequacy of phylloquinone intakes and 
the contribution made by food groups to phylloquinone intakes in adults aged 18–90 years. 
We also wished to compare thisnewer information on dietary phylloquinone in a subset of 
NANS adults aged 18-64 y with those similarly-aged from the previous survey over a decade 
before (Duggan et al, 2004). Data from the national nutrition surveys in the UK suggest 




with a concomitant decline in leafy green vegetable consumption (Thane et al, 2006). Finally, 
as the NANS included blood sampling, we measured serum %ucOC as an index of vitamin K 
status in bone and explored its associations with phylloquinone intake as well as with serum 
C-terminal telopeptide of type I collagen (CTx), a marker of bone resorption (Chubb, 2012).  
6.2 Materials and methods 
 
6.2.1 The National Adult Nutrition Survey sample 
 
A detailed description of the methodology used in NANS, including the sampling procedure 
as well as sample recruitment has been reported elsewhere (IUNA, 2011; Cashman et al, 
2013].   Briefly, the fieldwork phase of NANS was carried out between October 2008 and 
April 2010, providing a seasonal balance to the data and biological sample collection. To 
achieve a nationally representative sample of community-dwelling adults aged 18 years and 
over, a quota sampling approach was adopted using data from the 2006 Census (CSO, 2007).  
A sample of 1500 free-living adults to represent a population of ~4.2 Million participated in 
the dietary survey.  There were few exclusion criteria, other than pregnancy/lactation and 
inability to complete the survey due to disability.  The study was approved by the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals, University College Cork and the 
Human Ethics Research Committee of University College Dublin.  All eligible and willing 
participants gave their written consent according to the Helsinki declaration.   
 
Analysis of the demographic features in this sample has shown it to be a representative sample 
of Irish adults with respect to age, gender, social class and geographical location when 
compared to Census data (CSO, 2007; IUNA, 2011; Cashman et al, 2013).  While 
participation in the survey did not require provision of a blood sample as an eligibility 
criterion, all participants were asked if they were willing to provide a blood sample.  Of the 
total group of respondents, 75% provided a blood sample.  The demographic features of the 
group of participants who provided a blood sample and those in the entire sample have been 
described elsewhere (IUNA, 2011; Cashman et al, 2013).   
 
Information on social class and education level, smoking status, alcohol intake, medication 
usage (including those which contained nutrients) was also collected (IUNA, 2011; Cashman 
et al, 2013). Blood pressure and anthropometric measures including height, weight, waist and 
hip circumference as well as measures of body composition were taken in the respondents’ 
homes, as described previously (IUNA, 2011). Blood samples were collected by venepuncture 




the respondent’s home if the respondent could not travel.  Bloods were transported to the 
laboratory for further processing and serum was stored at -80oC until required for analysis.  
6.2.1.1 Food consumption data 
 
Food intake in NANS was recorded using a 4-d estimated food diary: participants were asked 
to provide detailed information on the types and amounts of all foods, beverages, and 
nutritional supplements consumed over a 4-d recording period. The detailed methodology of 
the 4-d estimated food diary, which was used to collect food and beverage intake data during 
the survey, and the methods used to quantify food and drink intake are described in detail 
elsewhere (IUNA, 2011).  As one of the aims of the present work was to investigate if temporal 
changes had occurred in phylloquinone intakes in Irish adults, intake estimates for the 18-64 
y-old subgroup of participants in the NANS were compared with those of the previous 
nationally representative survey of adults (aged 18-64 y) in Ireland (Northern Ireland and 
Republic of Ireland) from 1997 to 1999, called the North/South Ireland Food Consumption 
Survey (NSIFCS) (n=1379), and which was performed by the same team and using similar 
sampling and dietary methodology as for NANS. The NSIFCS used a 7-d estimated food 
diary, and a detailed description of the sampling procedure, survey design, and methodology 
for the NSIFCS is available (Kiely et al, 2001; Harrington et al, 2001). Data on the 
phylloquinone intake estimates for the participants in NSIFCS were published previously 
(Duggan et al, 2004). 
6.2.1.2  Vitamin K compositional data 
 
The procedures to update the vitamin K composition data in NANS were along similar lines 
as that used in the NSIFCS.  In brief, while the version of WISP© software used at the time of 
the analysis of NSIFCS (because it relied on data from the 5th edition of McCance and 
Widdowson’s The Composition of Foods (Holland et al, 1993 and supplemental volumes) did 
not include data on phylloquinone levels (and instead we relied on a database established by 
Bolton-Smith et al. (Bolton-Smith et al, 2000a) which contained the phylloquinone content of 
approximately 2000 foods), the more recent version of WISP© software used for the present 
analysis of NANS food consumption data used the 6th edition of McCance & Widdowson’s 
The Composition of Foods (FSA, 2002) and supplement editions as the core food composition 
databank.  In cases where phylloquinone values for foods were not contained in the 6th 
edition, these were derived by recipe calculation or based on similarity to other foods, 
as described in detail elsewhere (Duggan et al, 2002). In some instances the data from 
the database established for the NSIFCS was used to augment the 6th edition of The 




Nutrient Database for Standard Reference (US Department of Agriculture, 2016) were 
used in a few food codes. 
 
Nutritional supplement intake data were collected from the prospective food diary because 
participants were requested to record nutritional supplements as consumed and these data were 
confirmed in a face-to-face interview, as previously described (Kiely et al, 2001). 
Composition data were transcribed from the product label. This methodology is considered 
valid for assessing supplement use (Patterson et al, 1998; Kiely et al, 2001).  
6.2.1.3  Compilation of the food groups 
 
Seven major food groups contributing to the mean daily intake of phylloquinone were derived 
from nineteen large food groups previously devised by the Irish Universities Nutrition 
Alliance (IUNA, 2001) as follows:  Alcohol was excluded as it made no contribution to the 
mean daily intake of phylloquinone. Bread and rolls, and biscuits, pastries and cakes were all 
aggregated into one food group. Eleven Irish Universities Nutrition Alliance food groups that 
contributed <5% to the mean daily intake of phylloquinone were aggregated to form the 
‘Other’ group: eggs and egg dishes; grains, rice, pasta and savouries; milks and yoghurts; 
cream, ice cream and chilled desserts; non-alcoholic beverages; cheeses and fat spreads; 
breakfast cereals; fruit and fruit juices; nuts, seeds, herbs and spices; fish and fish products; 
sugar, confectionery, preserves and savoury snacks; and nutritional supplements. The 
remaining five food groups were retained: vegetable group; potato group (including chipped 
and fried potatoes); meat group; dairy and fat spreads; soups, sauces and miscellaneous foods.   
 
6.2.1.4  Assessment of adequacy of phylloquinone intake 
 
As no Estimated Average Requirement (EAR) has been established for vitamin K in adults it 
was not possible to use the cut-point method of Carriquiry (1999) to estimate the prevalence 
of inadequacy of dietary intake. However, the US Food and Nutrition Board has recently 
established an adequate intake of 90 and 120 g/d for adult women and men, respectively 
(IOM, 2001), based on reported intakes in apparently healthy US population groups. In the 
UK and EU, the recommended intake for phylloquinone is 1 g/kg body weight per d (DOH, 
1991; Scientific Committee for Food [SCF], 1993), based on its classical role in blood clotting. 
Therefore, to gain some measure of the adequacy of phylloquinone intakes, the proportions of 
the population not meeting the UK/EU recommendation and consuming the US adequate 




intake of a nutrient that is unlikely to pose a risk of adverse health effects to humans (SCF, 
2000). There is no UL set for vitamin K (SCF, 2000).  
 
6.2.2 Laboratory analysis 
 
6.2.2.1 Serum carboxylated and undercarboxylated osteocalcin. 
 
The concentrations of serum carboxylated-osteocalcin (cOC) and under-carboxylated 
osteocalcin (ucOC) were measured using ELISA (Gla and Glu EIA kits, Takara Biomedical 
Group, Otsu, Shia, Japan). The intra-assay CV for ucOC and cOC was 4.4% and 4.5%, 
respectively. %ucOC has been suggested as a key biochemical index of vitamin K status 
(Gundberg et al, 1998; Sokoll & Sadowski, 1996). The %ucOC was calculated by expressing 
serum ucOC as a percentage of total osteocalcin values (serum ucOC + serum cOC) as 
described recently (O’Connor et al, 2014). At the time of this work, serum was available for 
analysis of serum cOC and ucOC for 692 participants within the NANS sample.   
 
6.2.2.2 Serum C-terminal telopeptide of type I collagen. 
 
Serum C-terminal telopeptide of type I collagen (CTx) was measured using the Serum 
CrossLaps® ELISA kit (Nordic Bioscience Diagnostics A/S, Denmark). The intra-assay CV 
was 5.0%. 
 
6.2.3 Data and statistical analysis 
 
Statistical analysis of the data was conducted with PASW (version 21, for Windows; SPSS 
Inc.). Distributions of all variables were tested with Kolmogorov-Smirnov tests. Descriptive 
statistics on phylloquinone intakes, including mean, SD, median, IQR, and 5th and 95th 
percentiles, were determined from all sources (i.e., food sources and supplements) as well as 
food sources only, using the daily average method: phylloquinone intakes from each food and 
supplement reported were quantified by multiplying the weight of the food (grams) by the 
phylloquinone content (micrograms per 100 g).  Phylloquinone intakes for the total population 
were also stratified by sex and age group (i.e., 18–35-y, 36–50-y, 51-64-y and ≥65-y).  Dietary 
phylloquinone (from all sources and food-sources only) were not normally distributed and, 
thus, were log transformed to achieve near-normal distributions.  Differences in phylloquinone 
intakes between men and women were compared using independent t-tests, and differences 
between age groups were compared using one-way ANOVA using either Tamhane, if the 





Phylloquinone intakes in this study were derived from daily average intakes from 4 
consecutive recording days. When using repeated short-term measurements of intake, such as 
24-h food records, the variance of reported intake is inflated by the day-to-day variation of 
dietary intake within individuals (Willett, 1998). To estimate usual intakes of a nutrient, the 
within subject variation must be eliminated by an appropriate statistical method. Along with 
the daily average method, the National Cancer Institute (NCI) method (Tooze et al, 2010) was 
applied to NANS data and a usual intake estimate was calculated for the total population and 
stratified by sex. The NCI method was not applied to age groups because of the relatively 
smaller numbers of participants in these subgroups.  The NCI-method was applied using SAS 
macros (version 2.1) which were downloaded from the website 
www.riskfactor.cancer.gov/diet/usualintakes/macro.html (date of download: July 2015).  In 
the current analysis, we compared usual intake estimates based on the NCI method with 
intakes estimated from the daily average method. 
 
Under-reporting of energy intake by self-reported dietary methods is well documented (Black 
et al, 1993; Livingstone et al, 1990). Energy under-reporters in NANS were identified by 
calculating basal metabolic rate and applying a Goldberg cut point of 1.1, as described 
previously (Goldberg et al. 1991; McGowan et al. 2001).  We examined the impact of energy 
under-reporting on phylloquinone intakes by estimating median intakes when under-reporters 
were included and excluded. 
 
The percent contribution of food groups to intakes of phylloquinone were calculated by the 
mean proportion method, as defined by Krebs-Smith et al.(1989) using SPSS© for Windows™ 
Version 20.0 (SPSS, Inc., IBM, Chicago, IL, USA). This method provides information about 
the sources that are contributing to the nutrient intake ‘per person’.  The mean proportion 
method is the preferred method when determining important food sources of a nutrient for 
individuals in the population group as opposed to investigating the sources of a nutrient within 
the food supply. 
 
To allow for a comparison between the NSIFSC and NANS, those in the latter aged 18–64 y 
only were compared, because the NSIFSC did not include participants >64 y old. While we 
performed a statistical comparison of the mean daily intake estimates of phylloquinone among 
the two surveys (unpaired t-tests), it is important to stress that the survey sample sizes are 
sufficiently powerful to consistently observe statistically significant results even with 





Serum cOC, ucOC and %ucOC as well as CTx were not normally distributed and, thus, were 
log transformed to achieve near-normal distributions.  Differences in serum %ucOC (the 
priority marker of vitamin K status; Shea & Booth, 2016) between men and women were 
compared using independent t-tests, and differences in %ucOC and ucOC between age groups 
were compared using one-way ANOVA using either Tamhane, if the Levene test for equality 
of variance was not satisfied, or Scheffe’s post hoc test.   
 
Pearson’s correlations were performed between mean daily intake of phylloquinone and 
markers of vitamin K status (serum cOC, ucOC and %ucOC), and between mean daily intake 
of phylloquinone (and serum %ucOC) and serum CTx.  Linear regression analysis was 
performed to test these associations while controlling for potential confounding factors such 
as age, sex, BMI, smoking, serum 25(OH)D, calcium intake, serum PTH, use of HRT/oral 
contraception, and total osteocalcin (marker of bone formation), as appropriate. 
6.3 Results 
 
6.3.1 Phylloquinone intakes.  
 
The mean daily intakes of phylloquinone (g) from all sources (i.e. food and supplements), 
and from food sources only, in men and women of different ages in NANS, which was a 
representative sample of the Irish adult population, are shown in Table 1. The mean daily 
intake of phylloquinone in the total group from all sources was 85.2 (SD 59.1) g and from 
food sources only was 84.2 (SD 58.7) g, showing that about 99% of the phylloquinone intake 
came from food. Median intakes of phylloquinone (from all sources) in men (71.8 g/d) and 
women (70.2 g/d) were similar (P>0.2). However, energy-adjusted median intakes 
(expressed as µg/10 MJ food energy) were significantly higher (P<0.001) in women than in 
men of all ages (102 and 79, respectively). In both men and women, phylloquinone intakes 
(g/d from all sources, and from food sources only) were significantly lower (P<0.05) in the 
18–35-year age group than in any of the other three age groups (i.e., 36–50 y, 51-64 y, and 
≥65 y), with no differences between these latter three groups. This was also the case in women 
(Table 1); but in men, while the phylloquinone intake of the 18–35 y age group was also 
significantly lower (P<0.05) than that of the 36–50 y and 51-64 y age groups, it was similar 








Table 1 Daily intakes of phylloquinone in Irish adults (aged 18-90 y), from all sources (food and supplements) and from food sources only as well as estimates of adequacy of intakes 
of phylloquinone 
Medians in a row (within All, Men or Women) without a common letter differ, P<0.05 (either Tamhane, if the Levene test for equality of variance was not satisfied, or Scheffe’s post hoc test) and 
P<0.0001 [1-factor ANOVA for both all sources and food sources only of vitamin K1 in All, Men and Women]. 
1Based on n of 1354, 495,399, 272, 188 (All); 658, 255, 185, 133 and 85 (Men); and 696, 240, 214, 139 and 103 (Women), respectively due to unavailability of body weight data for some participants. 
 All Men Women 
 All 18-35y 36-50y 51-64y ≥65y All 18-35y 36-50y 51-64y ≥65y All 18-35y 36-50y 51-64y ≥65y 
  n=1500 n=513 n=437 n=306 n=226 n=740 n= 276 n= 205 n=153 n=106 n=760 n= 255 n= 232 n=153 n=120 
                
Phylloquinone intakes  
(All Sources) 
               
Mean 85.2 75.7 86.4 97.8 87.7 86.0 79.8 86.7 97.9 83.4 84.4 71.3 86.2 97.8 91.5 
SD 59.1 56.3 54.4 62.3 66.2 57.4 60.9 52.7 57.0 55.5 60.7 50.6 56.0 67.3 74.4 
Median 71.2 62.2a 73.6b 82.9b 72.4b 71.8 64.5c 73.2de 83.2d 70.8de 70.2 59.4f 74.3g 82.6g 79.2g 
5th percentile 25.1 23.2 28.5 30.3 20.5 25.1 23.6 28.7 30.9 19.1 25.0 21.2 28.0 29.2 26.8 
95th  percentile 194.4 171.6 186.8 239.5 193.9 188.9 171.9 187.5 213.0 197.1 196.8 172.6 190.8 250.4 195.3 
                
Phylloquinone intakes  
(food sources) g/d 
Mean 84.2 74.6 85.7 97.0 86.7 85.3 78.9 86.3 96.9 83.1 83.2 69.9 85.2 97.1 90.0 
SD 58.7 55.9 54.2 61.3 65.6 57.2 60.9 52.5 56.0 55.4 60.1 49.6 55.8 66.5 73.5 
Median 70.8 61.1
a 73.3b 82.6b 72.4b 71.6 62.4c 73.2de 83.2d 70.8c,de 69.5 58.3f 73.5g 82.0g 78.7g 
5th percentile 25.1 22.8 28.5 30.3 20.5 25.1 23.6 28.7 30.9 19.1 24.9 20.3 28.0 29.2 26.8 
95th  percentile 192.8 171.4 186.8 235.2 190.5 188.1 171.9 187.5 206.4 197.1 195.5 169.0 189.1 249.3 190.8 
  
Adequacy of  
phylloquinone intakes % 
% >Adequate Intake 26.3 17.9 28.1 35.3 30.5 18.8 14.1 20.0 26.8 17.0 33.7 22.0 35.3 43.8 42.5 
% <1 g/kg body 
weight/d1 




Along with the daily average method, the NCI method (Chubb, 2012) was applied to NANS, 
with intakes stratified by sex, and phylloquinone intakes were compared with the daily average 
method.  Intake estimates for the total NANS population were almost identical by the 2 
methods (85.2 g/d and 84.5 g/d for daily average method and NCI method, respectively) 
but as expected there was a marked reduction in the SD using the NCI method compared to 
the daily average method (39.7 g/d v. 59.1 g/d, respectively). This was also the case when 
intake estimates for men and women, separately, from the two methods were compared (data 
not shown). The greatest difference was seen in the 95th percentile of intakes in women, for 
which the usual intake was 43 g lower than the daily average intake.   
 
Basal metabolic rate was used to identify under-reporters within the full NANS sample for 
which measured body weight data existed (n=1354). When under-reporters (29%) were 
included, median (IQR) phylloquinone intake was 71.2 (47.5-103.2) g/d; when excluded, the 
intake was 76.8 (54.3-113.3) g/d.   
 
Mean daily intakes of phylloquinone in adults aged 18-64 y participating in the NANS 
(n=1274) and the NSIFCS (n=1379) are shown in Figure 1. Mean (SD) intakes of adults aged 
18-64 y only increased very modestly between the NSIFCS survey in 1997-‘99 and the NANS 
in 2008-‘10 survey 79.5 (44.2) and 84.7 (57.8) g/d, respectively]. 
 
6.3.2 Estimation of adequacy of vitamin K intakes.  
 
Of the 1354 participants in NANS with measured body weight data, 55% had phylloquinone 
intakes below the UK and EU recommendation of 1 g/kg body weight per d (DOH, 1991; 
SCF, 1993) (Table 1), while 29% (33% of men, 26% of women) failed to meet 67% (two-
thirds) of this recommendation (data not shown).  Furthermore, when phylloquinone intake 
data for full NANS (n=1500) were compared with current US adequate intakes (IOM, 2001), 
only 19% of men and 34% of women met or exceeded these intakes of 120 and 90 g/d, 
respectively (Table 1).  
 
6.3.3 Food sources of vitamin K.   
 
 
The major food groups contributing to total intake of phylloquinone in men and women, aged 18-
64 y, in NANS are presented in Figure 2. Overall, vegetables and vegetable dishes contributed 
44% of the phylloquinone intake.  Meat and meat products also made a significant contribution 
of 10%, while potatoes/potato products (primarily from the oils used in chips and fried potatoes) 
and dairy and fat spreads contributed 8% and 7%, respectively. These were in general similar to 
those reported in the NSIFCS of 18-64 y olds: vegetables and vegetable dishes (48%), 
potatoes/potato products (10%), dairy and fat spreads (10%), and meat and meat products (8%) 






Figure 1. Phylloquinone intakes (from all sources) in all adults (aged 18-64 y), and stratified 
by age, who participated in the National Adult Nutrition Survey (NANS; n=1274) in 2008-
‘10 (black bars) and North/South Ireland Food Consumption Survey (NSIFCS; n=1379) in 




















































Figure 2.  Percentage contribution of main food groups to the mean daily intake of 
phylloquinone in Irish men (n=634; dark bars) and women (n=640; grey bars), aged 









































The major food groups contributing to total intake of phylloquinone in men and women aged 
≥65 y old in NANS were vegetables and vegetable dishes (49%), dairy and fat spreads (12%), 
meat and meat products (6%), and potatoes/potato products (4%). 
 
6.3.4 Vitamin K status markers 
 
The biochemical markers of vitamin K status in men and women of different ages in NANS 
are shown in Table 2. There was no significant difference in demographic features of the 
group of participants for whom we had a blood sample to undertake vitamin K status analysis 
(n 692)and those in the entire sample (P>0.1; data not shown).   Median serum %ucOC in men 
(40.0%) and women (40.6%) were similar (P>0.3).  In both men and women, as well as in 
both sexes separately, median serum %ucOC was significantly higher (P<0.05 in all cases) in 
the 18–35-year age group than in any of the other three age groups (i.e., 36–50-y, 51-64 y, and 
≥65 y), with no differences between these latter three groups (Table 2).  Serum ucOC has also 
been reported separately as a measure of vitamin K status (Szulc et al, 1993; Duggan et al, 
2004; Bügel et al, 2007; Yamauchi et al, 2010). In general, median serum ucOC was 
significantly higher (P<0.05 in all cases) in the 18–35-year age group than in any of the other 
three age groups (i.e., 36–50-y, 51-64 y, and ≥65 y), with no differences between these latter 
three groups (Table 2).   
 
6.3.5 Associations between vitamin K intake and status markers, and with a marker of 
bone resorption.  
 
The mean daily intake of phylloquinone was positively associated with serum cOC and 
inversely with serum ucOC and %ucOC (r = 0.095, -0.114 and -0.164, respectively [all in log 
scale], P<0.02 in all cases; n= 692). There was only a trend (P=0.067) for an inverse 
association between mean daily intake of phylloquinone and serum CTx (r = -0.070 [both in 
log scale]; n= 692).  In a regression model adjusting for age, sex, BMI and smoking, the mean 
daily intake of phylloquinone (log) remained a significant determinant of serum %ucOC (also 
Log) [B = -0.694 (95% CI: -1.113, -0.275), P=0.001].   
 
Serum %ucOC was positively associated with serum CTx (r = 0.196 [both in log scale]; 
P<0.0001; n= 692) (Figure 3). In a regression model adjusting for age, sex, BMI, smoking, 
dietary calcium intake, serum 25(OH)D, HRT/oral contraception use, PTH, and total serum 
osteocalcin,  serum %ucOC (log) remained a significant determinant of serum CTx (also log) 
[B = 0.078 (95% CI: 0.049, 0.107), P=0.001].  Interestingly, serum 25(OH)D was not 








Table 2.  Biochemical markers of vitamin K status in Irish adults, aged 18-90 years, and stratified by age-group and sex1 
 
1Values are medians and interquartile ranges in parenthesis 
Medians in a row  (within All, Men or Women) without a common letter differ, P<0.05 (either Tamhane, if the Levene test for equality of variance was not satisfied, or Scheffe’s post hoc test) and 
P<0.0001 [1-factor ANOVA for both all sources and food sources only of vitamin K1 in All, Men and Women]. 
ucOC; under-carboxylated osteocalcin; cOC, carboxylated-osteocalcin;  %ucOC, under-carboxylated osteocalcin as a percentage of total (i.e., under-carboxylated osteocalcin plus carboxylated-
osteocalcin) 
 
 All Men Women 
 All 18-35y 36-50y 51-64y ≥65y All 18-35y 36-50y 51-64y ≥65y All 18-35y 36-50y 51-64y ≥65y 







































































































Figure 3. The association between percent serum under-carboxylated osteocalcin (%ucOC) 
and serum C-terminal telopeptide of type I collagen (CTx) [both in log scale] in Irish adults, 







The present study estimated the phylloquinone intake, as well as, for the first time, assessed a 
biomarker of vitamin K status, in a representative population sample of Irish adults aged 18-
90 y.  The mean phylloquinone intakes of adults aged 18-64 y reported in the present study of 
86 and 83 g/d in men and women, respectively (85 g/d for the entire group) were modestly 
higher than those reported by us previously for Irish adults aged 18-64 y (84 and 75 g/d in 
men and women, respectively) (Duggan et al, 2004) and for values reported for Scottish men 
and women aged 25-65 y (76 and 69 g/d, respectively; 73 g/d for entire group) (Price et al, 
1996).  Likewise, in 1995, a 10-year follow-up study of the Scottish Heart Health Study 
participants estimated phylloquinone intakes of 54 g/d for men and 56 g/d for women 
(Bolton-Smith et al, 2000b). 
 
The mean phylloquinone intakes of older adult men and women aged 65-90 y reported in the 
present study of 83 and 92 g/d, respectively (88 g/d for the entire group) were similar to 
that reported for elderly men in the UK (84 g/d), but higher than that for women, and entire 
group, in the UK (73 and 78 g/d, respectively) (Thane et al, 2002). Reported phylloquinone 
intakes of other older European populations are limited and, in some cases, have used different 
dietary tools that preclude comparison with the present data.  For example, in The Netherlands, 
Schurgers et al. (1999) reported mean daily phylloquinone intakes of 250 g/d for adults aged 
55 y and older in the Rotterdam study; however, these intake data were obtained using a food-
frequency questionnaire (FFQ). As the FFQ can tend to estimate higher vegetable intakes than 
a food diary method, phylloquinone estimates from these two assessment tools should not be 
compared.   
 
Some studies have reported a decrease in phylloquinone intake with age, but especially in 
adults over the age of 65 years (Schurgers et al, 1999; Thane et al, 2002).  However, in the 
present study, the younger adults (aged 18–35 years) had a lower mean phylloquinone intake 
than adults (either those aged 36–50 or 51-64 years) and older adults (65-90 years), and 
likewise serum %ucOC was higher in 18–35 y-olds than any of the other three age groups.  
The lower vitamin K nutritional status may be due to the lower vegetable consumption of 
younger Irish adults compared with over-35-year-olds, previously reported by O’Brien et al. 
(2003).  In the present study, an investigation of the major food groups contributing to mean 
daily intake of phylloquinone showed that while vegetables and vegetable dishes were the 
main dietary sources of the vitamin, they made a greater contribution in ≥65 y-olds than 18-
64 y-old (at 49% [43 g/d] and 44% [37 g/d]).  Booth & Suttie (1998) reviewed eleven 




consistently higher intakes in older adults than younger adults, most probably due to lower 
green vegetable consumption in younger adults.  Green vegetables alone (including lettuce) 
contributed 25% and 33% to the total intake, in 18-64 y olds and ≥65 y-olds, respectively.  
While potatoes and meat contain relatively little phylloquinone (~0.9 and 2.3 g/100 g, 
respectively), in the present study, the meat group and potato group (including chipped and 
fried potatoes) contributed significantly to mean daily intakes of phylloquinone (about 10-
18%, depending on age-grouping) due to the considerable quantities consumed and to the 
contribution from vegetables consumed in meat dishes. Thane et al. (2006) compared 
geometric mean phylloquinone intakes of adults aged 16-64 years from two national nutrition 
surveys in the UK (1986-7 and 2000-1) and reported a significant decrease (72 g/d to 67 
g/d; P<0.0001), consistent with a concomitant decline in leafy green vegetable consumption.  
In contrast, the present study showed that contribution of green leafy vegetables to mean daily 
intake of phylloquinone in adults aged 18-64 y in Ireland remained relatively static from 26% 
in 1997-99 to 25% in 2008-’10, while mean daily intake of phylloquinone marginally 
increased (79 g/d versus 85 g/d, respectively).   
 
Dietary supplements made essentially no meaningful contribution to the mean daily intake of 
phylloquinone at a population level (only 1 g additional intake from all sources compared to 
food sources only). This agrees with data from adults (aged ≥19 y) who participated in 
NHANES 2003–2006 in the US which showed that the mean intake of vitamin K from food 
sources (including enriched/fortified) was 88.2 g/d and increased only marginally to 94.7 
g/d when that from dietary supplements was accounted for (Fulgoni et al, 2011).  
 
Without an EAR value, it is difficult to draw firm conclusions on the degree of inadequate 
intakes of vitamin K within the population. Only 19% and 34% of women and men, 
respectively, met or exceed their sex-specific AI values for vitamin K and thus had a high 
probability of having adequate intakes, while the proportion with inadequate intakes is less 
certain. Over a half of the entire population of adults had intakes which were less that the UK 
and EU suggested 1 g/kg body weight per d, derived on the basis of coagulation (DOH, 1991; 
SCF, 1993), and in fact about a third and quarter of men and women, respectively, failed to 
meet ever two-thirds of this recommendation.  Beyond the AI values for vitamin K, there is 
some evidence that even higher intakes are beneficial for bone health.  For example, in the 
Nurses’ Health Study, phylloquinone intakes less than 109 g/d were associated with an 
increased risk of hip fracture (Feskanich et al, 1999). In the Framingham Heart Study, elderly 
men and women in the highest quartile of phylloquinone intake (median 254 g/d) had a 




of intake (median 56 g/d) (Booth et al, 2000). While phylloquinone intake is associated with 
lower risk of hip fracture in the majority of observational studies, associations with bone 
mineral density (BMD) are less consistent [see review by Booth (2009)]. 
 
In the present study, while there was only a trend towards an inverse association between 
phylloquinone intake and serum CTx, serum %ucOC was positively associated with serum 
CTx, suggesting that as vitamin K status dis-improved, the rate of bone resorption increased.  
An increased rate of bone turnover in adults may be a risk factor for fracture (Riggs et al, 
1996), because it exacerbates bone loss (Hansen et al, 1991). High rates of bone turnover are 
also associated with a disruption of the trabecular network, leading to a loss of connectivity 
which is not necessarily reflected in a decrease of bone mass (Parfitt, 1984).  Yamauchi et al. 
(2010) showed a significant positive association between serum ucOC and urinary NTx 
(another biochemical marker of bone resorption) in 221 healthy Japanese women (31 pre- and 
190 post-menopausal), even when adjusted for age, height, body weight and vitamin K intake.  
Interestingly, there was no significant association between serum ucOC and BMD at any site 
in the postmenopausal women (Yamauchi et al, 2010). There was a moderately strong inverse 
association (r=-0.259; P<0.001) between serum ucOC and vitamin K intakes in the 221 
healthy Japanese women in that study (Yamauchi et al, 2010), whereas the inverse association, 
while evident, was weaker (r=-0.114; P=0.003) in the 692 NANS adults in the present work.  
The mean vitamin K intakes (both phylloquinone and MKs, as assessed by FFQ) in the 
Japanese women were 260 g/d, whereas the mean phylloquinone intake in the present study 
(as assessed by 4 d food diary) was only 85 g/d, which may have influenced the strength of 
the associations.  It is important to note that serum ucOC and %ucOC are also influenced by 
a number of factors other than vitamin K intake, including waist circumference, season, HDL 
cholesterol, smoking, menopausal status and use of HRT (Shea et al, 2009). The inverse 
association between dietary vitamin K intake and serum ucOC has also been shown to depend 
on a functionally relevant allelic variant of the vitamin K epoxide reductase gene (Nimpstch 
et al, 2009). 
 
Booth (2009) has recently suggested that one of the challenges in many observational studies 
is the inability to isolate the physiological effects of vitamin K deficiency from those of overall 
poor nutrition.  Furthermore, she suggested that since the primary source of phylloquinone is 
green leafy vegetables, as it was in the present study, any positive associations between 
vitamin K intake and skeletal outcomes may just be reflective of generally healthier diets 
(Booth, 2009). While this is certainly a limitation in the present population study, the statistical 




and BMI amongst other non-nutritional-related factors.  While the findings are based on 
analysis of a nationally representative population study, which is a key strength of the work, 
it is important to stress that, as such, causality between vitamin K nutritional status and the 
rate of bone resorption can’t be inferred.  Finally, as the UK food composition data used in 
the present study is largely based on phylloquinone content of foods (FSA, 2002), the 
contribution of MKs to total vitamin K intake and vitamin K status in Irish adults remains 
unknown.   
 
In conclusion, despite being regarded as an at-risk population group, phylloquinone intakes in 
the elderly were not any worse than younger adults and, in fact, younger adults (aged 18-35 
y) appear to be at a higher risk of inadequacy due to lower than average intakes of green 
vegetables.  Irrespective of age-group, habitual intakes of phylloquinone in a significant 
portion of Irish adults may not be adequate based on comparisons with the 2001 US AI values 
(IOM, 2001), but also in relation to maintaining bone health (Feskanich et al, 1999; Booth et 
al, 2000), a suggestion supported by the findings of the present study which showed an 
association with a biochemical marker of bone resorption. Strategies to increase 
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The drivers and motivation behind the work undertaken in this PhD thesis can be summed up 
by the following: 
 
“One in every eight Europeans has vitamin D deficiency”, according to University College 
Cork-based coordinators of the European Commission-funded ODIN vitamin D project’ 
 
“Knowing is not enough; we must apply.  Willing is not enough; we must do” 
- Goethe 
 
Thus, the main objectives in relation to vitamin D in this thesis were to address key knowledge 
gaps in terms of:  
 calcium and vitamin D interactions in the body and how these may influence dietary 
vitamin D requirements;  
 devising creative food-based solutions (particularly, bio-fortification approaches) for 
the prevention of vitamin D deficiency that are sustainable and effective;  
 
Separately, in light of ongoing international concern in relation to vitamin K status of many 
population groups, an additional main objective of the thesis was: 
 to gain some perspective on vitamin K nutritive status in a nationally representative 
sample of Irish adults.  
 
To achieve these objectives, we aimed to elucidate the relationship between habitual calcium 
intakes and the dietary vitamin D requirement through a combination of post-hoc analysis of 
our previous placebo-controlled, dose-related, vitamin D RCTs (randomised controlled trials) 
(Cashman et al, 2008; Cashman et al, 2009; Cashman et al, 2011a), perform an update of our 
previous meta–analysis (Cashman et al, 2011b), and then ultimately conduct a de novo, 
specifically designed, RCT of potential vitamin D – calcium interaction, which was informed 
by the post-hoc analysis.  Following this, in an effort to inform options for the modification 
of the current food supply to deliver an increased content of vitamin D, several animal feeding 
trials were conducted to determine the feasibility of bio-fortification of animal-based foods 
with vitamin D, followed by consumer acceptability trials of resulting produce, and, finally a 
specific food-based intervention in free-living adults to assess the effectiveness of bio-fortified 
eggs (as an exemplar vitamin D-biofortified food) in terms of protecting serum 25(OH)D in 
winter. 
 
In a separate piece of work to gain a better understanding of vitamin K’s role in health and 




serum carboxylated and undercarboxylated osteocalcin concentrations, as measures of vitamin 
K status, in the National Adult Nutrition Survey (NANS) in Ireland, as a nationally 
representative sample.  The association of vitamin K intake and status with a marker of bone 
turnover was also assessed to explore vitamin K-bone health relations in this population 
sample.  
 
Overall, these objectives were met and the following sections will contextualize and 
summarize the key findings of the thesis, and highlight their relevance to potential stake-
holders as well as possessing their own academic merit. 
Dietary vitamin D requirements 
 
There has been increased interest in the area of vitamin D in the last fifteen years that has 
prompted several regulatory bodies to re-evaluate their Dietary Reference Intakes (DRI) and 
Dietary Reference Values (DRV) for vitamin D (Cashman, 2015). As outlined in Chapter 2 of 
this thesis, these recommendations are extremely important tools in the development of public 
health policy to address the clearly evident and worrisome prevalence of vitamin D deficiency 
in the population.  DRV/DRI reports have highlighted key knowledge gaps, which they 
identified in the respective processes that need to be addressed not only to inform and enhance 
the next iteration of vitamin D requirement estimates, but also in order to ultimately produce 
an effective and sustainable policy that will promote adequate intakes of vitamin D in the 
population.  In this regard, a key knowledge gap identified by the Institute of Medicine (IOM) 
in their 2011 report on calcium and vitamin D, and by ourselves in light of the close interaction 
of these two nutrients (Cashman & Kiely, 2011) was a better understanding of the influence 
of habitual dietary calcium intakes on the regulation and catabolism of serum 25(OH)D.  
 
The vitamin D DRI established by the IOM in 2011, as per convention, was based on the 
assumption that the requirement for dietary calcium was being achieved (IOM, 2011), 
however their report highlighted the potential for inadequate calcium intakes to cause changes 
in the efficient handling of, or physiological response to, vitamin D that might not otherwise 
be present. Considering a significant portion of adult populations in Europe and North 
America fail to meet respective dietary calcium requirements (Flynn et al, 2009; IOM, 2011; 
IUNA, 2011), and that both the 2010 and 2015 Dietary Guidelines Advisory Committee in the 
US identified four nutrients of public health concern with calcium (and vitamin D) being one 
of them, clarification of whether inadequate intakes of calcium increase the dietary 
requirement for vitamin D was of significant importance from a public health perspective, 




in devising preventative strategies for vitamin D deficiency. In the UK, the Department of 
Health commissioned a research project to address this key knowledge gap, so as to inform its 
ongoing re-evaluation of vitamin D DRV, but also the associated risk management options 
that may stem from that (e.g. vitamin D supplementation and fortification). The Vitamin D 
Research Group at University College Cork successfully competed for this commissioned 
research and the work conducted formed the basis of my Chapter 3 in the present thesis. We 
aimed to clarify the inter-relationship of calcium and vitamin D in the body in terms of an 
influence on dietary vitamin D requirements using a three-pronged approach:  
 
Firstly, post hoc analysis of data from four placebo-controlled, dose-related, individual 
vitamin D RCTs (Cashman et al, 2008; Cashman et al, 2009; Cashman et al, 2011a) suggested 
very little, if any, effect of habitual calcium intake on the response of serum 25(OH)D to 
vitamin D intake (and thus vitamin D requirements). However, it is important to note, that 
none of the four previously-published vitamin D RCTs were specifically designed to 
investigate to impact of dietary calcium level and accordingly had relatively small numbers of 
subjects with calcium intakes below the lower cut-offs of 550 mg/d [EU Estimated Average 
Requirement (EAR)] and 700 mg/d [UK Reference Nutrient Intake (RNI)] (Department of 
Health, 1991; Scientific Committee on Foods, 1993), which are important public health-
related intakes. This was an important limitation in terms of drawing conclusions on the impact 
of dietary calcium on response of serum 25(OH)D and thus dietary requirement estimates for 
vitamin D.  
 
As an additional approach which favoured inclusion of a wider collection of studies, our 
update of our previous meta-regression approach (Cashman et al, 2011b) using data from a 
mix of winter-based RCTs in children (n 2 RCTs), adults (up to 50 y; n 4 RCTs) and older 
adults (>50 y; n 5 RCTs) suggested an interaction between the response of winter serum 
25(OH)D to total vitamin D and dietary calcium category (i.e., group mean above or below a 
threshold of 1092 mg/d). Using a target serum 25(OH)D of 50 nmol/L (which the IOM suggest 
covers the needs of 97.5% of the population in terms of bone health), then those with a higher 
mean calcium intakes (≥1092 mg/d) required a lower vitamin D intake compared to those with 
lower mean intakes (<1092 mg/d). It is important to stress that the 1092 mg/d cut-off was a 
median of group mean calcium intakes and thus reflected more a delineation of high calcium 
intake from lower intake. It is possible that the significant interaction in this meta-regression 
approach may be related to the relatively unadjusted analysis. In the analysis of the four 
previous vitamin D RCTs some of the significant differences in response of serum 25(OH)D 
to different doses of vitamin D, especially in 64+ year olds became non-significant when 
adjusted for smoking, BMI, age and gender. Data on possible confounding variables were not 




such that they couldnot be included. Overall, the ambiguity in the resulting data from this 1st 
prong of our investigation, reinforced the need for a de novo RCT that was specifically 
designed to address the hypothesis that calcium intake modifies vitamin D requirement (this 
formed the 2nd prong of our approach).   
 
For this 2nd prong, we conducted a 15-week, winter-based, vitamin D3 intervention study in 
125 apparently healthy, free-living, white adults (aged ≥50 y) at a latitude of 51oN that 
examined the potential interactions of dietary calcium intake on both the decline of serum 
25(OH)D over winter whilst on a habitual inadequate vitamin D intake, as well as, on the 
response of serum 25(OH)D to an intake aimed at achieving at least the IOM suggested ‘RDA-
like’ 25(OH)D concentration of 50 nmol/L (IOM, 2011). Recent dietary requirement estimates 
for vitamin D from both sides of the Atlantic have prioritized winter-time as a critical period 
during which intakes of vitamin D should maintain serum 25(OH)D concentrations above 
chosen cut-offs (IOM, 2011; German Nutrition Society, 2012; Nordic Nutrition 
Recommendations, 2012; SACN, 2016; EFSA, 2016). A key finding of this RCT was that the 
responses in serum 25(OH)D concentrations throughout winter, as well as indices of vitamin 
D activation and catabolism as potential explanatory variables, were similar in older adults 
irrespective of whether they were on relatively low (<550/700 mg/d) or high habitual 
(>1000/1200 mg/d) calcium intakes. Further to this, and as the 3rd and final prong of our 
approach, we analysed a subset of bio-banked sera from the NANS in Ireland for serum 
24,25(OH)2D, the first metabolite produced in the pathway of vitamin D catabolism.  Using 
existing data from the survey (NANS, 2011), we identified participants within the survey with 
highest and lowest calcium intakes, and high and low vitamin D status, and measured serum 
24,25(OH)2D in this subset.  This analysis showed a lack of association between calcium 
intake and serum 24,25(OH)2D in adults aged 18-84 years; which further supports the findings 
of the our de novo RCT (Cashman et al, 2014a).  
 
Collectively, these new data from Chapter 3 suggest that recently proposed dietary 
requirement estimates for vitamin D in North America (IOM, 2011) and subsequently in a 
number of European member states (German Nutrition Society, 2012; Nordic Nutrition 
Recommendations, 2012; Health Council of the Netherlands, 2013; SACN 2016; EFSA 2016) 
will ensure the adequacy of serum 25(OH)D concentrations in older adults even when the 
calcium intakes of these adults are in the inadequate range (<700 mg/d, and even <550 mg/d).  
These findings will be of interest to the North American IOM in relation to filling one of its 
identified key knowledge gaps from their DRI and re-evaluations exercise (IOM, 2011).  The 





Beyond their direct relevance to agencies briefed with development of DRI/DRV, these 
findings also are important from a policy perspective in terms of devising preventative 
strategies for vitamin D deficiency. Strategies for bridging the gap between these new vitamin 
D requirement estimates and current intake of vitamin D in the UK, Ireland, US and elsewhere 
will not be dependent on habitual calcium intakes, at least for those with intakes >550 mg/d, 
which is reflective of habitual calcium intakes in the vast majority of Irish and UK adults [87% 
of Irish adults have habitual calcium intakes > 550 mg/d; (NANS, 2011)] The data will inform 
Irish and UK government, as well as European, policy on vitamin D supplementation and 
fortification of foods. Foods considered for fortification will not necessarily be required to 
also contain calcium (e.g. dairy produce), which will aid wider distribution of vitamin D 
throughout the food supply and accommodate diversity in the diet. Overall,these data helps 
contribute to a sound scientific basis for development of nutrition policy and programmes for 
ensuring adequate vitamin D status in the population. 
 
As mentioned above, and outlined in detail in Chapter 2, DRI and DRV for vitamin D are 
important from a public health point of view, as they are designed by authoritative agencies 
to prevent vitamin D deficiency in the population and thus are the targets at which we aim our 
food-based solutions. The low dietary vitamin D intakes in European populations, as outlined 
comprehensively by Vinas et al. (2011), highlight the fact that the current food supply (even 
including current food fortification and vitamin D supplementation practices) does not provide 
enough to prevent wide scale low vitamin D status in Europe (Cashman et al. 2016). Recent 
reports from Canada and the US have also suggested that the current food supply is unable to 
provide sufficient protection against vitamin D deficiency (Calvo & Whiting, 2013). Thus, 
there is a pressing need for creative food-based solutions to increase the distribution of vitamin 
D intakes for prevention of vitamin D deficiency and maintenance of nutritional adequacy. 
However, persistent knowledge gaps hinder development and implementation of safe and 
effective food-based approaches to vitamin D deficiency (Kiely & Cashman, 2015). The work 
as outlined in Chapters 4 and 5 in this thesis aimed to address some of these gaps in terms of 
biofortification of eggs, pork and beef with vitamin D to improve the total vitamin D activity 
and to provide evidence of the effectiveness of vitamin D biofortified eggs, as one exemplar, 




Vitamin D biofortification of eggs, pork and beef  
 
Biofortification of food with vitamin D is a novel approach aimed at improving the dietary 
availability of vitamin D from the current food supply and by that means, increasing the 
distribution of vitamin D intakes in the population. Chapter 4 in the present work focuses on 
the biofortification of animal produce, such as eggs, pork and beef, with vitamin D (as vitamin 
D3 and/or 25-hydroxyvitamin D3).  Previous research in this area was primarily focused on the 
impact of additional vitamin D on the welfare of the animal itself or the quality of its resulting 
animal produce (e.g., eggs and meat). Nevertheless, these older animal trials provided data on 
the potential of biofortification to increase the vitamin D content of the food supply.  The 
difficulty with the evidence-base, however, was that the majority of these studies in hens, pigs 
or cattle included levels of vitamin D and/or HyD® (as commercially available 25-
hydroxyvitamin D) in the feed which exceed the EU allowable maximum levels for use in 
respective feeds.  Thus, the primary aim of the current research was to use levels of additional 
vitamin D and/or HyD® (where permissible) in the diets of hens, pigs and beef heifers that 
adhered to EU regulations, so as to provide key quantitative data on vitamin D content and 
total activity of the resulting foodstuffs, as well as new data on the sensory acceptability of 
these vitamin D biofortified foods.  These are key data underpinning the development of bio-
fortified foods suitable for human consumption. 
 
In relation to vitamin D biofortification of eggs, we had three key research questions: 
 
1. Using levels of addition of vitamin D and/or HyD® in the feed which did not exceed 
the EU allowable maximum levels for use in laying hen feed (equivalent to 3000 
IU/kg feed; EFSA, 2009, EFSA, 2012), what increases in the content of vitamin D3 
and 25-hydroxyvitamin D3 and in total vitamin D activity in the resulting eggs were 
possible?   
 
2. Did these vitamin D biofortified eggs have a good consumer acceptability profile?  
 
3. What was the impact of consumption of seven of these vitamin D biofortified eggs 
weekly on vitamin D status of older adults during two months of winter? 
 
Importantly, as outlined in Chapter 4, the findings of our hen-feeding trials suggest that the 
addition of vitamin D and/or HyD® at levels that adhere to the EU maximum allowable levels 
can increase the total vitamin D activity of an egg to ~5 µg/whole egg (or half that of the 
IOM’s EAR of 10 µg/d).  Consumer taste panel trials confirmed that these vitamin D 
biofortified eggs had full consumer acceptability and no deterioration in any sensory 




that consumption of seven of these vitamin D biofortified eggs per week, which does not 
conflict with healthy eating guidelines, helped to maintain serum 25(OH)D concentrations 
over winter months, and prevented the occurrence of vitamin D deficiency, as evidenced in a 
control group who consumed up to 2 commercial eggs per week.   
 
In countries that do not implement mandatory fortification of milk, meat (such as pork and 
beef) can be a significant source of vitamin D in the diet (Hill et al, 2008). Importantly, pork 
and beef naturally contain small amounts of 25-hydroxyvitamin D in addition to vitamin D, 
which contribute to their overall total vitamin D activity. The current work (Chapter 4) has 
shown that the total vitamin D activity of these meats can be increased following 
biofortification with vitamin D and/or HyD®  (where permissible) at levels that adhere to EU 
regulations.  The total vitamin D activity of lean pork meat appears to be in the range 1.0 to 
2.9 g/170 g meat (which is an average serving size) based on data from the present work and 
that from another study of pigs by Burild et al. (2016).  In fact, the total vitamin D activity of 
less lean pork products could be even higher, as Burild et al. (2016) have shown that the total 
vitamin D activity of fat from animals fed HyD® or vitamin D3 (2000 IU/kg feed) was 24.0 
and 17.7 g/kg, respectively.  In addition, the total vitamin D activity of beef (rib eye) steak 
appears to be around 1.5 g/144 g meat (average serving size).  Importantly, these small to 
moderate increases made to the total vitamin D activity of pork and beef, following the 
addition of vitamin D3 and/or HyD® to animal feedstuffs, had no adverse effect on consumer 
acceptability, based on the findings of the sensory panel trials as outlined in Chapter 4.  In 
fact, there was some suggestion of the overall consumer acceptability of beef steaks being 
higher in animals receiving 2000 or 4000 IU vitamin D3/kg diet compared to no addition to 
the feed.  This has implications potentially for vitamin D content of beef from entirely grass-
feed animals versus those who receive a finishing diet containing vitamin D in the mix.  
 
Overall, this work adds to the evidence-base that vitamin D biofortified eggs and meats can 
be produced with enhanced vitamin D content and also maintain consumer acceptability.  The 
new data on the impact of vitamin D biofortified eggs on vitamin D status in particular has 
public health relevance in light of the percentage of the population with vitamin D deficiency 
in winter (Cashman et al, 2013), but also as one in two adults are reported to include eggs or 




Determination of vitamin D and 25-hydroxyvitamin D in foods: importance to 
public health nutrition and also methodological issues to be aware of for future 
work 
 
It is important to stress that the calculation of total vitamin D activity of the eggs and meat in 
the present work in this thesis applies a conversion factor of 5 for 25-hydroxyvitamin D, based 
on RCT data presented by us previously (Cashman et al, 2012) and is that used in several Food 
Composition tables, including the McCance & Widdownson’s The Composition of Foods in 
the UK (FSA, 2008; Zurich, 2010; Saxholt et al, 2008).  For example, this underpinned our 
estimates that the Vitamin D3-eggs and HyD®-eggs groups in our RCT in Chapter 5 received 
an additional 3.5 and 4.5g/d of vitamin D, respectively, which together with the their 
habitual dietary vitamin D yielded a mean daily intake of ~10g/d.  There is ongoing 
discussion on whether this factor 5 may be used in the calculation of total vitamin D for 
nutrition labeling of foods, and may differ country by country.  Nevertheless, Chapter 5 in the 
present work again highlighted the potential underestimation of vitamin D intake in estimates 
from countries where the contribution of 25-hydroxyvitamin D to total vitamin D content of 
animal-based foods is not accounted for in the food compositional tables.  For example, the 
current USDA National Nutrient Database for Standard Reference suggests the vitamin D 
content of 100 g raw egg is 2 g, an estimate which does not include 25-hydroxyvitamin D.  
Accordingly, vitamin D intake estimates from NHANES in the US do not account for the 
contribution of 25-hydroxyvitamin D (Fulgoni et al, 2011).  Importantly, Taylor et al. (2014) 
recently performed some modelling to include overall food-derived 25-hydroxyvitamin D in 
intake estimates for US adults, which showed that there was a potentially meaningful increase 
(1.7-2.9 μg or 15-30% of the EAR) in vitamin D intake estimates.   
 
The issue of assessment of vitamin D, and its metabolites, in foods is an important one overall.  
As mentioned in Chapter 2, evidence of effectiveness of food fortification (including 
biofortification) approaches from RCTs which evaluate their impact on reducing the 
prevalence of vitamin D deficiency in the populations studied is a key priority, but also dietary 
modelling analysis based on data from nationally representative dietary surveys can provide 
in silico projections of how these food interventions may impact on the degree of vitamin D 
intake inadequacy in the population (Cashman & Kiely, 2011).  Such dietary modelling 
whichassesses the risk of inadequate or excessive intakes of vitamin D in the population, is 
reliant on accurate and up-to-date food composition data. It is difficult for the various food 
composition databases to consistently provide accurate information as regards the provision 




innovative strategies, such as biofortification. However, the food composition databases do 
not have a standardised approach to reporting vitamin D compounds, in particular 25-
hydroxyvitamin D (Taylor et al, 2014), which should be addressed to prevent confusion 
arising.  
 
Accurate representation of the vitamin D content of the current dietary supply is further 
compounded by the lack of a standardised method for the determination of vitamin D and 25-
hydroxyvitamin D in food. It has been suggested that an accurate database is dependent on 
accurate analytic methods for food (Byrdwell et al, 2008).  The method for the measurement 
of vitamin D compounds in food is continuously being revised to optimise this time-
consuming analysis.  However, due to the nature of the method involved, a low number of 
laboratories undertake this type of analysis, and even in those that do, the between-laboratory 
variability in reported vitamin D, but even more so 25-hydroxyvitamin D, content is large.  In 
this regard, the development of control and reference materials is particularly important, as 
currently it is not possible to determine whether variability in results should be attributed to 
real differences in food composition or differences in analytical methods and skill in assay 
performance. Furthermore, it has been suggested that differences in matrix and analyte levels 
may affect the assay performance even if the same methodology is used, again highlighting 
the pressing need for use of control and reference materials across a wide range of foods 
(Byrdwell et al, 2008; Roseland et al, 2016). Importantly, a recent vitamin D round-robin 
analysis of five different foods by Roseland et al. (2016) has paved the way for the 
development of reference materials for use in food analyses and data from that study will be 
used to assign reference values for vitamin D3 and 25(OH)D3 in several NIST standard 
reference materials in the US, which will come on stream in the near future. This advancement 
will aid further research in determining amounts of vitamin D and 25(OH)D in foods (and 
supplements) to provide accurate and precise food composition data. 
How analysis of other vitamin D metabolites is of importance in informing the 
world of vitamin D nutrition 
 
In an aside to the main objective of Chapter 3, additional LC-MS/MS analysis on samples 
utilised in that work showed that serum 24,25(OH)2D may be responsible for the positive bias 
observed in some commercial immunoassays for the measurement of serum total 25(OH)D, 
relative to LC-MS/MS derived estimates of 25(OH)D. We showed that this is likely due to the 
cross-reactivity of the anti-bodies utilised in some immunoassays with serum 24,25(OH)2D. 
In addition, the research also suggests that serum 24,25(OH)2D may be potentially informative 




particularly when expressed as a molar ratio to 25(OH)D, has found favor as an index of 
vitamin D deficiency and catabolism in healthy individuals (Schoenmakers et al, 2010; 
Wagner et al, 2011; Cashman et al, 2015; Kaufmann et al, 2014), as well as in those with rare 
genetic mutations in the CYP24A1 gene (Schlingmann et al, 2011; Kaufmann et al, 2014). 
The ratio of 24,25(OH)2D to 25(OH)D may also be an indicator of response to vitamin D 
supplementation (Wagner et al, 2011) and may help to explain some of the well-documented 
inter-individual differences in response of serum 25(OH)D to the same administered dose of 
vitamin D.  DEQAS has very recently begun to collect 24,25(OH)2D data on its regular 
quarterly serum cycles from those laboratories which assess it, highlighting the growing 
interest in this serum metabolite.  The additional analysis of serum from the de novo RCT in 
Chapter 3, when combined with existing data from NANS on the serum concentration of 3-
epimer of 25(OH)D (3-epi-25(OH)D₃), showed how the concentration of 3-epi-25(OH)D₃ 
increased with vitamin D supplementation and decreased in the placebo group over winter 
(Cashman et al, 2014b), pointing towards possibility that both dietary supply and dermal 
synthesis of vitamin D₃ contribute to serum 3-epi-25(OH)D₃ concentration.  
Phylloquinone intakes and food sources in a representative sample of Irish 
adults 
In a separate piece of this PhD’s research programme, we aimed to gain some insight into 
vitamin K status in a nationally representative sample of Irish adults. As new roles for vitamin 
K emerge beyond coagulation (Booth, 2009), there is increased interest in measuring vitamin 
K status in population-based studies, particularly, nationally representative samples. In this 
regard, the present work (Chapter 6) estimated phylloquinone intakes and, in addition, for the 
first time assessed a biomarker of vitamin K status (percent undercarboxylated osteocalcin in 
serum [%ucOC]), in a representative sample of Irish adults aged 18-90 years.   Mean 
phylloquinone intakes of adults (aged 18-64 y) reported in NANS (as our most current national 
nutrition survey of adults in Ireland) at 86g/d and 83 g/d in men and women, respectively, 
were only modestly higher than those reported by us previously for Irish adults (aged 18-64 
y) in our previous survey of adults, ten years prior (84 g/d and 75 g/d in men and women, 
respectively) (Duggan et al, 2004).  The mean phylloquinone intakes of older adult men and 
women (aged 65-90 y) in NANS were 83 and 92 g/d, respectively. This is the first 
representative data of phylloquinone intakes in older Irish adults (>65 y), as the previous 
survey only included adults aged 18-64 y (Duggan et al, 2004).  The main dietary contributors 
to mean daily intake of phylloquinone intakes in the Irish diet were green vegetables (25-
33%), followed by the meat and potato group (10-18%) dependent on age group, with 





Interestingly, other studies have reported a decrease in phylloquinone intake with age, but 
especially in adults over the age of 65 years (Schurgers et al, 1999; Thane et al, 2002). 
However, in the present study, the younger adults (aged 18–35 years) had a lower mean 
phylloquinone intake than adults (either those aged 36–50 or 51-64 years) and older adults 
(65-90 years), and likewise serum %ucOC was higher in 18–35 y-olds than any of the other 
three age groups. This may be a result of the distribution of vegetable intakes being skewed 
with age as previously reported by O’Brien et al. (2003).   
 
It has been over a decade and a half since the IOM (2001) has considered vitamin K 
requirements and established AI values based on representative dietary intake data from 
healthy individuals in the US.  An ongoing limitation in terms of assessing the degree of 
vitamin K inadequacy within the population is the lack of an EAR value, as well as non-
defined thresholds for many of the biochemical markers of vitamin K status.  Without an EAR 
value, it is difficult to draw firm conclusions on the degree of inadequate intakes of vitamin K 
within the population. However, the present work suggests that only 19% and 34% of women 
and men, respectively, met or exceeded their sex-specific AI values for vitamin K and thus 
had a high probability of having adequate intakes, while the proportion with inadequate 
intakes is less certain. Over a half of the entire population of adults had intakes which were 
less that the UK and EU suggested 1 g/kg body weight per d, derived on the basis of 
coagulation (Department of Health, 1991; Scientific Committee on Foods, 1993), and in fact 
about a third and quarter of men and women, respectively, failed to meet even two-thirds of 
this recommendation.  
 
As the UK food composition data used in the present study are largely based on phylloquinone 
content of foods (FSA, 2002), the contribution of MKs to total vitamin K intake and vitamin 
K status in Irish adults remains unknown.  This is an area which may be addressed by 
collaboration with the limited number of laboratories, both in Europe and the US, who 
generate food MK compositional data and application of these data within NANS.    
 
In conclusion, Chapter 6 showed that despite being regarded as an at-risk population group, 
phylloquinone intakes in the elderly were not any worse than younger adults and, in fact, 
younger adults (aged 18-35 y) appear to be at a higher risk of inadequacy due to lower than 
average intakes of green vegetables. Irrespective of age-group, habitual intakes of 
phylloquinone in a significant portion of Irish adults may not be adequate based on 
comparisons with the 2001 US AI values (IOM, 2001), but also in relation to maintaining bone 




the present study which showed an association with a biochemical marker of bone resorption 
(serum CTx). Strategies to increase phylloquinone intakes include, increasing consumption 
levels of green vegetables, and/or food fortification. Interestingly, there are some preliminary 
data to suggest that biofortification of foods with vitamin K, akin to the vitamin D approach, 
may be feasible, and this an area of future research worth progressing.  
Concluding remarks 
In conclusion, this thesis provides key new data which will be of use to the IOM and other 
regulatory bodies in their future revisions of DRI and DRVs. In addition, considering the 
pressing need for creative food-based solution to bridge the gap between current intakes and 
these vitamin D recommendations, the present work contributes to our understanding of bio-
fortified foods, as one subset of such food-based solutions, and provides the first RCT proof 
of efficacy for bio-fortified eggs as an exemplar in protecting against low vitamin D status in 
winter. Finally, it provides informative data on current phylloquinone intakes and for the first 
time, vitamin K status, in an Irish population, which suggests the need to explore strategies to 
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